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ABSTRACT
Restoration of blood flow after myocardial infarction (MI), surgery or fibrinolytic 
therapy is necessary, but can lead to cardiomyocyte dysfunction within a generalised 
condition commonly known as “reperfusion injury”. The role of cyclophilins, heat 
shock proteins (HSP), and the mitochondrial chaperone complex (MCC), was studied in 
this pathological condition.
In vitro and in vivo models were used to replicate conditions of ischaemia / reperfusion 
(IR) injury. H9c2 and COS-7 cell lines were employed in nitric oxide (NO) donor and 
transfection applications. Experimental protocols were used to determine mitochondrial 
membrane potential (A\|/ra), mitochondrial morphology, protein expression, enzyme 
activity and cell damage in these models.
No difference was observed in activity or expression in cyclophilin or expression of the 
MCC in any of the models. It was noted that in the in vitro model, cell death was 
predominantly necrotic with only a minority of cells undergoing apoptosis, and as the 
degree of ischaemia increased cell death was 100% necrotic. The NO donor afforded 
protection against lethal ischaemia in H9c2 cells, but there was no detectable increase in 
expression of any HSP’s. Transfection of cyclophilin-D (CyP-D, CyP3) into COS-7 cell 
lines demonstrated no changes in any tested parameters. Both subsarcolemmal (SSM) 
and interfibrillar (IFM) mitochondrial A\j/m decreased in all experimental groups, which 
were reperfused after ischaemia. More importantly SSM A\j/m decreased to a greater 
extent than IFM Avj/m, therefore demonstrating a greater sensitization to IR.
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CHAPTER 1
1. INTRODUCTION TO CARDIOVASCULAR 
DISEASE
1.1 History of Cardiovascular Disease
Cardiovascular disease (CD) is a number one killer of both men and women in all ethnic 
groups in the UK and USA. This has been the situation since the 20th century. Before 
the 1900’s very few people died of CD, because of poor hygiene many people died of 
infectious diseases such as: dysentery, cholera, typhoid, polio, plague and tuberculosis. 
(Although some of these infections may have resulted in some form of cardiovascular 
disease). 1 This was before the advent of the industrial revolution, when most people 
made their living through some sort of manual labour. The main form of transportation 
was walking, people washed their own clothes and many chores were carried out by 
hand. With the arrival of automation many of these tasks were taken over by machinery 
and therefore physical activity became unnecessary. Along with the change in lifestyle 
also came a change in diet, as high fat treats were easier to produce, which in all, made 
people more prone towards cardiovascular disease. Heart disease was rising so 
dramatically that it became commonplace especially during 1940 and 1967, which led 
to the World Health Organization describing it as one of the world’s most serious 
epidemics.
1.2 Risk factors for Cardiovascular Disease
High levels of low-density lipoprotein (LDL) cholesterol and reduction in the levels of 
high-density lipoprotein (HDL) cholesterol are known to be risk factors in the 
development of heart disease. HDL is known as “good cholesterol” because it helps to 
remove “bad cholesterol” (LDL) from the blood and prevents it clogging up the arteries,
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therefore reducing the risk of arteriosclerosis. Hypertension (high blood pressure) 
predisposes to left ventricular hypertrophy (LVH). LVH is described as the increase in 
the size of the individual muscle cells, generally visualised as thickening of the wall of 
the ventricle. Studies have revealed that LVH seriously increases the risk of 
cardiovascular disease. It is considered to be a greater risk factor than cigarette 
smoking or hypertension. Patients with diabetes mellitus often demonstrate a four-fold 
increase in propensity to suffer from a vascular disease than a non-diabetes patient and 
commonly show symptoms at a much younger age. The greater prevalence of obesity in 
the United States correlates with the increased risk to heart disease faced by Americans 
than other populations in the Western world. The increased morbidity due to obesity is 
mediated through metabolic consequences such as decreased HDL cholesterol and 
hypertension, but one of the most potent risk factors is visceral adipose tissue, which 
can be determined by waist circumference.
Nowadays there are many diagnostic modalities to help us identify the development of 
CD. These are positron emission tomography (PET), magnetic resonance imaging and 
electrocardiogram (ECG), which can be used to determine the viability of myocardial 
tissue and help the clinician to determine the optimum procedure to be used.
So what is CD? To explain what this is, it is better to explain the normal function of the 
heart (Figure 1-1). The heart is a small muscular organ located in the centre of the chest, 
which is composed of four chambers. From the upper chambers (atria), deoxygenated 
blood is carried from the venae cava to the right atrium of the heart into the lower 
chambers called ventricles, which with every heart beat pumps blood via the pulmonary 
artery (blue vessel) to the lungs. There the blood gets rid of its load of CO2 and is 
replenished with oxygen. This oxygenated blood then enters the left atrium (red vessels) 
via the pulmonary vein and into the left ventricle whence it is pumped to all parts of the 
body via the aorta, which normally takes around a minute before the cycle continues 
again. A built in pacemaker called the sinoarterial node controls this cycle. The 
pacemaker functions by generating electrical signals that spread throughout the 
myocardium, triggering the heart to pump blood out.
18
Normal Heart
Figure 1-1. Diagram of the heart.
*LV:left ventricle, RV: right ventricle, LA: left atrium, RA: right atrium, LA: left 
atrium, AS: atrial septum, VS: ventricular 1 septum, l:tricuspid valve, 2:pulmonary 
valve, 3:mitral valve, 4:Aortic valve, Ao:aorta, PA:pulmonary artery, SVC:superior 
vena cava, I VC: inferior vena cava
*Diagram taken from Royal Children’s Hospital, website (www.rch.unimelb.edu.au/)
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1.3 Heart Disease
This is a broad term referring to many types of cardiovascular disorders, which come 
under the umbrella term heart disease. The heart like any other muscle requires a 
continuous supply of oxygen and nutrients, which is transported to the heart by blood in 
the coronary arteries. This is prevented in the condition called atherosclerosis.
1.3.1 A therosclerosis
This is a disease, which leads to the formation of fibrous plaques (fatty deposits) on the 
inner surface of artery walls that along with the proliferation of smooth muscle cells and 
accumulation of lipids, results in occlusion of the artery. When atherosclerosis is severe 
(>60%), there is a major reduction in the supply of oxygenated blood to the heart. This 
results in symptoms characterized by severe chest pain called angina.
1.3.2 Angina Pectoris
Angina pectoris “angina” is best described as recurring pain localised to the chest area. 
This occurs when the blood supply to the heart is restricted such as in atherosclerosis. 
Angina occurs during emotional stress, consumption of alcohol and physical exercise. 
These are common triggers for angina because they are conditions where the heart 
demands a greater supply of blood. Angina is symptomatic of coronary heart disease 
and if left untreated, will soon result in myocardial infarction.
1.3.3 Hypertension
Hypertension or “high blood pressure” often called the “silent killer” because by the 
time people find they have this condition, it is often too late. The reason for this is that
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the symptoms are not easily detectable and consequently most people who have this 
condition are quite unaware.
With each heartbeat, blood pressure is generated by blood being forced through the 
small constricting blood vessels of the circulatory system and in this manner oxygen, 
nutrients and other materials are supplied to the cells. As the demand for these nutrients 
changes, the circulatory system responds by constricting or dilating the arteries, which 
alters the blood pressure and therefore the speed at which the blood travels. In some 
people these arteries remain constricted and thereby cause the blood pressure to remain 
high. This increase in blood pressure as well as damaging the circulatory system also 
damages the brain, kidney and the eyes.
1.3.4 Myocardial Infarction
Myocardial infarction (MI) is the correct term for a heart attack. This term means that as 
a result of the lack of supply of oxygen and other nutrients to the heart cells, these cells 
die. As a clinical entity, MI has been redefined by a document produced at a conference 
by the joint European Society of Cardiology/American College of Cardiology 
Committee for redefinition of myocardial infarction as “myocardial cell death due to 
prolonged ischaemia”.
1.3.5 Current Procedures Used to Rectify Cardiovascular Conditions.
These are angioplasty as well as the use of drugs.
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1.3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA)
Balloon angioplasty or PTCA is a commonly used non-surgical procedure in blockages 
of the coronary artery. A small incision in the groin or arm is needed to insert a small 
catheter to keep the artery open. Attached to the catheter is a deflated balloon, which is 
inflated in order to compress the blockage and thereby provide an adequate passage for 
blood to flow. If successful, PTCA can reduce the risk of heart disease and may prevent 
the patient needing to undergo the more invasive coronary artery bypass surgery. This 
procedure is quite simple and may take from 20 minutes to a few hours. In arteries that 
are totally occluded, or have bends, PTCA is not recommended. PTCA may actually 
weaken the artery such that a heart attack may result and sometimes restenosis may 
occur in previously PTCA treated arteries.
If PTCA is not successful in all situations previously described or where there are 
multiple occluded arteries, then a common surgical treatment called coronary artery 
bypass surgery or grafting (CABG) is used.
1.3.7 Coronary Artery Bypass Grafting (CABG)
This procedure utilises pieces of veins or arteries from the legs, which are then 
connected to the arteries of the heart in order to bypass the blocked vessels and thus 
increase the flow of blood to the heart. This procedure lasts several hours and the patient 
is placed in intensive care immediately after the operation, probably leaving hospital 3 -  
7 days later if the procedure is successful.
In an occluded artery, an injection or intravenous drip can be used to administer a 
thrombolytic agent such as streptokinase. These thrombolytic agents boost the action of 
an enzyme called plasmin, which dissolves the clot and restores normal blood flow. 
These drugs are administered after a patient has a heart attack, which in some cases can 
be between 4 to 24 hours afterwards. Many clinical trials have now demonstrated that
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these thrombolytic drugs are most effective within 90 minutes post MI in combination 
with the use of aspirin.
There are generally four types of medications used to treat CD: anti-platelet drugs, 
nitrates, calcium channel antagonists and beta-blockers. Aspirin is a drug that interferes 
with platelet aggregation and therefore the clotting process. It makes platelets less sticky 
and thus prevents clots forming on fatty plaques, which block the artery. It is because 
of this action of thinning the blood that makes it effective in reducing a person’s risk for 
heart disease.
Nitrates in the form of nitroglycerin can give immediate relief from the pain of angina, 
when the heart muscle is not getting enough oxygen. As oxygen is supplied to the heart 
muscle via blood, then the blood supply must be increased. Nitrates such as 
nitroglycerin dilates the blood vessels and so give relieve to angina. Administration is in 
the form of an oral spray, tablet, patch or paste. Short acting nitrates last for 30 minutes 
but longer acting nitrates are available.
Other types of medication used are beta-blockers, which are able to reduce the heart rate 
by blocking cardiac p-receptors. The neuroendocrine system governs catecholamines, 
which are a group of hormones that include norepinephrine. When released into the 
blood, catecholamines increase the heart rate by acting on the p-adrenergic receptors. 
Investigators have determined that patients with chronic heart disease had increased 
norepinephrine plasma levels. These levels were normal in milder cases of the disease; 
therefore abnormally high levels are indicative of a poor prognosis.4
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1.4 Ischaemia /Reperfusion Injury
1.4.1 Cell Injury During Ischaemia
ISCHAEMIA REPERFUSION
CytosolCytosol
^RC activity ! t  Reactivity
!
iff R0S
< $ >
| |  ROS
<$>
MPTP
closed
MPTP
open
Figure 1-2. This is a schematic of the movement of ions during 
ischaemia/reperfusion.
As ischaemia ensues, adenosine triphosphate (ATP) synthesis is halted as respiratory 
chain (RC) activity slows down and ATP levels drop, inorganic phosphate levels 
increase (Pi). Anaerobic glycolysis is switched on in order to maintain the proton 
motive force (pmf) and the resultant production of lactate reduces matrix pH below ~7 
which prevents the MPTP from opening (pH paradox). During reperfusion, matrix pH 
increases, RC activity is restored and ATP synthesis continues, but sudden influx of O2 
results in increased production of ROS and therefore oxidative stress Ca2+ overload. If 
there is not sufficient ADP and ATP and antioxidants such as glutathione, then these 
conditions promote the opening of the MPTP with a concomitant decrease in 
mitochondrial membrane potential (Ai\rm) eventually resulting in inhibition of 
mitochondrial function and cell death. (Diagram from Morin and colleagues)5
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In myocardial cells, upon obstruction of blood flow, oxidative phosphorylation is unable 
to produce the energy rich adenosine 5’-triphosphate (ATP) and so these levels decrease 
and pH decreases as metabolism switches from aerobic oxidation to anaerobic 
glycolysis producing lactic acid (Figure 1-2). This is quickly followed by a reduction in 
contractile force, as the energy-dependent pumps in the cellular membranes are 
impaired. In an attempt to restore the pH, the Na+/H+ antiporter is activated and as ATP 
levels are low and the Na/KATPase is inhibited which, with the increase of cytosolic 
Na+, the Na+/H+ antiporter does not pump Na+ out. This results in an increase in the 
level of Ca2+ as the Na+/Ca+ antiporter is inhibited and as a consequence, does not pump 
Ca2+ out resulting in a decrease in Ai|/m. The increased Ca2+ intracellular levels result in 
the release of enzymes such as protease, phospholipases and nucleases, which, 
depending on the duration of ischaemia may cause permanent damage to tissue. 
Mitochondrial respiration decreases and as a result of adenine nucleotide catabolism, 
hypoxanthine accumulates which will become toxic upon the re-introduction of blood 
flow. At this point damage is reversible if the blood flow is re-established but, if 
ischaemia progresses, then cardiomyocyte membrane integrity is reduced, thereby 
resulting in ultrastructural changes and cell death is inevitable. Usually it takes about 15
0  fkminutes of myocardial ischaemia before cell death begins to appear ’ in the 
myocardium.
1.4.2 Reperfusion
Following cardiac therapies, reperfusion of ischaemic tissue is fundamental in order to 
salvage cardiomyocytes and in some cases, damage caused by myocardial ischaemia, 
can be reversed. The patient in the condition previously described as angina may often 
experience transient periods of ischaemia, but due to immediate restoration of blood 
flow, permanent damage is not usually incurred.
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1.4.3 Reperfusion/ Injury
Although reperfusion of ischaemic tissue is necessary, it may paradoxically cause more 
harm than good especially in cases where ischaemia has been long and severe. Then 
upon reperfusion, any cardiomyocyte damage sustained during the preceding ischaemia 
is exacerbated, resulting in a predisposition to a pathology of conditions called 
ischaemia /reperfusion (IR) injury.7
Myocardial stunning is an established manifestation of IR injury. It is defined as 
“myocardial dysfunction that persists after reperfusion despite the absence of 
irreversible damage”.8 This contractile dysfunction is completely reversible, but 
requires a long period of time before the myocardium regains total functionality. The 
use of inotropic agents helps to reverse this syndrome.
Hibernation is another manifestation of IR injury although it helps to avoid an energy
deficit, in the context of coronary heart disease, maintaining myocardial integrity and
viability, 9 and is defined as “ a form of prolonged contractile dysfunction associated
with ongoing low blood flow”.10 It is thought that hibernation may represent chronic
stunning, as repeated ischaemic episodes causes prolonged myocardial stunning which
lasts longer than the stunning exhibited after a single ischaemic bout.11 Some authors
suggest from their experimental data in humans, that different biochemical mechanisms
1 0are involved in the pathophysiology of stunning and hibernation. However, it has been
1 %demonstrated in pigs, that repetitive stunning induces myocardial hibernation. 
Myocardial hibernation and chronic stunning would seem to be phenomenona that are 
very similar; however in the former case, blood flow is reduced, and in the latter, blood 
flow is normal.11 Clinical evidence has lead to speculation, that hibernation is an 
adaptation process, because in times of reduced coronary flow and energy availability, 
reduction in contractile activity is an appropriate response. Ultrastructurally de­
differentiation changes have been observed leading to the postulation that this is a 
degenerative process. 14 Little is known about myocardial stunning and less about 
hibernation. However, it is believed that the key players in the pathogenesis of 
myocardial stunning are reactive oxygen species (ROS) and Ca2+. 6,11,15 In view of this,
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during the 1980’s two hypotheses were proposed which are the oxyradical hypothesis 
and the calcium hypothesis. The first postulates that ROS is involved whilst the calcium 
hypothesis postulates that disruption of Ca2+ homeostasis is a causative factor in 
myocardial stunning. Both are related to each other so their separate roles cannot be 
clearly defined in the pathophysiological process of myocardial stunning. 11,16
1.4.4 ROS and Ca2+ as the Main Mediators o f IR Damage
ROS may be oxygen-centered radicals that contain one, or more unpaired electrons, for 
example, superoxide anions (O2’) and hydroxyl radicals (OH') or covalent molecules 
such as hydrogen peroxide (H2O2) and hypochlorous acid (HOC1). Some ROS, as they 
contain unpaired electrons, are better described, as free radicals of which O2’ and OH' 
are good examples. 17,18 These ROS cause oxidative stress, occurring as the generation 
of ROS increases, overwhelming endogenous antioxidant defence mechanisms leading 
to the oxidation of biological molecules. Examples include deoxyribonucleic acid 
modification and the more common lipid peroxidation damage of polyunsaturated fatty 
acid contained in cell membranes. 19,20 ROS can also stimulate leukocyte activation, 
leukocyte adhesion molecules and cytokine gene expression.8
The main sources of ROS are hypoxanthine and the mitochondrial respiratory chain. An 
enzyme xanthine oxidase converts hypoxanthine to xanthine in the presence of oxygen, 
producing oxygen free radicals as a by-product of this reaction. Generally in non- 
ischaemic cells, hypoxanthine is converted to uric acid by xanthine dehydrogenase, a 
reaction that does not produce ROS. During ischaemia, increased Ca2+ concentrations 
initiate the conversion of xanthine dehydrogenase to the oxidase form, xanthine oxidase. 
16 In the other source of ROS (mitochondrial respiratory chain), the respiratory chain is 
inhibited by the lack of oxygen and consequently ubiquinone is reduced to 
ubisemiquinone. This upon reperfusion transfers an electron to molecular oxygen to 
produce H2O2 which is toxic, but is not a free radical; however, in the presence of heavy 
metals (Fe2+ or Cu2+) it is converted into the more toxic OH' species. 8’17)I9>21 
Reperfusion also serves to attract and activate neutrophils that also produce O2' free
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radicals through the membrane bound NADPH oxidase system thereby causing further 
oxidative injury. 6,17
The superoxide ion (O2") is a weak oxidising agent and is incapable of peroxidising 
membrane lipids. The injury that occurs is dependent on more powerful oxidising 
agents such as OH'. Generally in the presence of H2O2 and superoxide generating 
systems, the Haber -Weiss equation, produces O H -.17
0 2' + H20 2  ► OH' + OH' + 0 2
Equation 1-1. Haber-Weiss
Without a catalyst this reaction proceeds too slowly; however, in the presence of 
transition metals, the reaction speeds up. During ischaemia as the pH drops, iron (Fe) 
attached to an Fe carrier protein in plasma (transferrin), starts to dissociate making it 
available for catalysing formation of OH' in the Fenton reaction. Fe2+ is deemed to be 
the most significant metal catalyst in physiological systems.17
Fe3+ + 0 2'  ► Fe2+ + 0 2
20 2" + 2H+---------------------------► H20 2 + 0 2
Fe2+ + H20 2  ► Fe3+ + OH* + OH'
Equation 1-2. Fenton reaction
In this reaction Fe is acting as a redox agent and accepts an electron from oxygen in 
the manner of a Fenton catalyst.
Many investigators have demonstrated that oxidative stress increases upon reperfusion. 
The ROS species identified include H2O2, O2', OH' and peroxynitrate. This manifests 
itself in the heart as arrhythmias, loss of adrenergic pathways, changes in gene 
expression and a reduction in contractile function. These clinical results have been
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paralleled with experimental systems containing ROS generating substances. The
99increase of ROS during ischaemia remains controversial. Vanden Hoek and 
colleagues observed that significant amounts of O2 ' and H2O2 were generated during 
ischaemia as well as during reperfusion. 22
Increased intracellular Ca2+ levels are associated with IR induced cardiomyocyte
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damage. It is now widely accepted that the balance between influx and efflux of Ca 
across the mitochondrial inner membrane regulates mitochondrial dehydrogenases, 
which are rate-limiting for citric acid cycle metabolism. 23 In short, when cell activity 
leads to a substantial or excessive rise in Ca2+, the mitochondria may accumulate large 
amounts of calcium24 This is due to the uniporter carrying calcium into the 
mitochondrion along the electrochemical gradient, which has a much higher total 
activity than the export pathways, which encompass Na+- Ca2+ exchange. This basically
means that if the net influx of Ca2+ exceeds the capacity of the extrusion pathway
^ 2 +  7 +
through Na - Ca exchange, intramitochondrial Ca concentration increases, and Ca
will be sequestered within the mitochondria. This is detrimental to the mitochondrion
and may lead to the formation of a large conductance pore called the mitochondrial
permeability transition pore (MPTP).25 MPTP formation results in cessation of
mitochondrial function which is an underlying cause of necrotic and apoptotic cell
death. 26-29 However, it is believed that the MPTP may participate as a Ca2+ release
channel when calcium overload occurs. 24 The increased Ca2+ encourages the production
of O2' and this in combination with the available Fe drives the Fenton chemistry
production of OH*. 19 The increasing levels of Ca2+ also result in activation of calcium-
dependent proteases leading to myofibril proteolysis. 6
Mitochondria as well as being one of the main sites of ATP synthesis, is also one of the 
main production sites and targets of oxidative damage. With ROS species emanating 
from the respiratory chain of the mitochondria, as part of normal cell respiration. ’ In 
mitochondria, organic compounds are oxidised by atmospheric oxygen to CO2 and H2O 
32(Figure 1-3) and the energy produced is stored as ATP (Figure 1-3). Oxidation of 
NADH supplies electrons to complex I of the respiratory chain which reduces a
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membrane associated ubiquinonol/ubqinone (UQH2/UQ) pool via complex II. 
Oxidation of flavin-linked dehydrogenases reduce UQH2/UQ as they do not posses a 
negative enough redox potential to enter complex I. Electrons are transferred from 
ubiquinol to complex III and then to cytochrome C (Cyt C), which in turn reduces 
complex IV (cytochrome oxidase). From complex IV, 4 electrons are transferred to 
molecular oxygen. In this circuit, the complexes I, III and IV are essentially acting as 
proton pumps in respect to the electron flux. As the electrons pass through these 
complexes the redox potential decrease is used to generate a proton electrochemical 
potential gradient (Ajih+), which is generally expressed in electrical potential units as 
(Ap) the proton motive force (pmf) and is represented by the following equation.
Ap (mv) = A\i/m -  (2.3/? 77F) ApH (At 37oC Ap = Ai|/m - 60ApH)
Equation 1-3. Generation of the proton motive force (pmf)
ApH = pH gradient across the inner membrane where a positive value is indicative of an 
acidic matrix.
R, T and F refer to the gas constant, absolute temperature and the Faraday constant
As demonstrated above (Equation 1-3), the pmf is composed of the ApH and the 
mitochondrial membrane component (A\j/m) of which under most conditions Ai|/m is the 
dominant component.
30
Complex I Complex II Complex III Complex IV ATP svnthase/
MPP+ 3-NPA Antimycin A Cyanide Complex V
INHIBITORS Rotenone Malonate Myxathiazol Azide Oligomycin
4H
inner
mitochondrial
membrane
2e-
Trll
mitochondrial
matrixf a d h 2
l/2 0 2 + 21 [+ H20NADPH FAD ATP
Figure 1-3. Schematic of the chemiosmotic proton circuit.
Electrons deriving from intermediary metabolism enter the respiratory chain at 
complexes I and DL These electrons are transferred by the respiratory chain by reduction 
and oxidation of enzyme complexes to oxygen with the generation of water via a 
process linked to H+ ejection generating an electrochemical gradient known as the 
proton motive force (pmf). The generation of the pmf is then used to drive ATP 
synthesis. Also listed are the range of respiratory chain inhibitors such as rotenone, 
which by blocking electron transfer at specific sites, block respiration through the whole 
chain. This will cause hydrolysis of ATP, but at a rate such that the function of the cell 
is not compromised, as long as glycolysis is still able to maintain sufficient ATP 25,32 
Diagram adapted from review by Nicholls and Budd.32
When ATP is split into adenosine diphoshate (ADP) and inorganic phosphate (Pi), a 
large amount of energy is liberated which can be used to drive many cellular processes. 
ATP is commonly known as the universal energy carrier within the cell. The actual 
process where ADP and inorganic phosphate (Pi) form ATP from respiration is termed 
“oxidative phosphorylation”. The mechanism by which electron transfer coupled to 
ATP is synthesised during oxidative phosphorylation was not known until the 1960’s. 
Many researchers such as Chance, Slater, Lehninger and Emster performed in-depth 
pioneering work on mitochondrial research during this time, but it was Peter Mitchell 
who formulated an alternative view on the coupling of electron transfer to ATP 
synthesis. He proposed that the flow of electrons through the respiratory chain drives 
positively charged hydrogen ions or protons across the mitochondrial membranes that
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generate an electrochemical potential gradient across the membranes. This gradient is 
composed of: a difference in electric potential and a difference in hydrogen ion 
potential, or pH, which Mitchell collectively calls the “ protonmotive force”. ATP 
synthesis occurs by the reverse movement of electrons down this gradient (Figure 1-3). 
Mitchell’s proposal was called the “chemiosmotic theory” 33, that is now a fundamental 
principle in bioenergetics and resulted in him being awarded the Nobel prize for 
Chemistry in 197832>34'35
Mitochondrial energy production may also be harnessed in different ways, diverted 
form the business of ATP production into the generation of heat through the expression 
of catecholamine-regulated uncoupling proteins in brown fat in neonates and in 
hibernating mammals.36 It has also been suggested that these proteins may be evolved 
in regulating the production of free radical species. This is particularly useful in the 
scenario where electrons from the fatty acid chain are fed to the electron transport chain, 
in excess to that is which is required to produce ATP. This would then result in the 
overproduction of ROS 34 possibly leading to the pathological opening of the 
mitochondrial permeability transition pore (MPTP). Increased levels of these 
uncoupling proteins reduce ROS levels and therefore the formation of MPTP.34
Elevated levels of ROS in combination with high levels of Ca2+, adenine nucleotide
2 _|_
depletion and increased inorganic phosphate accumulation, induce opening of a Ca 
dependent reversible permeabilisation of a non-specific, high conductance pore in the 
mitochondrial inner membrane. 29,37 This pore is commonly known as the mitochondrial 
permeability transition pore (MPTP). 38,39 This process is termed mitochondrial 
permeability transition (MPT) originally described by Hunter and colleagues. 40 
Mitochondrial Ca2+ overload is not the only major causative feature of MPT, as Ca2+ 
overload alone appears to be relatively harmless since ATP concentrations remain high 
and the cell may still be viable. This situation changes with the addition of the other 
factors symptomatic of IR such as depletion of adenine nucleotides and high phosphate 
concentrations 41 Also it has been determined that ROS via oxidation of critical thiol 
groups contributes to the formation of the MPTP 42 The formation of the MPTP allows 
molecules of <1500 Daltons to travel across this channel resulting in mitochondrial
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membrane potential (Av|/m) depolarisation due to a reduction of the proton motive force 
(pmf). Therefore Aij/m is indicative of the energy status of the mitochondrion and
O')
therefore of homeostasis in general. ’ ’ The Av|/m collapses after severe exhaustion of 
glycolytic ATP and/or oxidative damage. ATP depletion occurs as oxidative 
phosphorylation breaks down and calcium overload leads to mitochondrial swelling and 
outer membrane rupture.41,44 Mitochondria control cell death pathways by determining 
whether the mode of cell death is by apoptotic or necrotic pathways. This is believed to 
be dependent on the intracellular ATP levels.45 Transient opening means that ATP 
levels may be maintained, as apoptosis is an energy requiring process resulting in the 
release of pro-apoptotic factors such as apoptosis inducing factor (AIF) and cytochrome 
c.46 It has been suggested that transient opening could imply a role for the pore in 
calcium homeostasis. 47 During extensive opening of the pore ATP production stops, 
ionic gradients cannot be maintained and with the release of degradative enzymes the 
damage becomes irreversible and therefore necrosis ensues 41,48,49 At this point 
mitochondria switch from being the major ATP producers to being the major ATP 
consumers due to the hydrolytic action of ATPase as the mitochondria struggles to 
maintain the pmf.44,48
The main protein composition of the MPTP is controversial, but it is thought to be 
composed of the voltage dependent anion channel (VDAC) found in the outer 
membrane, cyclophilin D (CyP-D) located in the matrix, adenine nucleotide translocase 
(ANT) and associated kinases such as hexokinase and creatine kinase.50 ANT is a 
specific carrier for ATP/ADP and is located in the mitochondrial inner membrane.51 The 
mechanism involved in the formation of the pore has been studied at length using 
agonists and antagonists of MPTP such as cyclosporin A, bongkrekic acid and 
carboxyatracyloside.
The ANT exists in 2 states “c” (cytoplasmic) and “m” (inner membrane) or “ high” and 
“low” affinity states. When occupied by transportable substrates, the ADP/ATP-binding 
sites are either on the c- site or m-site 49 Carboxyatracyloside when bound to the “c” 
state activates the pore whereas bongkrekic acid upon binding to the “m” state inhibits 
pore opening.41 In other words the c-state conformation is required for MPTP
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formation. The immunosuppressive drug cyclosporin A binds to CyP-D 52 and inhibits 
its binding to ANT thus preventing formation of the pore. VDAC and the ANT have 
recently been described as forming a complex, which straddles the inner and outer 
membranes,41,53 although Halestrap and colleagues 54 do not recognise the existence of 
VDAC in pore formation. They proposed that increasing Ca2+ levels causes the ANT to 
undergo a conformational change to form the pore. This process is greatly enhanced by 
the binding of CyP-D to the ANT and it’s binding increases with increasing oxidative 
stress. CyP-D possess peptidyl-prolyl cis-trans isomerase activity which when bound to 
the ANT is believed to induce a conformational change to form the MPTP.55 A previous 
study demonstrated that when ANT-1, an ANT isoform, was overexpressed, this 
resulted in apoptosis. To explain this theory a model was proposed in which normal 
circumstances ANT-1 did not form the MPTP, due to the presence of inhibitors or 
endogenous repressors of pore formation. However, upon overexpression of ANT-1 
titrated out these endogenous repressors to promote apoptosis. When CyP-D was co­
expressed it suppressed the ANT-1 induced pore.56
Griffiths and Halestrap developed a model to prove the existence of the mitochondrial 
pore opening during IR. They used [H3]-2-Deoxyglucose (DOG), which after entering 
the heart was metabolised to DOG-6-Phosphate; this, after being trapped in the cells 
will only enter the mitochondria once the pore forms. They ascertained that the pore did
f<7
not open during ischaemia but 2 minutes post reperfusion.
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1.4.5 Endogenous protection against ROS
Ischaemia/Reperfusion
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Contractile
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Apoptosis
Second line of defence
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Superoxide dismutase and catalase
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Protect against Protect against
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Figure 1-4. Ischaemia/reperfusion flow chart
Schematic diagram, detailing the main protagonists in ischaemia/ reperfusion injury and 
the manifestations of this phenomenon. Also mentioned are the various substances 
which inhibit and delay against ischaemia/reperfusion injury. (Modified from Dhalla 
and colleagues)16
The myocardium contains numerous endogenous protective systems that are activated 
upon reperfusion, such as the antioxidants. Antioxidants in the myocardium are 
substances that can delay or inhibit oxidative stress damage to carbohydrates, 
subcellular proteins, DNA and lipids. Even though the interactions and mechanisms in
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different antioxidants are not completely understood, the possibility exists for one 
antioxidant to equilibrate with another and thereby establish a redox potential such that 
all antioxidants may act simultaneously to protect against an oxidative insult.16 It has 
been speculated that by different mechanisms, antioxidants can: (1) prevent the 
production of ROS as well as scavenge them and their precursors; (2) increase 
endogenous antioxidant formation; (3) attenuate ROS production via binding to metal 
ions; and (4) induction of the anti-death gene (BC1-2) thus reducing apoptosis.16
Table 1-l.Endogenous antioxidants
A list of the major endogenous antioxidants, which are found in cardiomyocytes (taken 
from Dhalla and colleagues 2000)16
Name Site Action
Superoxide dismutase (SOD) Catalyses 0 2' dismutation to H202
Cu, Zn SOD Cytoplasm, cell 
Surface and
2 0 2 + 2H+ >  H20 2 + 0 2
Mn SOD mitochondria
Catalase Peroxisomes and 
mitochondrial membrane
H20 2 >  2H20  + 0 2
Glutathione peroxidase Cytoplasm H20 2 +2GSH >  2H20  + GSSG
Glutathione Intracellular Cellular reductant
Coenzyme Q10 Cell membrane Redox active electron
(ubiquinone) carrier
Vitamin E (a-tocopherol) Cytoplasm and Break lipid peroxidation
plasma chain and LDL reaction
P-Carotene (pro-vitamin A) Plasma Inhibits oxidation of LDL
Vitamin C (ascorbic acid) Cytoplasm and Directly as an antioxidant or
plasma as a cofactor for vitamin E
Exogenous antioxidants are drugs containing thiol compounds such as p-adrenergic
9+blockers, iron chelating agents and Ca antagonists. Examples of known endogenous 
antioxidants are shown in Table 1-1.
36
Glutathione (GSH), catalase and SOD have been extensively studied. GSH is the most 
important and is an intracellular non-protein sulphydryl antioxidant, which is depleted 
during ischaemia. Its primary role is in the maintenance of cellular proteins and lipids in 
a functional state, protecting them against the threat of oxidation. Other roles include: a) 
regeneration of ascorbate (AA) from dehydroascorbate (DHA), its oxidised form; 2) 
detoxification of hydrogen peroxide and other toxic intermediates of drug metabolism 
and lipid peroxides. Further reductions in the levels of these antioxidants increase 
oxidative stress.16
Antioxidant levels have been found to decrease to varying degrees depending on the 
severity of IR injury. Ascorbate and glutathione are hydrophilic substances whose levels 
decrease after 40 minutes of reperfusion but not following ischaemia.16 Contrary to this, 
ubiquinol 9 and vitamin E are lipophilic antioxidants and their levels are unchanged 
during IR. Moreover, the addition of H2O2 increases the severity of IR resulting in the 
depletion of vitamin E and ubiquinol 9. This suggests that ascorbate and glutathione are 
the first line of defence against IR whereas vitamin E and ubiquinol 9 are considered to 
be the second line (Figure 1.4).
Once it was recognised that ROS played a major role in reperfusion injury, attention 
turned to mechanisms to attenuate their harmful effects. This led to a widespread 
interest in antioxidant therapy.6 Classical models of ischaemia/reperfusion have given 
mixed results, due to the variety of experimental protocols. However clinical results 
have been quite disappointing according to some investigators.6
1.4.6 Heat Shock Proteins
Heat shock proteins (HSP) are synthesised when an organism is subjected to 
environmental or physiological stresses. They are classified according to their molecular 
weight in kilodaltons (kDA). These proteins are members of large multigene families,
co
which are present in all major cellular compartments.
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Stress disrupts protein homeostasis resulting in the appearance of non-native proteins, 
which if left, are prone to misfold or aggregate causing cellular damage. Heat shock 
proteins restore protein homeostasis and in this manner confer cytoprotection against 
stress-induced damage. This is one of the reasons why many HSP’s are referred to as
C O
molecular chaperones.
1.4.7 Molecular Chaperones
Molecular chaperones are proteins that assist the folding, refolding, translocation and 
transport of proteins. They provide a stable environment for non-native proteins to 
achieve the native state without the risk of misfolding or aggregating.59 One of the best 
studied is HSP70, which is upregulated in IR and its increasing expression is directly 
correlated with its cytoprotective properties.60 It has been reported to be overexpressed 
in rat myogenic cell lines and rat hearts by many scientists and found to improve 
myocardial function. ' Synthesis of heat shock proteins in response to stress is 
regulated by the heat shock transcription factor (HSF)58’64’65.
Originally the idea was proposed that in the non-stressed cell, HSF1 is attached to 
HSP70. However, upon the appearance of non-native, misfolded or aggregating 
proteins, HSF1 detaches from HSP70,65 trimerises and travels to the nucleus where it 
binds to the heat shock element (HSE) upstream of the heat shock promoter gene and 
initiates synthesis of various molecular chaperones including HSP70. New data indicate 
that HSP90 is bound to HSF1 and unbinding of HSP90 results in activation of HSF1 
leading ultimately to HSP70 synthesis.66
Newly synthesised polypeptides can fold spontaneously, or with the assistance of 
molecular chaperones such as HSP70, they fold to achieve the tertiary native form.67 
HSP70 binds to the exposed hydrophobic residues, preventing off-pathway reactions 
and transports those polypeptides destined to go to the mitochondria where its targeting 
sequence is recognised prior to the polypeptide being released and directed towards the
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general insertion pore (GIP). The non-native protein passes through the GIP and along 
the inner membrane; this translocation procedure requires the interaction between 
mitochondrial HSP70 (mHSP70/HSP75) and Tim44,68 which pulls the protein through 
and prevents it from sliding back. mHSP70 passes the protein to the chaperonin 
complex, which mediates folding to the native state. The chaperonins HSP60/HSP10, 
which are the mammalian homologues of the bacterial GroEL-GroES, are arranged in 
two rings in which the two six membered rings formed by groEL form a central cavity 
where protein folding takes place in the hydrophobic interfaces. The two ends of the 
central cavity are capped by groES.69 It has been demonstrated that simultaneous 
overexpression of both components of the chaperonin complex (HSP60/HSP10) is 
necessary for the survival of myogenic cells after IR injury.64
1.4.8 Preconditioning
Subjecting the whole heart or cardiomyocyte to an initial sublethal stress (commonly 
referred to as “pre-treatment”), is enough to enhance the tolerance of the heart or 
cardiomyocyte and render them relatively resistant to subsequent exposure to a more 
lethal stress. Using heat to precondition a cell will ensure that it is protected against 
other stresses (cross tolerance) such as UV light, heavy metals and amino acid
7 0analogues. This phenomenon is known as stress tolerance or preconditioning.
Adaptation of tissue to repeated stresses such as hypertrophy has long been appreciated, 
it was however, not commonly known that cells could revert back to their original
71phenotypic steady state. True preconditioning or ischaemic preconditioning (IPC) was
77first reported in 1986. When Murray and colleagues experimented in a dog’s heart, 
they demonstrated in this canine model that hearts subjected to 40 minutes ischaemia, 
the size of the infarct was substantially reduced in preconditioned hearts as opposed to 
non-preconditioned. The authors concluded that this phenomenon was initiated by 
ischaemia, especially as the observed protection could not be explained by increased
77blood flow through collaterals. This phenomenon was later demonstrated to occur in
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many species. There is also evidence that ischaemic preconditioning exists in several 
organs such as the central nervous system 74 skeletal muscle,75 intestine 76 and liver.77 It 
was a few years later that Yellon and colleagues suggested that it was possible to 
precondition human myocardium.
It is important to note that ischaemic preconditioning only delays the development of 
cell death. If the subsequent long lasting ischaemic period is prolonged to several hours, 
eventually all the cells will die.72,79 Furthermore, the protective effect of IPC is of 
limited duration.79 Preconditioning occurs in two protective phases, the first classical or 
early and the second delayed or late. Murray and co-workers first described the early 
phase in 1986.72 Marber and colleagues,80 who referred to it as the “second window of 
protection”, first described this phenomenon. Early preconditioning appears minutes 
after the initial stimulus, and lasts a short time, whereas delayed preconditioning 
requires longer to develop, but lasts for hours. Classical preconditioning has been 
demonstrated to protect against infarction and arrhythmias while the late stage in
O 1
addition protects against myocardial stunning. The prolonged duration of protection 
makes delayed protection a viable option in the clinical setting. Short episodes of 
occlusion of one artery can protect against a sustained period of occlusion in another 
artery, a process known as remote preconditioning.82,83 Other authors have reported on 
more intriguing examples whereby preconditioning the small intestine and kidney in 
rats afforded protection to the myocardium, and their results suggested that the 
mechanism of protection involved activation of a neurogenic pathway.84
The cellular mechanisms contributing to this endogenous protection system have been 
studied in great detail, in order to allow therapeutic induction of protection.85 Even with 
the use of many in vitro and in vivo model systems, they still remain incompletely 
resolved. It has been proposed that initiation of signalling pathways require one or 
several “triggers”, which in turn activate one or a few “mediator(s)” and eventually 
activating one or several “end-effectors” as demonstrated in Figure 1-6.79 These 
signalling pathways result in amplification of the initiating signal(s), and permit 
interaction between the different biochemical components. Pharmacological agents that 
can also mimic preconditioning, can block these intracellular pathways at certain
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steps. The classical and delayed form of preconditioning may have similar 
biochemical components, which may be activated at different times during the 
ischaemic episodes to trigger and/or mediate preconditioning thus offering differing
0*7 oo
degrees of protection. ’ One of the first major breakthroughs was the discovery that
O Q
preconditioning was receptor mediated. Numerous agonists are released during 
ischaemia in particularly adenosine from the breakdown of ATP. Administration of 
adenosine antagonists blocked the IPC response whereas an infusion of adenosine
O Q
afforded protection that was similar to IPC. Hence adenosine was recognised as 
playing a critical role in triggering IPC. Parratt and colleagues 90 proposed that 
bradykinin is a major trigger in the anti-arrhythmic effect of ischaemic preconditioning. 
However, between different species, triggers of classical preconditioning may vary, for 
example. Adenosine is not involved in preconditioning the rat heart91 but is involved in 
the IPC of rabbit and human myocardium.86 It was proposed by Goto and colleagues,92 
that in order to trigger preconditioning, a threshold must be reached. This is 
characteristic of an “all or nothing” response equivalent to that seen in synaptic nerve 
transmissions. Whereby an accumulation of impulses is achieved until the threshold is 
reached thereby inducing synaptic transmission. It should be noted that preconditioning 
triggers are often different from mediators. Bradykinin is a good example of a trigger of 
IPC, but it is not important in the sustained ischaemic episode. In contrast adenosine, is 
an important trigger and mediator of preconditioning.79,88
Some of the above mentioned triggers (Noradrenaline, Bradykinin and adenosine) are 
coupled to G protein and pre-treatment with pertussis toxin has been proven to block the
Q 1
protective effect of IPC. It has been proposed that the activated receptors couple 
through G proteins to phospholipase C and the formed diacylglycerol activates protein 
kinase C and facilitates the translocation of the PKC to different subcellular 
compartments, a hypothesis proposed by Downey and colleagues94 (Figure 1-5). 
Experiments with the tyrosine kinase inhibitor genistein imply that PKC is not the only 
kinase involved in classic preconditioning. Researchers wondered if other substances 
released during ischaemia, such as epinephrine, acetylcholine and opioid-peptides, 
could also be involved in triggering the ischaemic preconditioning response by binding 
to inhibitory G-coupled receptors. 95 In addition, endogenous substances (angiotension
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II, NO, O2 ' radicals, metabolic products, endothelin and Ca2+) were also proposed to be 
involved in this phenomenon. Therefore IPC appears to involve activation o f several 
signalling pathways. Integral members o f these pathways are Norepinephrine, K Atp  
channels, adenosine 96 and protein kinase C. They participate in the signalling that 
occurs in delayed preconditioning. 71 This is also generally believed to involve 
manganese superoxide (MnSOD), HSP’s, inducible nitric oxide synthase (iNOS) and 
cyclo-oxyygenase-2 (COX-2). 97
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Figure 1-5. Schematic representation of the signalling events that are thought to
occur during cardiac preconditioning in the early and delayed phase.
Stimulation o f the agonist’s receptor triggers, which are coupled to a G-protein, 
activates either phospholipase C (PLC) or D (PLD). This results in degradation o f 
membrane phospholipids and the formation o f diacylglycerol (DAG), the required 
cofactor for activation (also by reactive oxygen species) and translocation o f protein 
kinase C (PKC) from cytosol to cell membranes. Once activated, PKC can then 
phosphorylate other end-effectors, possibly K a tp  channels via tyrosine kinases or p38 
mitogen activated protein kinase to precondition the cell in the early phase with possible
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regulation of K a t p  channels by NO. The delayed phase occurs with the possible 
involvement of adenosine receptor activation of PKC, which sets off complex 
downstream signalling processes. These consist of p38 MAPK, NF-«B or hypoxia 
inducible factor-1 resulting in gene transcription, protein synthesis and with the putative 
regulation of K a t p  channel by NO as with the early phase. (Adapted from Yellon and 
colleagues.)86
During the late phase of preconditioning, it is believed that the involvement of the 
cellular memory results in protein synthesis and therefore takes time to occur hence 
protection also requires time. It is the production of cytoprotective proteins such as the 
heat shock family (HSP70, 60, 27, 32 and 90) and antioxidant enzymes such as 
manganese superoxide dismutase (MnSOD), catalase, glutathione peroxidase/ - 
reductase and alkyl hydroperoxide reductase that are instrumental in protecting the cell. 
Some researchers speculate that oxidative stress may trigger the production of these 
protective proteins. 98 The enzyme NO synthase appears to be involved 99 and Guo and 
colleagues 100 have demonstrated that iNOS is an essential mediator of delayed 
preconditioning. They disrupted the iNOS gene that abolished the infarct sparing effect 
of late preconditioning. In rabbits, Xuan and co-workers demonstrated that the biphasic 
activity of NOS isoforms, eNOS and iNOS served as a trigger and mediator of the late 
phase of preconditioning respectively. 101 Cyclooxygenase-2 (COX-2) induced 
protection is due to increased production of prostanoids mainly PGIi and PGI2 mediated 
via 8-opioid receptor induced cardioprotection. 102 Baxter has commented on the fact 
that even before preconditioning was defined, prostanoids were successfully used for 
many years to induce delayed preconditioning. 97 Transient ischaemia-reperfusion that 
is associated with preconditioning activates a complex cascade of signalling events 
associated with delayed preconditioning. These include cellular kinases and 
cardioprotective transcription factors. PKC is known to be involved in the early 
preconditioning phase, 103 but it was Baxter and colleagues who demonstrated its 
important role in delayed preconditioning, 97 by inhibiting PKC resulting in the 
abrogation of protection. There are many different isoforms of PKC in differing species 
but it appears that PKCe is required for delayed pc which is activated by the NO 
generation. 103,104
An end effector of preconditioning has not been clearly identified, although there have 
been many suggestions of possible candidates, such as the ion channels occurring in the
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cell membrane and mitochondria. These are known as the ATP-sensitive potassium 
( K a t p )  channels. Although these channels are known to be cardioprotective in classical 
preconditioning, there is a lot of speculation as to their role in delayed preconditioning. 
A lot of attention has been focused on the mitochondrial inner membrane rather than 
sarcolemma or cell membrane K a t p  channels, as K a t p  inhibitors for mitochondria and 
sarcolemma have provided evidence that inhibition of mitochondrial K a t p  channel has 
abolished delayed preconditioning. However, Bernardo and colleagues 105 reported that 
the delayed preconditioning they observed in the rabbit was due to sarcolemma K a t p ,  a
0 7result differing from the majority. The actual mechanism of protection has not been 
elucidated, but as mitochondria can exist in a low conductance state whereby the 
mitochondrial permeability transition pore (MPTP) can reversibly open and close for 
short periods without causing mitochondrial swelling or cytochrome c release. This
7+allows mitochondria to purge itself of excess metabolites and ions specifically Ca , 
whilst others state that regulation of K + ion influx/efflux by K a tp  opening is another
possible mechanism which ultimately results in better preservation of ATP energy
^  88 stores.
Preconditioning in humans has undergone extensive research, but results are hard to 
define as patients with CD often have collateral circulation that can give false readings. 
Moreover, using infarct size as a measure of injury is not a practical endpoint. There is 
evidence of naturally occurring preconditioning in humans. Patients who experience an 
episode of angina prior to a myocardial infarction (preinfarction angina) often have a 
better prognosis. In the “ warm up angina” phenomenon, patients have painful episodes 
of angina in the morning but as the day progresses their symptoms improve. There is 
also evidence that preconditioning can occur during coronary artery bypass surgery and 
percutaneous transluminal coronary angioplasty (PTCA). 86,88,97 Pharmacological 
preconditioning as opposed to using ischaemia (because of the risk of contractile 
dysfunction or stunning) is more effective, as drugs can activate specific protective 
pathways, although data from clinical trials has proved to difficult to interpret. 79 97 88
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1.4.9 Cyclophilin
Some proteins, which contain Xaa—Pro peptide bonds, need cis-trans isomerisation in 
order to achieve their native state. 106 In the fungus neurospora crassa, mitochondrial 
cyclophilin 20 (now more commonly termed cyclophilin-D or cyclophilin-3) binds to 
mitochondrially-imported polypeptides that require proline isomerisation. These authors 
determined that cyclophilin 20 catalyses the rate limiting step in this folding pathway 
since in mutated neurospora crassa lacking cyclophilin 20, folding of the imported
iTO
polypeptide was significantly delayed.
Isomerisation is accomplished by a family of cis-trans isomerases called 
cyclophilins.67,107 Other closely related members are FK506 binding proteins (FKBP) 
and the parvulins. Cyclophilins and FKBPs cannot be defined as true molecular
107chaperones, because they do not increase the yield of a reaction, but only the rate. 
All peptide bonds in proteins exist in a partial double bond form; existing mostly in the 
trans isomer form. In peptide bonds adjacent proline residues exist in the cis state and 
need to be isomerised in order to achieve their fully functional form. PPIases catalyse 
the cis -  trans isomerisation of these bonds and accelerate the rate of the reaction. 106 
They were identified as the receptors for the immunosuppressant drugs cyclosporin A 
(CsA) and FK506 respectively. When these immunosuppressants bind to their 
respective receptors, PPIase activity is inhibited. Hence it has been proposed that PPIase 
activity must be involved in the immunosuppression mechanism; however, other
i o r  i nocompounds that inhibit PPIase activity lack immunosuppressant actions ’ so this is 
in doubt.
The actual mechanisms of immunosupression are not now thought to be linked to their 
PPIase enzymatic activity. They probably involve stimulation of the T-cell receptors by
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Figure 1-6. Diagrammatic demonstration of T-cell inactivation by CsA
Antigen binding activates the T-cell receptor which causes an increase in Ca2+which 
acts through calmodulin (CAM) thereby activating Calcineurin resulting in the 
dephosphorylation o f NF-AT. NF-AT must be dephosphorylated before it can enter the 
nucleus to activate the transcription factor IL-2 resulting in T-cell proliferation. The 
dephosphorylation o f NF-AT can be blocked by the binding o f CsA to cyclophilin 
(CyP) or FK506 to FK506 binding protein (FKBP), forming complexes that prevent this 
dephosphorylation activity o f Calcineurin and subsequent translocation o f NF-AT to the 
nucleus. (Modified from review by N ab e l)110
46
antigens resulting in increased cellular Ca2+ levels that then activate a Ca2+ dependent 
protein phosphatase (calcineurin), which (Figure 1-6) in turn dephosphorylates the 
transcription factor, nuclear factor of activated T-cells (NF-AT). 111 This in turn allows 
translocation to the nucleus and activation of the transcription factor interleukin-2 (IL-2) 
and other cytokine genes resulting in T-cell clonal expansion. The binding of both 
FK506 and CsA to their respective receptors inhibits activation of calcineurin thus 
preventing dephosphorylation of NF-AT. IL-2 gene activation is regulated by NF-AT 
and therefore it is reliant on the translocation of NF-AT to the nucleus to stimulate the 
immune response. NF-AT must be dephosphorylated for it to enter the nucleus, if this is
119prevented by calcineurin inhibition, immunosuppression results.
Cyclophilins are comprised of: CyP A (18 kDa) which is localised in the cytoplasm; 
CyP B (21 kDa) found in the endoplasmic recticulum, CyP C (21 kDa); murine and 
(CyP-D) CyP 3(18 kDa) localised to the mitochondrion; and CyP40 which is part of the 
HSP90 steroid receptor complex.113 The ubiquity of their expression would suggest that 
they might have many functions in the cell. Cyclophilins have been reported to possess 
nuclease activity, which is unrelated to their PPIase activity. Cyclophilins are 
structurally similar to NUC18 (18 kDa) nuclease isolated from apoptotic rat thymocytes 
and can degrade DNA. 114
Ischaemia/reperfusion injury is characterised by collapse of the mitochondrial 
membrane potential due to the formation of the mitochondrial permeability transition 
pore. 115 High membrane potential is necessary to maintain ATP synthesis; however due 
to a dramatic increase in membrane permeability, mitochondrial permeability transition 
(MPT) occurs, which is the process allowing solutes less than 15 kDa to pass across the 
membrane. This results from elevated levels of Ca2+and the presence of free radicals in 
the mitochondria undergoing reperfusion after a long ischaemic period. The formation 
of the MPTP is often an indicator of the change from reversible to irreversible cell 
injury. 116,117 However, despite the role proposed by Halestrap and colleagues whereby 
CyP-D promotes MPT, overexpression of CyP-D has recently been shown to be 
protective.56,118
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1.4.10 Nitric Oxide
Nitric oxide (NO) is one of the most potent and most recognised endogenous 
vasodilators in existence. 119 NO is an unstable, poisonous free radical gas which is a 
constituent of the pollutant air 120 and was originally discovered by Joseph Priestly in
191the early 1770’s. Numerous cell types can produce NO including vascular smooth 
muscle cells, neutrophils, liver and heart cells. 122,123 It has a short half-life, reacts with 
oxygen-derived free radicals, and plays an extensive role in human biology, with 
outcomes ranging from pathology to homeostasis.
NO is generated from the oxidation of the substrate amino acid L-arginine and an 
enzyme, NO synthase (NOS) of which there are a three isoforms namely neuronal NOS 
(nNOS) or NOS3, endothelial or constitutive NOS (ecNOS) or NOS1 and inducible 
NOS (iNOS) or NOS2. 124 Due to their omnipresent expression, these enzymes have 
diverse physiological actions. Furchgott and co-workers suggested that endothelium- 
derived relaxing factor (EDRF) might be N O ;125 Palmer and colleagues determined that 
NO in the vascular endothelium was identical to EDRF. 126
When produced in the presence of ROS species or in excess, NO induces apoptosis and
1 90displays neurotoxicity in neuronal cells. This neurotoxicity is known to be mediated
197by OONO', formed from NO and O2'. This discovery led many investigators to 
believe that NO was responsible for beneficial biological functions whereas 
peroxynitrite mediated cytotoxic functions especially as it can induce the formation of
191MPTP. This analysis was later found to be too simplistic. NO inhibits respiration by 
inhibiting the electron transport chain at complex IV where it competes with O2 for
1 98binding to cytochrome oxidase in the mitochondrion. As mitochondrial respiration is 
the main source of energy production in mammals and the fact that mitochondria are 
involved in apoptotic and necrotic cell death, led to excitement in the scientific 
community in 1994 when it was discovered that very low levels (nanomolar) of NO was
191possibly a physiological regulator of mitochondrial function. This study demonstrated 
that exogenously applied nanomolar concentrations of NO was a reversible and
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competitive inhibitor of cytochrome oxidase activity which was later found not to be 
tissue or species specific. Ever since these discoveries, many researchers have been 
investigating NO in different organs of the human body. NO has many biological 
functions, of which some are mediated through the second messenger guanosine 3*5’- 
cyclic monophosphate (cGMP) by the action of the enzyme guanylyl cyclase. 128 In the 
brain, NO plays a role in neurotransmission. 124 NO has been found to be involved in 
many diseases such as sickle cell anaemia, 129 as well as in various neuronal disorder 
such as Parkinson’s disease.120,130 Robert Furchgott’s discovery in 1980 was recognised 
in 1998 when he was awarded the Nobel Prize in Medicine. In the same year Pfizer 
marketed the drug Viagra for erectile dysfunction, which enhances the physiological 
action of NO by preventing the breakdown of cGMP 131.
There are many reports linking NO in the mechanisms of preconditioning. Over a ten- 
year period the interest in NO in myocardial ischaemia and preconditioning has been 
growing rapidly. During ischaemia, iNOS is upregulated and NO production is 
increased which in turn decreases blood flow. These are methods, which help the 
myocardium to adapt to ischaemia, and may play a role in the mechanism of hibernation
n'i
. There has been substantial evidence presented indicating the necessary role of NO in 
the late phase of ischaemic preconditioning. 81,104 NO is thought not to be involved in 
classical preconditioning. 40,83 However Nakano and colleagues discovered that 
administration of the NO donor S-nitroso-N-acetylpenicillamine (SNAP) caused the 
production of free radicals. This in turn resulted in protection possibly due to activation 
of protein kinase C (PKC). They could not find any evidence of protection from 
endogenous sources of NO. Boli’s group have presented evidence of a biphasic 
protection mechanism of NO synthase isoforms. In rabbits subjected to brief ischaemic 
periods resulted in upregulation of cNOS lasting for 30-60 minutes, which then 
subsequently ceased. No upregulation of iNOS activity was noticed until 24 hours later. 
At this point no cNOS activity was recorded. The mechanism responsible for the 
delayed upregulation proved to involve generation of NO, oxidant species and PKC 
activation which played no part in the observed early cNOS activity.84
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1.5 Hypotheses and aims
Cyclophilins are stress inducible proteins which have been found in every organism. 
Due to their cis-trans isomerase activity, they are classified as molecular chaperones 
catalysing rate limiting steps in vitro and in vivo protein folding. We are particularly 
interested in the functional role of mitochondrial cyclophilin as they form part of the 
MPTP which is crucial in all death pathways 34,85 and because they protect against
o /
oxidative stress. Therefore in this research programme I will endeavour to address the 
following aims and objectives:
• The functional role of cyclophilin and the mitochondrial chaperone complex 
during ischaemia /reperfusion injury and its involvement in the phenomenon of 
ischaemic preconditioning.
• Differences in cyclophilin and the mitochondrial chaperone complex activities in 
different types of mitochondria.
• To investigate the effect of increased CyP-D expression on cell survival after 
ischaemia/reperfusion injury.
I will try to prove my hypothesis, which states: Cyclophilin-D is an important 
component of the MPTP and as such plays an important role in cell death pathways.
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CHAPTER 2
2. MATERIALS AND METHODS
2.1 Materials
All cell culture manipulations were conducted in a sterile class II culture hood (Jencons, 
UK). Tissue culture vessels were obtained from Nunc (Costar, Cambridge, MA). All 
chemicals unless stated were obtained from Sigma (Poole, UK) and antibodies for 
Western blotting were obtained from Stress Gen Biotechnologies Corp. (Bioquote Ltd, 
UK) and Calbiochem-Novabiochem Corporation (San Diego, USA).
2.1.1 Preparation o f Chemical Reagents.
The nitric oxide donor S-nitroso-acetyl pencillamine (SNAP) was dissolved in DMSO 
to make a stock concentration of ImM, stored at -70°C and then used in the 
concentrations as described. The cationic flurochrome 3,3’-dihexyloxacarbocyanine 
iodide (DiOC6 (3) was diluted to 40pM in DMSO, which was further diluted to 400nM 
and used at a final concentration of 0.8 nM in medium. The immunosuppressive cyclic 
oligopeptide cyclosporin A (CsA) was dissolved in ethanol and added to cell solutions 
for a final concentration of 30nM.
2.1.2 Cell Biology
H9c2 cells were obtained from the American Type Culture Collection (CRL-1446, 
ATCC Rockville, MD, USA). These myoblasts are large flat spindle - shaped cells with
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prominent nuclei that grow in unorganised arrays at low densities, but upon confluency 
they form organized identical rows. When confluent, they undergo morphological 
changes becoming net-like in appearance, forming myotubules following fusion 
providing they are not senescent.
A
Micrograph A. Typical phase contrast of primary rat neonatal cardiomyocytes
This Micrograph is demonstrable o f a typical phase contrast image of cardiomyocytes 
after 24 hours in culture.
They were grown in full growth medium (FGM), Dulbecco’s Modified Eagle Medium 
(DMEM) with sodium pyruvate and 1000mg/l glucose (Gibco-BRL) and 10% (v/v) 
fetal calf serum in 95% atmosphere and 5% CO2 . These cells were subcultured every 3- 
4 days and not used beyond passage 29. They were originally derived from a section of 
a 13-day embryonic rat heart and possess more skeletal than cardiac muscle properties. 
Due to extensive dedifferentiation they cannot be considered as a true model of
1 70
mammalian myocardium. Therefore we also used a primary rat neonatal 
cardiomyocyte model, which better represents a truly myocardial cell population.
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Figure 2-1. Flow chart representing a rat neonatal cardiomyocyte isolation 
procedure.
Using this rat neonatal cardiomyocyte isolation procedure a total o f 48- 72 x 106 cells 
can be isolated from 25 -  30 Sprague -  Dawley neonate hearts.
These cells were isolated from three litters o f between 25 to 30, 1- 3-day-old Sprague -  
Dawley neonates using collagenase/pancreatin digestions (Figure 2-1). Their hearts 
were quickly removed, trisected and immersed in ADS, a HEPES buffered salt solution, 
88 After four digests in 500pl pancreatin plus 30 mg type II collagenase (Worthington 
Biochemicals, UK) per 100ml ADS, the myocytes were resuspended in plating media 
4:1 DMEM/ Medium 199 (Gibco-BRL, UK) with the addition o f  1% 
penicillium/streptomycin, 5 % fetal calf serum, 10% horse serum and preplated into 
100mm petri dishes for 30 minutes in order to remove any contaminating fibroblasts.
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The densely enriched myocyte population was then seeded into gelatine coated tissue
culture plates at a concentration of 1 x l06/ml for 24 hours, whereupon the medium was
changed to maintenance medium comprised of virtually serum free DMEM/ Medium
1199, thereby reducing fibroblast growth. After 24 hours in maintenance medium they 
were used in experiments only if ~90% were beating (Micrograph A).
CV-1 origin, SV40 (COS) cells (of which there are 3 clones 1, 3 and 7) are immortal 
fibroblasts originally derived from kidneys of the African green monkey. This 
expression system is ideal for transient transfections because they are easily transfected. 
These cells grow quickly to produce substantial quantities of recombinant proteins.
2.1.3 Long-term Storage o f Commercial Cell Lines
For long term preservation, cells from a T75 culture flask were trypsinised, pelleted 
and resuspended in 1ml freezing mixture (8 ml foetal bovine serine (FBS), 1ml dimethyl 
sulfoxide (DMSO) and 1 ml medium) that were transferred to 1.5ml cryotubes. They 
were then wrapped in tissue paper and kept at -70°C for short-term storage ( 2  or 3 
months). For long-term storage (4 months or more) they were placed into liquid 
nitrogen tanks (-196°C). When required cells were recovered by warming rapidly 
(within 1 minute) in a water bath at 37°C, spun and after aspiration of the freezing 
mixture (to free the solution of DMSO), the cells were resuspended in the appropriate 
media and seeded into tissue culture flasks.
2.1.4 Rat Left Anterior Descending (LAD) Coronary Artey Occlusion Model
All the rat hearts used were obtained from female adult Sprague-Dawleys of which 
there where six experimental groups, each rat weighed between 250 to 300g. 
Myocardial Ischaemia was induced by left anterior descending (LAD) coronary artery 
occlusion as described in the experimental procedure below.
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2.1.5 Surgical preparation *
Following anaesthesia with hypnorm and diazepam, a surgical incision was made in the 
breastbone and the chest area was opened. The rib cage was retracted back over the 
head and the heart was positioned such that the LAD was exposed. A 7/0 silk suture 
(W817) was tied loosely around the LAD and attached to a snare wire. A snugger tube 
was pushed over the wire. By pulling the snare wire and at the same time pushing the 
tubing onto the heart resulted in a gentle occlusion. Placing a small artery forceps 
around the snugger tube trapped the suture around the LAD thereby securing the 
occlusion. Reperfusion was performed by removing the forceps and pulling the snugger 
tubing away from the heart, loosened the suture around the LAD, allowing reperfusion 
of the ischaemic area. A group of rats underwent the above procedure except for the 
LAD occlusion and reperfusion stage and thus served as controls.
*A11 surgical procedures were performed by Milan under a home office licence.
2.1.6 Determination o f Area at Risk (AAR)
Finally to determine AAR the femoral vein was cannulated and clamped off. A syringe 
was then attached containing Evan’s blue dye. The LAD was re-occluded and 1ml of 
Evan’s blue dye was infused into the heart. The heart was removed and the AAR was 
determined by negative staining. The non-blue area (left ventricle) was then removed 
for mitochondrial isolation.
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2.1.7 Experimental Groups
Group 1 (Control)
Control rat hearts (n=4) were treated as above but the silk suture was loosely attached 
around the LAD coronary artery for 60 minutes. The left ventricle was then surgically 
removed for mitochondrial isolation.
Group 2. 60 minutes LAD occlusion
Rat hearts (n=4) were subjected to 60 minutes LAD occlusion as described (section 
2.1.5) and the infarct size and risk area was evaluated via a perfusion technique using 
Evan’s blue dye. The left ventricle was removed for mitochondrial isolation.
Group 3. 60 minutes LAD occlusion and 15 minutes reperfusion.
Rat hearts (n=4) were subjected to 60 minutes LAD occlusion as described (section 
2.3.1) with 15 minutes reperfusion. As above Evan’s blue dye was used and the left 
ventricle was removed for mitochondrial isolation.
Group 4. (control)
Rat hearts (n=4) were treated as in Group 1 (control) except silk suture was loosely 
attached around LAD for 90 minutes. Hearts was then surgically removed for 
mitochondrial isolation.
Group 5. 90 minutes LAD occlusion
Rat hearts (n=4) were subjected to 90 minutes LAD occlusion and then treated with 
Evan’s blue dye as above and removed for mitochondrial isolation.
Group 5. 90 minutes LAD occlusion with 15 minutes reperfusion 
Rat hearts (n=4) were subjected to 90 minutes LAD occlusion and 15 minutes 
reperfusion followed by treatment with Evan’s blue dye as above and the left ventricle 
was removed for mitochondrial isolation.
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2.2 Biochemical assays
2.2.1 Determination o f Peptidyl - Prolyl Isomerase (PPI-ase) Activity
The basis of this assay is the measurement of the time course of the rate of conversion 
of the cis to trans conformer of the substrate N-Succinyl-Ala-Ala-Pro-Phe p- 
Nitroanilide (pNA) because the applied isomer specific chymotrypsin will only cleave 
pNA when it is in the trans conformer releasing a chromogenic dye that can be 
measured spectrometrically. Since the spontaneous cis-trans isomerisation of pNA was 
found to be too fast for reliable calculation of rate constants at room temperature, the 
assay is now carried out at or below 10°C. The oligopeptide pNA contains a prolyl 
bond, where the cis form is used as substrate in protease-coupled PPIase assays. It 
consists of a mixture of two conformers, cis and trans, in solution. In some solvents the 
percentage of the cis conformer is in the range of 5-35% whereas dissolving pNA in 
Trifluoroethanol (TFE) containing 235- 470mM LiCL, has been found to increase the 
cis conformer to 50% and in some circumstances 70%. 134 As detailed below, PPIase 
activity was measured with bovine a-chymotrypsin as the isomer-specific protease.
Cells were trypsinised and washed in PBS and spun down at 1500 rpm for 5 minutes. 
They were resuspended in (depending on pellet size) cold ~0.5-2ml 35mM HEPES 
buffer in 2ml microfuge tubes. They were then freeze- thawed in liquid nitrogen and 
placed immediately into a 37°C water for duration of 30 seconds each time (repeated 4 
times) rupturing the cell membranes. The cells were spun down for 10 minutes at 
3000rpm (4°C) and the supernatant was transferred to clean 2ml microfuge tubes. From 
the lysate the protein concentration was ascertained (Biorad protein assay). Generally 
20pg cell lysate was used in each assay. HEPES buffer, 100 pi a-chymotrypsin and cell 
lysate were added in a cuvette to a volume of 990pl. They were cooled to 4°C, 5 
minutes before the addition and rapid mixing of lOpl of the substrate pNA (at a 
concentration of 80mM in 470mM LiCl/TFE) to the mixture. This initiated the reaction, 
which was recorded for two minutes on a spectrophotometer at an absorbance of A390 
after which the process was repeated twice more. Each sample was assayed three times
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in order to determine an average of the PPIase enzymatic activity that was finally 
calculated by an enzymatic program (GraFit), which calculated the enzymatic activity 
based on this equation.
K  — ( kobs" k 0) /ko
Equation 2-1. Determination of PPIase activity.
Where PPIase activity is determined as (K) arbitrary units and kobs as the first order rate 
constant of the PPIase catalysed reaction and ko is the cis -  trans conversion of the 
uncatalysed reaction. This method was taken from the protocol of Kofron and 
colleagues 89 and Kullertz and co-workers. 135
2.2.2 Isolation ofMitochondria from Cells
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resuspend in lOOpl 
MSMEB on ice and 
measure protein 
concentration
Figure 2-2. Flow diagram of mitochondrial isolation from cells.
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Primary neonatal cells were trypsinised and resuspended in MSMEB. After 
permeabilisation with digitonin, homogenisation and a series of differential 
centrifugations yielded mitochondria. S/N: supernatant,
Cells were harvested and resuspended in MSMEB (210mM mannitol, 70mM sucrose, 
lOmM MOPS, ImM EGTA and 0.5% BSA). The following procedures were all 
performed at 4°C. Digitonin (5% in DMSO; 0.1 mg/ml) was added until >90% cell 
permeabilisation occurred as confirmed with Trypan Blue exclusion. After the addition 
of a further 1ml MSMEB, the samples were spun and the supernatant removed. The 
pellet was homogenised 10 times in a Dounce homogeniser. The supernatant was spun 
initially at 2500g for 3 minutes and finally for 10 minutes at 12000g. The resulting 
pellet (mitochondrial fraction) and the supernatant (cytosolic fraction) were washed 
separately. Protein concentration was calculated using Bio-Rad protein assay (Figure 2- 
2).
2.2.3 Buffer for Isolation o f Subsarcolemmal (SSM) and Interfibrillar Mitochondria 
(IFM) from Rat Heart Using the Protease Nagarse
Table 2-1. List of ingredients for mitochondrial isolation MSE buffer
MSE Buffer 1 Litre (g)
225 mM Mannitol 40.995
75 mM Sucrose 25.673
10 mM MOPS 2.093
10 mM Tris HCL 1 . 2 1 1
ImM EGTA pH 7.3 .380
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Figure 2-3. Diagrammatic representation of SSM and IFM isolation.
SSM and IFM were isolated from the left ventricle of a female Sprague-Dawley rat. 
Isolation of SSM was achieved by disruption of the tissue using a polytron tissue 
processor and differential centrifugations; nagarse digestion of the remaining tissue was 
necessary to release IFM.
The left ventricle was removed from the hearts and immediately placed into cold MSE 
buffer (Table 2-1) and washed three times. The ventricles were minced in cold MSE 
(5ml), homogenised using a polytron tissue processor for 10 seconds and, after the 
addition of 45ml MSE, were centrifuged at lOOOg for 10 minutes. The resulting pellet 
containing the interflbrillar mitochondria was placed on ice. The supernatant containing 
the subsarcolemmal (SSM) fraction was centrifuged at lOOOOg for 10 minutes. The 
pellet was resuspended in 15 ml of MSE buffer and further centrifuged at 6000g for a 
further 10 minutes in order to enrich this mitochondrial fraction (Figure 2-3).
60
In order to release the interfibrillar mitochondria (IFM) from the myofibrils, the lOOOg 
pellet from the first spin was resuspended with 1.5mg nagarse in 5 ml MSE and left on 
ice for 5 minutes and homogenised for 20 seconds. Then 10 ml MSE was added prior to 
centrifugation at lOOOg. The resultant supernatant was discarded to remove any 
contaminating SS mitochondria. The pellet was resuspended in 50 ml MSE and re­
centrifuged at lOOOg for 10 minutes. The pellet was discarded and the supernatant was 
centrifuged at lOOOOg for a further 10 minutes and following this the pellet was 
resuspended in 15ml MSE and centrifuged at 6000g for 10 minutes. These 
mitochondrial fractions were re-suspended in 50 - lOOul PBS + 1% Triton or HEPES 
buffer and the protein concentrations were determined.
2.2.4 Cell Viability Assays
Mitochondrial-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2-diphenyl 
tetrazolium bromide (MTT) formazan assay (Sigma, UK) was one method used to 
determine cell viability. This was added to the cells at a concentration of 0.5mg/ml and 
incubated for 30 minutes. After development of the MTT formazan crystals, 0.5ml of 
stop solution (89ml anhydrous isopropanol; 1% triton; 10ml 0.1N HCL) was added for 
another 30 minutes until these crystals dissolved. Finally the degree of reduction of the 
MTT reagent was ascertained spectrophotometrically at 570nm, normalised to control 
cells in maintenance medium that were considered to be 1 0 0 % viable.
2.2.5 Trypan Blue Exclusion Assay
Treated cells were incubated with a 0.8% Trypan blue solution and then using a 
haemocytometer the average number of viable cells able to exclude this dye was 
calculated and compared to control cells.
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2.2.6 Lactate Dehydrogenase (LDH) Assay
Cytotoxicity was also determined by LDH (Sigma Diagnostics, UK) release into the 
medium. This assay measures the quantity of the cytosolic enzyme in extracellular 
fluids, which is indicative of cell lysis or injury. The reduction of pyruvate due to the 
oxidation of NADH results in the decrease in absorbance at 340nm and is directly 
proportional to LDH activity in the medium. In order to measure this cellular activity, 
medium was collected and LDH activity measured on a plate reader (Molecular 
Dynamics, UK) and results were calculated as a percentage of the positive control, 
which was considered to represent 100% LDH release. The positive control were 
cardiomyocytes subjected to 30 seconds immersion in liquid nitrogen imediatetely 
followed by 30 seconds immersion in a 37°C waterbath. Controls were cardiomyocytes 
incubated in normal maintenance medium for the duration of the experimental periods. 
This cycle was repeated twice more to invoke cell lysis after which the medium was 
assayed for LDH activity.
2.2.7 Flow Cytometry Analysis
All analysis was performed by fluorescence activated cell sorter (FACS) using a flow 
cytometer (FACScan) from Becton Dickinson (San Jose, CA) equipped with a single 
488-nm argon laser. A minimum of 10,000 cells per sample was analysed and 
quantified using cellquest software.
Flow cytometry enables the detection of fluorescence and scattered light from the 
analysed cells by forward-angle light scatter (FSC) and side-angle scatter (SSC). FSC 
relates to cell size and SSC relates to cell granularity. These parameters are able to 
distinguish between cell populations and aggregates as well as viable and non-viable 
cells, as dead cells have a lower FSC signal. This ability is further enhanced by adding 
propidium iodide (PI) to the sample.
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2.2.8 Propidium Iodide Staining
This dye is able to enter dead cells whereupon it binds to nuclear DNA and fluoresces 
red. Viable cells with intact plasma membranes do not demonstrate any fluorescence.
As a positive control for necrosis, lxlO6 cells were immersed in liquid nitrogen for 15 
minutes and then placed immediately into a 42°C water bath for 15 seconds in order to 
induce necrosis. This cycle was repeated twice more eventually resulting in >95% PI 
permeable cells.
Following trypsinisation cells were spun and to the resultant pellet was added 2pi of a 
2mg/ml propidium iodide solution. These pellets were then resuspended in 500pl PBS 
and analysed by flow cytometry.
2.2.9 Mitochondrial Membrane Potential (A y/nj Measurements
Formation of the mitochondrial permeability transition pores resulting in a decrease in 
the mitochondrial membrane potential (Ai|/m) was measured using the lipophilic cationic 
flurochrome 3.3' dehexyloxacarboncyanine iodide (DiOC6 (3)), 136 which accumulates 
in the mitochondrial matrix of cells depending on their mitochondrial membrane 
potential. Cells were incubated with 0.8 nm DiOC6 (3) in tissue culture media for 30 
minutes at 37°C. They were then harvested, washed and resuspended in PBS prior to 
analysis performed on the FACScan flow cytometer (Becton Dickenson, excitation 
488nm, emission 495nm)
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2.2.10 Simulated Ischaemia Buffer and Hypoxic Chamber
Cells in tissue culture flasks were incubated in a simulated ischaemia (SI) buffer based
Q 1 0 0on a protocol from Esumi and colleagues but modified by Dr. R. Heads. This 
consisted of 137mM NaCL, 1.2mM MgCb. 6 H2O, 2.5mM CaCl2 .2 H2 0 , lOmM 2- 
Deoxyglucose, 20mM Na lactate, 12mM KC1, the pH is initially 6.1 and after the 
addition of ImM sodium dithionite the pH was adjusted to 6.2 with very dilute NaOH 
and filter sterilised before being placed onto cells. This in combination with a hypoxic 
environment was called lethal simulated ischaemia (LSI) was designed to simulate 
myocardial ischaemic conditions occurring in vivo, replicating the approximate 
concentrations of potassium, hydrogen and lactate ions. Cells were placed in an 
incubator that had been converted into a hypoxic chamber (Billups-Rothenberg, Del 
Mar, CA, USA). Over a period of 2 hours the chamber was perfused at a flow rate of 5
Q9litres/hour that was later reduced to 1.5 litres/hour. The gas mixture consisted of 95% 
N2 and 5% CO2 ; after the initial two hours the p0 2  in the chamber was reduced from 
atmospheric pressure 160mmHg to 2mmHg. Whilst the chamber was in use, it was 
continuously perfused with this gas mixture in order to counteract any O2 released by 
the plastic, thereby maintaining the low p0 2 - After a defined period, cells were removed 
from the chamber whereupon they were reperfused with medium for different time 
points or subjected to further assays.
2.2.11 Measuring Oxygen Levels in the Simulated Ischaemic Buffer
This was performed by making up the simulated ischaemic buffer and immediately after 
the addition of ImM sodium dithionite; 1 ml of this solution was transferred into a 
water-jacketed incubation chamber containing a Clarke electrode (Yellow Springs 
Instruments Co., Ohio, USA.) The ischaemic buffer was maintained at a temperature of 
37°C and the percentage of oxygen in the buffer over a period of 3 - 6  hours was 
recorded.
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2.2.12 Electron Microscopy
Primary neonatal cardiomyocytes growing on 50mm petri dishes after the above 
treatments were washed with O.IM-phosphate buffer and then immediately fixed in 3% 
(v/v) glutaraldehyde (Agar Scientifics Ltd, Stanstead, UK) in O.IM-phosphate buffer for 
2 hours. Following two buffer washes, the secondary fixation process was applied by 
using 1% (w/v) osmium tetroxide (Agar Scientifics Ltd, UK) with a 1 hour, room 
temperature incubation. The cardiomyocytes were then washed twice with distilled 
water and block stained with 4% (w/v) aqueous uranyl acetate (Agar Scientifics Ltd, 
Stanstead, UK) for 1 hour in the dark, washed in ddlUO and then transferred into 
microfuge tubes. These samples were dehydrated through increasing acetone series and 
infiltrated with 1:1 acetone: araldite CY212 resin (Agar Scientifics Ltd, UK) overnight. 
Following two changes of fresh resin, each for a minimum of 3 hours, samples were 
embedded in araldite CY212 resin and blocks were polymerised at 60°C for 18 hours. 
Ultra-thin (lOOnm) sections were cut using a diatome diamond knife, on a Reichert- 
Jung Ultracut E ultramicrotome, floated on to distilled water, collected on formvar- 
coated copper grids and stained with 2% uranyl acetate for 30 minutes and in lead 
citrate for 5 minutes. The stained sections were viewed on a Jeol 1200EX electron 
microscope. (Electron microscopy carried out by Padmini Sarathchardra)
2.3 Molecular Biology
2.3.1 SDS -  PA GE and Western blotting
Cells on ice were scraped into cold phosphate buffered saline (PBS), spun down and 
lysed with PBS + 1%  triton. Protein concentration was determined using the Bio-Rad 
protein assay. The reaction between protein and copper leading to reduction of the Folin 
reagent is the basis of this method. It has been improved such that the colour 
development is quicker and more stable when compared to the assay upon which it was 
founded.
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Initially a protein standard curve was obtained using serial dilutions depending on the 
known concentration of BSA (usually 1 mg/ml) diluted to a final volume of lOOpl with 
dH2 0 . Then lOOpl was pipetted into a 96 well plate and the absorbance read on a 
microplate reader (VersaMax, Molecular Devices, UK) at 570nm. Once the protein 
curve was constructed, the absorbances of known protein concentrations were compared 
to those of the unknown samples in order to determine their concentrations. Then equal 
quantities of protein (usually between 40 pg - 60pg) was combined with Laemmli 
loading buffer (0.5M Tri-HCL, pH 6 .8 . glycerol, 10% (w/v) SDS, 2 p-mercaptoethanol, 
bromophenol blue), boiled for 5 minutes and loaded on 4% stacking gel and separated 
by electrophoresis on 12 or 15% SDS-polyacrylamide gels (Table 2-2).
Table 2-2. SDS -Acrylamide Gel
List of reagents used to make gels for Western Blot
Reagent 12% Gel 15% Gel Stacking gel (4%)
ddH20 3.35ml 2.3ml 6 .1 ml
1.5M Tris-HCl pH 8 . 8 2.5ml 2.5ml
0.5M Tris-HCl pH 6 . 8 2.5ml
10% (w/v) SDS Stock lOOpl lOOpl lOOpl
Acrylamide/Bis (30% stock) 4.0ml 5.0ml 1.33ml
TEMED 5pl 4pl lOjLll
10% Ammonium persulfate* 50pl lOOpl 50pl
* made fresh daily
The proteins were electroblotted at 30V overnight or lOOv for 1 hour onto nitrocellulose 
membrane (Hybond-ECL, Amersham, UK) and blocked with 5% non-fat milk and 
0.05% Tween-20 for 1 hour. The membrane was washed briefly with PBS + 0.05% 
Tween 20 and 0.1% non-fat milk (PBSTM) on a shaking platform (Janke and Kunkel
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GmBH, Germany). The membranes were probed with various antibodies (see Table 
2.3).
Table 2-3 List of antibodies used for Western blot
Antibodies Species Working dilution Molecular weight kDA
HSP 10 Rabbit 1 : 1 0 0 0 1 0
* Cyclophilin A Rabbit 1 : 1 0 0 0 18
HSP 60 Mouse 1 : 1 0 0 0 60
HSP 70 Mouse 1 : 1 0 0 0 70
HSP 75 Mouse 1 : 1 0 0 0 75
* It should be noted that where CyP-D protein expression is examined, generally mitochondria has been 
isolated from the cell, electrophoresed on a SDS-polyacrylamide gel. Following transfer the membrane 
was probed with Cyclophilin A antibody. As there was no commercially available CyP-D antibody at that 
time, it was believed that probing mitochondrial protein, where only CyP-D is present with a general 
cylcophilin antibody would allow CyP-D protein expression to be detected.
Using horseradish peroxidase conjugated secondary antibodies (DAKO); protein bands 
were visualized by enhanced chemiluminescence (ECL: Amersham, UK).
2.3.2 Plasmid Construction and Transfection -Restriction Enzyme Digest
The CyP-D gene was a gift from Dr D.Bergsma, which was subcloned into pBluescript. 
This procedure was performed by digesting 5 pi (approximately lpg  DNA) of the vector 
DNA in 1.5ml microfuge tubes (alpha laps, UK) with 2pl buffer E and after the addition 
of 11 pi DEPC H2O followed by lp l Eco R1 (12u/pl) restriction enzyme (Promega, 
UK). The microfuge tube containing the above solutions was incubated at 37°C for 1 
hour. To ensure that the cyclophilin inserts had been excised from the vector, 30pl was 
electrophoresed on a 1 % agarose gel.
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2.3.3 Agarose Gel Electrophoresis o f DNA
Gels were prepared by adding agarose (Sigma, UK), 1% (w/v) to a total volume of 100 
ml with lx TBE buffer and boiled in a microwave cooker for 3 minutes. The agarose 
solution was allowed to cool to 50°C and then 5pl ethidium bromide (EtBr) was added 
(0.5mg/ml) prior to casting. Gels were submerged in an electrophoresis tank containing 
TBE buffer (90 mM Tris; 90 mM boric acid; 2 mM EDTA; pH 8 ). Loading buffer (1/ 6  
volume of 6 x stock solution: 0.25% w/v bromophenol blue, 0.25% w/v xylene cyanol 
FF, 40% w/v sucrose in water) was added to the DNA solutions, which were then 
transferred into the wells, and electrophoresis was performed at constant voltage of 90v 
for 1 to 2 hours. The gel was illuminated with short wave ultraviolet light and the DNA 
bands were visualised by using Polaroid DS 34 camera with a DS H- 8  hood (Polaroid 
UK Ltd., St. Albans, Hertfordshire, U.K.)
2.3.4 Isolation o f DNA from Agarose Gel
Low melting point (LMP) preparative grade agarose gels were used for DNA isolation. 
After the digested insert and pBluescript vector was electrophoresed, the DNA was cut 
out of the low melting point gel and placed into pre-weighed microfuge tubes. The 
microfuge tubes were then weighed and the weights of the gel fragments were 
calculated and the DNA was extracted and purified using the QIA Gel Extraction Kit 
Protocol (Qiagen, UK). Briefly, 3 volumes of solubilisation and binding buffer QG were 
added to each volume of the gel (1 volume = lOOmg gel). The solution was then heated 
at 50°C for 10 minutes or until the gel was completely solubilised ensuring that the 
solution was still yellow confirming that it was at the correct pH. To this, 1 volume of 
isopropanol was added, mixed and centrifuged for 1 minute.
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2.3.5 Phosphatase Treatment o f Vector DNA
The vector was extracted with an equal volume of phenol/chloroform, spun on a 
microcentrifuge (Sanyo, MSE, Micro Centaur, UK) at 13000rpm and from the resulting 
two layers, the aqueous layer was removed and precipitated with 0.1 volume 4M NaCl 
and 2.5 volumes of absolute ethanol as above. The pellet was then resuspended in 90pl 
lOmM TrisHCl, pH8 , 10pi of lOx phosphatase buffer, lp l calf intestinal alkaline 
phosphatase and then incubated at 37°C for 1 hour. The reaction was stopped with the 
addition of stop solution (1% SDS/lOmM EDTA) and lp l 20mg/ml proteinase K and 
incubated at 56°C for 1 hour. It was then extracted with an equal volume of 
phenol/chloroform and precipitated with NaCl and ethanol. The pBluescript vector and 
insert were then ready to be ligated.
2.3.6 Ligation o f  Cyclophilin into pBluescript
Two microfuge tubes were labelled insert and control, to each was added 1.5pl 5x ligase 
buffer and 1.5pi DEPC H2O, lpl lOmM ATP, 8 pi of the vector and into a microfuge 
tube labelled insert 2pi of the cyclophilin DNA and 2ul DEPC H2O added to the control 
microfuge tube instead. Finally lpl T4 DNA ligase was added to each microfuge tube 
and they were incubated in a water bath overnight at 15°C. Previously competent cells 
had been made as described below for the transformation procedure.
2.3.7 Preparation o f  Competent Cells
E-coli DH5a strain were grown overnight in a 2ml culture and lOOpl was transferred 
into 100ml liquid broth (lOg tryptone, 5g yeast extract, lOg NaCl and made to 1 litre 
with ddF^O, pH 7.5 with ION NaOH and autoclaved) without antibiotics the following 
morning. They were grown up until the liquid broth (LB) became cloudy, which on the 
UV spectrophotometer gave an absorbance of 0.4 - 0.5 % at 550nm. The cells were then 
spun at 3000rpm for 10 minutes and the supernatant was discarded. The pellet was
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resuspended in 4ml lOOmM CaCl2 and stored at -70°C in 200pl aliquots in 0.5ml 
microfuge tubes until required.
2.3.8 Transformation
The ligation mixes were mixed with 200pl competent cells and immediately incubated 
on ice for 45 minutes. They were then heat shocked for exactly 2 minutes at 42°C and 
placed on ice for 5 minutes. Then 800pl LB (no ampicillin) was added to each 
microfuge tubes and left in a water bath at 37°C for 30 minutes. The cells were 
resuspended and lOOpl was plated onto ampicillin positive agar plates (low 
concentration) and spread evenly. For pBluescript the LB plates were coated with 50pl 
of a 0.02% X-gal solution, 4% solution in dimethyl formamide, (20mg/ml) and 50|il 
IPTG solution (0.1M in ddfbO, 200mg/ml) 30 minutes prior to use. Cloning into a 
vector such as pBluescript inactivates the lacZ gene meaning that recombinants were 
unable to produce p-galactosidase and will not be able to break down x-gal thereby 
producing white colonies. Non-recombinants, which are able to break down x-gal, then 
produce blue colonies. The remaining cells were spun down and resuspended in half 
the original volume and lOOpl was pipetted onto agar plates (high concentration) and 
these were then left upside down in an incubator at 37°C overnight or until colonies 
grew. Then 10ml LB was inoculated with a single recombinant colony for each sample 
and left overnight in a shaking incubator (Innova™ 4300, New Brunswick Scientific, 
UK).
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Table 2-4 List of ingredients for reagents for plasmid DNA isolation
Small scale preparation of plasmid DNA (Miniprep)
Solution 1 (GTE Buffer)
50mM glucose
25mM Tris.HCl, pH 8
lOmM EDTA
Alkaline/SDS solution
lOOpl lONNaOH
250pl 20% SDS
To 5ml with ddH2 0
Solution 3
Glacial acetic acid 11.5ml
ddH20 28.5ml
PH 4
All 10 ml cultures were spun down at 3000rpm for 5 minutes at 4°C. The supernatant 
was discarded and the pellet was resuspended in lOOpl cold GTE buffer, vortexed and 
the contents were then transferred into 2 ml microfuge tubes. To these microfuge tubes 
were added 200pi alkaline/SDS solution (Table 2-4) and inverting three times mixed 
them. Then 150pl of cold solution 3 (Table 2-4) was added, vortexed and placed on ice 
for 5 minutes. The white pellet that forms (cell debris) was spun down and the 
supernatant removed to a new 2  ml tube and mixed with 1 volume of 
phenol/chloroform/isoamyl alcohol (49:1:1). They were spun at 12000 rpm for 5 
minutes at 4°C and the supernatant was once again transferred to a new 2ml tube 
whereupon it was precipitated with 600pl isopropanol for 5 minutes. After spinning at 
13000rpm for 5 minutes at 4°C, the supernatant was removed to a new tube and washed
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with cold 70% ethanol and dried. Once the pellet was dried, depending on the size it 
was dissolved in 30 - 50pl ddH2 0  with lp l RNase A, measured on the 
spectrophotometer and then digested with the appropriate buffer and electrophoresed on 
a 1 % agarose gel in order to confirm the presence of the insert in this vector.
Initially CyP-D was cloned into pBluescript, which generated enough restriction sites 
enabling it to be further subcloned into the expression vector pcDNA3 using the BamHI 
and Hindlll site. After its orientation had been confirmed via restriction mapping, 
pcDNA3-CyPD was ready to be amplified.
2.3.9 Large Scale Preparation o f Plasmid DNA
A  Qiagen Plasmid Mega-kit was used, according to the manufacturer’s protocol, which 
is based on the modified alkaline procedure 137 involving the binding of plasmid DNA 
to an anion-exchange resin. A single colony was picked from the agar plate (containing 
the vector and insert), inoculated onto a starter culture of 10ml LB with ampicillin for 
each sample and was grown overnight at 37°C on a shaking incubator. The following 
day, this culture was then transferred to a previously autoclaved 2  litre conical flask 
containing 500ml LB ampicillin and grown for 16 hours at 37°C in a shaking incubator. 
Then 800pi of each culture was mixed with 200pl glycerol in a 1.5ml microfuge tube. 
These glycerol stocks were immediately placed into freezing boxes and placed into the - 
70°C freezer. The rest of the cultures were spun down in a Sorvall GSA centrifuge 
6000rpm at 4°C for 15 minutes. The supernatant was discarded and, using a pipette boy 
with a 10ml pipette, the pellet was completely resuspended in 50ml resuspension buffer 
PI. Then 50 ml of lysis buffer P2 was added and mixed thoroughly by inverting three 
times and left at room temperature for 5 minutes. Following this, 50ml of chilled 
neutralization buffer P3 was added and immediately mixed by inverting three times. 
The samples were placed on ice for 30 minutes and during this incubation period they 
were mixed six times. Centrifugation was performed at 11500rpm for 30 minutes at 4°C 
and the lysate was removed to a new tube and respun. The supernatant containing the 
plasmid was then respun at 11500 rpm for 15 minutes. The lysate containing the
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plasmid was carefully poured into a Qiagen-tip 2500 column ensuring that as little of 
the sediment as possible was transferred. The cell lysate was then filtered through this 
anion-exchange resin column, which had been pre-equibrilated with 35ml buffer QBT, 
by gravity flow. Under these conditions the plasmid DNA binds to the anion-exchange 
resin. In order to wash the resin; 200ml of medium salt buffer QC was poured onto it. 
This removed RNA, proteins and low molecular weight impurities. Then 35ml of high 
salt buffer QF was used to elute the plasmid DNA into centrifuge tubes and then 
desalted by precipitation with 24.5 ml isopropanol at room temperature. After the DNA 
was pelleted by centrifugation at llOOOrpm for 15 minutes at 4°C, the supernatant was 
discarded and the pellet was washed with 70% (v/v) ethanol at room temperature and 
spun at 11000 rpm for 10 minutes at 4°C. Following the spin, the resultant DNA pellet 
was air-dried and dissolved in ddlUO. After the concentration was measured by UV 
spectrophotometry, it was digested with BamHI and Hind III restriction enzymes and 
electrophoresed on a 1% agarose gel to confirm that the insert was present. The purified 
plasmid was then further purified on a caesium chloride (CsCl) gradient where 
appropriate.
2.3.10 CsCl Density Gradient Centrifugation
To 1ml of the plasmid prep, lg  CsCl and 120pl EtBr (lOmg/ml) was added. The tubes 
were spun at 5000rpm in order to collect the precipitate that forms as debris on the cell 
surface. The clear pink solution was transferred to a 2 inch Beckman tube (Beckman, 
USA). The tubes were balanced to O.lg of each other and then spun (Ultracentrifuge, 
TL-100, Beckman, USA) at 15°C for 16 hours at 100,000g. The tubes were removed 
from the ultracentrifuge and two EtBr bands were visualized. The lower band contains 
the denser supercoiled plasmid DNA. This band was carefully removed into another 
tube and mixed thoroughly with an equal amount of water-saturated butanol and spun at 
12000rpm for 2 minutes at room temperature in order to remove the EtBr. This was 
repeated and each time the upper pink organic layer was discarded, until this layer was 
eventually colourless. The CsCl was then removed by diluting the sample with 2 
volumes of water and then 6  volumes of cold ethanol, mixed, incubated for 30 minutes
73
at 4°C, spun, washed with 70% (v/v) ethanol and then the pellet was dried and 
resuspended in ddt^O + RNase A. The DNA concentration was measured on the 
spectrophotometer and electrophoresed on an agarose 1 % gel and then digested with the 
appropriate restriction enzyme.
It was further subcloned into the expression vector pcDNA3 in the correct orientation 
for expression into the BamHI and Hindlll site. CyP-D was transfected into 3-day-old 
isolated primary neonatal cardiomyocytes and H9c2 cells using a novel transfection 
method, which is based on a peptide that complexes well with DNA and possess and 
integrin targeting domain. This mediates the internalisation of the vector into 
mammalian cells by integrin cell surface receptors by a phagocytic mechanism . 138
2.3.11 Transfection o f pcDNA3-CyPD in Cardiomyocytes
In an autoclaved 1.5ml microfuge tube, 80pl (40pl/pgDNA) of the integrin targeting 
peptide was pipetted followed by 1.5jul lipofectin® reagent (GibcoBrl, Life 
Technologies, UK). Then the DNA to be transfected was diluted to 1 mg/ml and 2ul 
was mixed with 200pl optimem® to achieve a concentration of 1 jig/lOOpl in a separate 
microfuge tube. The DNA/optimem® and peptide/lipofectin mixes were combined, 
mixed and left for an hour in order for the peptide to form a complex with the DNA. In 
order to transfect into 6  well culture vessels, the contents of a 1.5ml microfuge tube was 
sufficient to transfect into 1 well of a 6  well culture vessel. After an hour, the cells to be 
transfected were washed with serum free DMEM. Then the contents of each microfuge
(r)tube were diluted to 800pl with Optimen and then each well was incubated with the 
contents of these microfuge tubes overnight at 37°C in incubator. Control cells were 
incubated with the same quantities of peptide and lipofectin plus empty vector 
(pcDNA3). The following day the transfection solution was replaced with normal 
maintenance medium and the cells were left for 24 - 48 hours in order to allow 
development of protein expression. As a measure of transfection efficiency, green 
fluorescent protein (GFP) was also transfected which was visualized on a fluorescent 
microscope (Carl Zeiss, West Germany).
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A further construct was made by subcloning the CyP-D insert directly into a vector 
which contained pIRES -GFP thereby allowing a more direct measure of transfection 
efficiency. This vector was called pcDCAG-CyP3.
2.4 Statistical Analysis
Data was expressed as mean ± SEM for at least 2 separate experiments employing cells 
from different isolations, which were performed by student’s two-tailed t-test. When 
data was expressed by 3 or more separate experiments, any differences between groups 
were analysed by analysis of variance using the Bonferroni test to account for multiple 
comparisons. All statistical analyses were performed with a statistical package 
associated with the scientific graph program Graphpad Prism® version 3 (GraphPad 
software, San Diego, CA, USA). PO.05 was considered to indicate a significant 
difference in mean values.
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CHAPTER 3
3. CHARACTERISATION OF AN IN VITRO 
MODEL OF LETHAL SIMULATED ISCHAEMIA/ 
REPERFUSION INJURY IN ISOLATED 
C ARDIOM Y OC YTES
3.1 Introduction
In the heart, loss of oxygen caused by a coronary obstruction reducing the blood flow is 
termed cardiac ischaemia. Cells will eventually die of oxygen deprivation if the blood 
flow is not restored. When the blood flow is re-established more cells may die because 
metabolites and ions produced during ischaemia react with oxygen to produce cytotoxic 
agents. 139
Mitochondria are major targets affected by oxidative deprivation. In these ischaemic 
surroundings, as the oxygen level decreases, mitochondrial oxidative phosphorylation is 
inhibited. However, anaerobic glycolysis is able to produce adenosine triphosphate 
(ATP). 140 This pathway also produces lactate, which causes a reduction in intracellular 
pH resulting in acidosis that eventually inhibits glycolysis and mitochondrial ATP 
production. 109 Because the demand of the myocytes for energy far exceeds the supply 
from anaerobic glycolysis, ATP decrease and ADP begins to accumulate in the latter 
part of the reversible phase of ischaemia, 75% to 80% of the ATP present at the onset of 
ischaemia has been consumed. 141 Lactate accumulation and glycogen depletion 
increase as a function of the severity of ischaemia. The decreasing ATP concentration 
inhibits Na+/K+ ATPase resulting in a progressive increase of the concentration of 
cytosolic Na+ and a concomitant increase of extracelllar K+. Na+, in turn activates 
Na+/Ca2+ and Na+/H+ exchange inducing an accumulation of Ca2+ and protons. The 
intracellular Na+ rise results in a depolarisation of the cell membrane with transient 
opening of the voltage-dependent Ca2+ channel increasing Ca2+ flux. The increase in
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intracellular Ca levels activates the release of various degradative enzymes and leads 
to the collapse of the mitochondrial membrane potential (A\j/m) in conjunction with a 
decline in ATP levels. 25>48’142
The formation of the mitochondrial permeability transition pore (MPTP) precedes 
collapse of the A\|/m. The process in which the MPTP forms resulting in massive 
swelling and depolarisation of the mitochondria commonly referred to as mitochondrial 
permeability transition (MPT). 143 Complete hydrolysis of ATP produced by glycolysis 
as well as uncoupling of any residual oxidative phosphorylation, eventually results in 
cellular death. Hunter and Howard discovered the MPTP in the 1970's. 40 At present it 
has been speculated by numerous investigators that MPTP dysfunction is a determinant 
in the event of cellular death. 37,142,144 Since then, the formation of the MPTP has been 
shown to be inhibited by cyclosporin A (CsA), which binds to cyclophilin D (CyP-D). 
In binding to CyP-D, CsA inhibits the PPIase activity of CyP-D and also prevents it 
binding to the adenine nucleotide translocase (ANT). Thus in this manner as already 
stated, the formation of the MPTP is inhibited. 142 CyP-D, a cis- trans isomerase, 
catalyses the interconversion between cis and trans conformations of peptide bonds 
adjacent to proline residues. 106 This protein is an integral member of the pore and 
therefore affords protection against IR injury when bound to CsA . 142
A hypoxic chamber was used in combination with a simulated ischaemia buffer 
133,145,146 tQ sjmuiate extracellular environment of myocardial ischaemia. This was 
the ischaemic model developed specially for this study (by our group) in rat cardiac 
myocytes to investigate A\j/m and other intracellular changes occurring during 
myocardial IR injury. Oxidative stress is an essential factor in IR injury causing 
recruitment of CyP-D to the ANT-VDAC complex, 44 Increased oxidative stress results 
in increased binding of CyP-D to this complex.54,55
77
3.2 Aims
The aims of this study were two fold:
1) To determine whether binding and increased levels in CyP-D might be detected 
as a change in protein expression or PPIase activity.
2) To determine whether apoptosis or necrotic cell death predominates in the lethal 
simulated ischaemia/reperfusion (LSI/R) model
The hypotheses to be tested are that:
• CyP-D binding to the ANT increases with increasing oxidative stress 
and the integral PPIase activity induces a conformational change to form 
the MPTP, which is represented by an increase in PPIase activity.
• As the duration of ischaemia increases, cells will die by necrosis rather 
than apoptosis
3.3 Methods
Primary neonatal cardiomyocytes were isolated as described in Chapter 2. These cells 
were plated in 6  or 12 well dishes and simulated ischaemia (SI) buffer was added. This 
buffer mimics ischaemic conditions such as inhibition of oxidative phosphorylation, 
acidic conditions and lack of oxygen. The ischaemic buffer was prepared from 
constituents of Tables 3-1 and 3-2 as follows:
The stock basal modified Krebs-Henseleit Buffer (KHB) was made to 10 times the 
normal concentration (pH 7.5) (Table 3-1). 5ml of this solution with the addition of 
components from Table 3-2 was diluted with ddH2 0  into a final volume of 50 ml.
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Table 3-1. List of components used for simulated ischaemia buffer
KREBS-HENSELEIT BUFFER
137mM NaCl 16g
3.58mM KC1 0.54g
0.49mM MgCl2 .2H20 0 .2 g
1.8mM CaCl2 .2H20 0.528g
4mM HEPES 1.906g
Table 3-2. List of components used for simulated ischaemic buffer
Reagent List Quantity Used
ddH20 45ml
2-deoxyglucose (2-DOG) 82.1 mg
Na lactate (30%: 1:2 dilution of sigma 
60% stock)
172pl
12mM KC1 (lOOx) 500pl
After the solution was warmed to 37°C, ImM sodium dithionite was added, and then 
adjusted to pH 6.3 and filter sterilized. Prior to addition of SI buffer, the cells were 
washed with PBS; 1ml of SI buffer was added to each well containing neonatal 
cardiomyocytes and immediately placed into the hypoxic chamber. Sodium dithionite 
was used as an oxygen scavenger. To determine how effective this oxygen scavenger 
was at maintaining a hypoxic environment, a Clark type oxygen electrode was used to 
measure oxygen levels in this buffer over a period of 3 hr.
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Table 3-3. Incubation time points for electron microscopy samples
Duration of Lethal Simulated Ischaemia only Hours of reperfusion
1 hour -
1 hour + 24hr
3 hours -
3 hours +2 hr*
3 hours +24hr
6  hours -
6  hours + 24hr
*Only used for the cell viability assays
Primary neonatal cardiomyocytes were incubated for periods of 1,3 and 6 hr simulated 
ischaemia (SI) in the hypoxic chamber (LSI) with reperfusion for 2hr and 24hr 
reperfusion (LSI/R) as demonstrated in Table 3-3. The floating cells in the supernatant 
were collected and spun down. The remaining adherent cells were trypsinised and both 
sets of cells were fixed for analysis by electron microscopy as previously described in 
Chapter 2.
In proceeding experiments, 1,3 and 6  hour incubations with subsequent reperfusions 
were used, and from the supernatant and cells collected, the following assays were 
conducted (Table 3-4).
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Table 3-4. List of experimental assays used.
Incubation time periods for LSI and LSI/R assays used for lethal simulated 
ischaemia/reperfusion experiments
LSI incubation Duration of reperfusion LDH MTT h 2d c f d a > 3
3hr - + + + +
3hr 15 min + + + -
3hr 2hr + + + +
3hr 24hr + + + +
The supernatant was collected immediately after LSI and various reperfusion (LSI/R) 
time points in order to measure viability via the LDH assay. The intracellular HSP70 
expression by Western blotting was analysed in the collected samples.
Mitochondrial membrane potential (A\|/m) was measured with DiOC6 (3) over the same 
period of ischaemia and reperfusion time points, and mitochondria were extracted in 
order to assay for PPIase activity. These procedures were carried out as previously 
described in Chapter 2.
3.4 Results
Reduced oxygen levels in tissues are termed hypoxia and results in numerous 
pathophysiological conditions such as ischaemia, cancer and atherosclerosis. Incubating 
isolated cardiomyocytes in hypoxic or ischaemic conditions result in the inducement of 
genes for HSP’s and antioxidant enzymes. 147In establishing this model cardiomyocytes 
were initially incubated for various periods in maintenance medium in a hypoxic 
chamber (described in Chapter 2).
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Figure 3-1. Effect of 18 hours hypoxia and differing periods of reperfusion on 
primary neonatal cardiomyocytes.
Isolated neonatal cardiomyocytes were exposed to 18 hours hypoxia whilst in 
maintenance medium. The medium was replaced with fresh maintenance medium
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(reperfusion) and incubated for 3, 4,5 and 6 hours. Then the 3-(4,5-dimethylthiazol-2- 
yl)-2-diphenyl tetrazolium bromide (MTT) formazan assay was performed (A) (as 
described in section 2.2.3) to assess viability. Then the Lactate dehydrogenase LDH 
assay was performed to assess viability (B) (as described in section 2.2.5). Viability of 
primary cardiomyocytes was not affected by 18 hours hypoxia and up to 6 hours 
reperfusion. Data are representative of the mean ± S.E.M. of 4 individual experiments.
Figures 3-1A and 3-IB show that exposure of cardiomyocytes to 18 hours hypoxia and 
up to 6 hours reperfusion has no effect on cell viability as measured by MTT and LDH 
assays. These were experiments were based on previous work carried out in our 
Laboratory in which H9c2 cell viability was reduced by 18 hours hypoxia followed by 5 
hours reperfusion.107 We were hoping to perform the same experiments in order to 
develop a model using rat neonatal cardiomyocytes. However, the above experiments in 
neonatal cardiomyocytes had no effect when incubated in maintenance medium. An 
ischaemic buffer was obtained (described in Chapter 2) from Dr Richard Heads (Rayne 
Institute) which when used in combination with the hypoxic chamber resulted in a 
decrease in viability of the cardiomyocytes as visualised in Figure 3-2.
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Figure 3-2. Primary rat neonatal cardiomyocytes cells subjected to differing 
periods of LSI.
An ischaemic buffer in combination with the hypoxic chamber (LSI) reduced the 
viability o f cardiomyocytes in a time dependent manner as measured by the (B) MTT 
assay and as indicated above. (A) LDH assay was performed on rat neonatal
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cardiomyocytes that had been subjected to LSI for 3,5 and 7 hours. LDH (A) release 
between the LSI samples and their controls did not demonstrate any significant 
differences. (B) On the contrary MTT activity between the LSI samples and their 
controls are statistically different in comparison to its control. The (A) LDH release 
from the treated samples is calculated as a percentage of LDH of the positive control as 
demonstrated previously (Figure 3-1B). This result is in contrast to the previous 
experiments (Figure 3-1A and Figure 3-1B) where the use of maintenance medium had 
no effect on the viability of cardiomyocytes. Data are represented by mean S.E.M ± of 6 
individual experiments. *P<0.001 vs control
The results from the MTT assay in Figure 3-2B shows the reduction in metabolic 
activity or viability that decreases with increasing duration of LSI. Interestingly in the 
corresponding LDH assay (Figure 3-2A) cardiomyocytes appear to be significantly 
unaffected by this buffer in respect to the control.
Interestingly the following LDH activity graphs (Figures 3-3A and 3-3B) demonstrate 
statistically significant LDH release in comparison to their respective controls upon 
reperfusion.
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Figure 3-3. LDH activity of cardiomyocytes subjected to LSI/R
Primary cardiomyocytes were subjected to (A) 3 and 4 hours LSI and both were 
reperfused for 2 hours (LSI/R) in normal maintenance medium. During 3 hours LSI 
there is no apparent difference between LDH release in comparison to the control, but
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upon reperfusion LDH activity is statistically significant after 3 and 4 hour LSI/R. As in 
(Figure 3-2A), the samples are calculated as a percentage o f the positive control. (B) 
Cardiomyocytes that have been reperfused demonstrate a statistically significant 
difference in LDH release as opposed to control cells. LSI only treated cardiomyocytes 
show comparatively the same LDH release as control cells Results are representative of 
the mean S.E.M ± o f 6 individual experiments. *P<0.01; **P<0.001 vs control
In order to establish the model, it was necessary to expose cardiomyocytes to hypoxia or 
simulated ischaemia such that a reduction o f cell viability o f ~ 50% was attained. This 
model could then be used to evaluate the effectiveness o f preconditioning protocols as 
well as studying cell death pathways in an in vitro cell system, which mimicked 
myocardial IR. From the combined data from Figure 3-2B and the subsequent LDH 
assays (Figure 3-3) an initial ischaemic or LSI period o f 3 hours was chosen. However, 
during this time course the hypoxic chamber achieves a hypoxic environment within 2 
hours. Figure 3-4 demonstrates that the combination o f the oxygen scavenger sodium 
dithionite and the chamber ensure that hypoxic conditions are maintained throughout 
the 3 hour time course.
A Clark type oxygen electrode was used to measure oxygen levels in this buffer over a 
period o f 3 hr in order to access how effective the sodium dithionite was at maintaining 
a hypoxic environment (Figure 3-4).
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Figure 3-4. Oxygen levels in the simulated ischaemia buffer
The level o f oxygen in the simulated ischaemia buffer was measured
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against time using a Clark type oxygen electrode after the addition of sodium 
dithionite. This experiment was conducted in order to ascertain how effective sodium 
dithionite was at scavenging O2 in this solution. After 60 minutes, O2 concentration was 
at 10%, 30% at 120 minutes rising to 50% at 180 minutes. Data are representative of the 
mean S.E.M ± of 4 sets of individual experiments.
This experiment proved that the sodium dithionite was only effective in suppressing O2 
levels for 90 minutes (Figure 3-4). It was necessary to find a way to maintain a low O2 ; 
therefore we used a hypoxic chamber. This device has been proven to lower pC>2 from 
atmospheric pressure to 2mmHg (as previously explained in Chapter 2) at 37°C within 2 
hours. However, hypoxic conditions are achieved within 2 hours in this chamber, 
therefore the use of sodium dithionite will ensure that hypoxic conditions are 
maintained until the pC>2 levels in the chamber drop to 2mmHg.
3.4.1 Effect o f LSI/R on Cell Viability
Primary cardiomyocytes were subjected to 3 hours LSI/R and the viability was assessed 
with the LDH assay (Figure 3-5). Upon addition of the ischaemic buffer there was an 
almost immediate cessation in cardiomyocyte contraction or beating; the 
cardiomyocytes resumed contracting as soon as they were reperfused after 3 hours LSI.
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Figure 3-5. Graph depicting viability of neonatal cardiomyocytes.
Survival o f cardiomyocytes after 3 hours in LSI and different periods o f reperfusion 
with fresh medium as measured by the (A) LDH assay. As demonstrated in Figure 3- 
2A, these samples are compared to the positive control, which is representative o f 100%
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LDH release. (B) Survival of primary cardiomyocytes that have all been subjected to 3 
hours LSI and some have been reperfused (LSI/R) for differing periods as measured by 
the MTT metabolic assay. This graph shows that 3 hours LSI and 3 hours LSI/R time 
points are all statistically significant in comparison to the control. Data from each bar 
are representative of means ± of 4 independent experiments where significance J 
represents PO.05 versus control; * is P<0.001 versus control.
The effect of 3 hours hypoxia with different periods of reperfusion on cell viability is 
demonstrated above (see Figure 3-5A and 3-5B). After the ischaemic period a time 
dependant decrease in cell viability was observed as shown in the MTT and LDH cell 
viability graphs. This demonstrated that 3 hours LSI and up to 24 hours reperfusion was 
sufficient in this myocardial IR model to allow an adequate reduction in cell viability to 
be used as a lethal insult in order to determine the effectiveness of preconditioning and 
other protection protocols. As well as enabling the study of cell death pathways in 
myocardial IR.
In the LDH assay 3 hours ischaemia and 0 hour reperfusion exhibited no change in 
release of the enzyme LDH (Figure 3-5A). In comparison we see a dramatic drop in the 
degree of viability as observed with the MTT assay after 3 hr ischaemia only. As MTT 
assay is dependent on mitochondrial reductase activity 148 and during ischaemia there is 
a reduction in oxygen and ATP, metabolic activity decreases which is visualised as a 
cessation in contractile activity. The LDH assay measures the reduction of pyruvate to 
lactate catalysed by LDH in the supernatant resulting in the oxidation of NADH to 
NAD that can be measured at 340nm. In other words it measures the release of lactate 
dehydrogenase from cells with compromised plasma membranes (necrotic cells). 
Therefore these LDH assay results point to the high amount of necrotic cellular death. 
Moreover, the decrease in metabolic activity as measured is indicative of cell damage 
but does not indicate if necrotic or apoptotic death is occurring.
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3.4.2 Effect o f LSI/R on PPIase Activity
In healthy mitochondria, the inner membrane is impermeable to the majority of small 
molecules. This situation maintains the membrane potential as well as ensuring that 
there is a pH gradient necessary for the production of ATP during oxidative 
phosphorylation. The mitochondrion is one of the primary sites of damage in 
myocardial ischaemia reperfusion, forming the MPTP. This has been described by 
Bemardi and colleagues as a CsA sensitive, voltage dependent, high-conductance inner 
membrane channel,46 It is induced by ROS and high concentrations of Ca2+ and 
phosphate as well as adenine nucleotide depletion. CyP-D located in the mitochondrial 
matrix, is recruited to a complex formed by VDAC and ANT, which assembles to form 
the MPTP in pathological conditions such as ischaemia/reperfusion injury. CyP-D, a 
member of the cyclophilin family, possesses the ability to catalyse protein conformation 
through its inherent cis -trans isomerisation activity. Upon binding to the ANT-VDAC 
complex, a conformational change is induced which is facilitated by the PPIase activity 
of CyP-D. As the level of ROS increases there is a parallel increase in binding of CyP-D 
to the ANT-VDAC complex. It may be possible to measure these changes by measuring 
PPIase activity. Initially when PPIase activity was measured concentrations that 
inhibited PPIase activity were toxic to cardiomyocytes after exposure to CsA and 6 
hours LSI/R. Using 30nm CsA was found not to be toxic to cardiomyocytes over the 
experimental time course (Figure 3-6) and inhibited PPIase activity (Figure 3-7). Hence 
PPIase activity was measured in mitochondria (Figure 3-8), which were isolated at 
different time points.
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Figure 3-6. Protective curve for CsA treated cardiomyocytes prior to 3hrs LSI/R
Primary cardiomyocytes were incubated with 30nm cyclosporin CsA for 30 minutes and 
then subjected to 3 hours LSI with 24 hours reperfusion. Viability was assessed by MTT 
metabolic activity. lOOnm, 150nm and 200nm samples are significantly different from 
control. Data are represented as the S.E.M of 4 individual experiments. *P<0.01 vs 
control.
When CyP-D enzymatic activity was measured, no statistically significant difference in 
PPIase activity was found between any o f the ischaemic/reperfused samples or between 
these and their respective controls (Figure 3-8).
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Figure 3-7. Reduction in PPIase activity as a result of CsA incubation
Neonatal cardiomyocytes were incubated with 30nm CsA for 30 minutes prior to 
analysis o f PPIase activity. Reduction o f PPIase activity by CsA is significant. 
Determination o f PPIase activity arbitrary units (K) is described in section 2.2.1. Data 
are representative o f the S.E.M of 3 individual experiments. *P<0.01 vs control
Figure 3-8. PPIase activity of isolated mitochondria
PPIase activity o f mitochondria from cardiac myocytes that have been subjected to 
varying degrees o f LSI/R. There was no significant statistical difference in activity 
between any o f the different groups or between the respective groups and the control. 
The PPIase activity in each group was measured three times (mean ±SEM).
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3.4.3 Western Blot
OA
Because IR is reputed to involve the de novo synthesis of heat shock proteins The 
synthesis of various HSP’s such as HSP70 was examined. As is evident in Figure 3-9, 
of the expression of HSP70 at 24 hours reperfusion post LSI. Evaluation of CyP-D 
protein expression revealed no significant differences between any of the samples 
(Figure 3-10).
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Figure 3-9 Cardiomyocyte protein expression of HSP70 after subjection to LSI/R
The Western blots for HSP70 expression in rat neonatal cardiomyocytes, subjected to 
differing degrees o f LSI followed by reperfusion (B). This is also represented in 
graphical form (A) by measuring the density o f the different bands using a densitometer 
as already described in Chapter 2. Data are representative o f 3 individual experiments 
**P<0.001 vs control
Mitochondria are considered to be one of the primary sites 41 o f I/R injury, characterised 
by the loss o f Ai|/m which features early in cell death.149 The decrease o f the A\\jm was
**P<0.001 vs control
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measured by the fluorochrome DiOC6 (3), a specific fluorescent cationic dye that is 
readily sequestered by active mitochondria depending on their Avj/m.
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Figure 3-10. Western blot analysis of CyP-D, HSP10, HSP60 and HSP75 
expression on cardiomyocytes.
LSI/R protein samples were electrophoresed on a 15% SDS-polyacrylamide gel. 
Following transfer they were probed for CyP-D, HSP10, HSP60 and HSP75 protein 
expression. LSI/R does not cause a significant change in CyP-D, HSP10, HSP60 and 
HSP75 expression
DiOC6 (3) was used at a concentration o f < lnm , to ensure that changes in the A\j/m were 
being measured and not the plasma membrane. 136 As a further measure to ensure that 
the lack o f change in A\\im was not due to any methodological problems, 
cardiomyocytes were incubated with differing concentrations o f carbonyl cyanide m- 
chlorophenylhydrazone (CCCP) ranging from 0 to 500pM  (Figure 3-11). This 
protonophore “short circuits” the respiratory chain by uncoupling respiration from 
oxidative phosphorylation which will abolish ATP synthesis collapsing the pm f and 
consequently Ai|/m, independently o f MPTP formation. 150’151 Viability was also 
measured by the MTT assay as demonstrated in Figure 3-13. In Figure 3-14 a dot plot 
demonstrates the effect o f various concentrations o f CCCP on cardiomyocytes as
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visualised on the FACscan flow cytometer and Figure 3-12 also demonstrates the shift 
in fluorescence caused by CCCP application as opposed to control samples.
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Figure 3-11. CCCP positive control
This reflects the decreases in Avj/m in response to the uncoupler CCCP. The 
mitochondrial uncoupler CCCP attacks the mitochondrial electron transport chain 
resulting in the disruption o f Ai|/m. The disruption o f Avj/m can be measured with the 
lipophilic cationic dye DiOC6 (3) manifesting itself as a reduction in fluorescence o f the 
probe DiOC6 (3) (reduction in geometric mean).
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Figure 3-12. CCCP administration causes a shift in fluorescence
Figure 3-12 shows the effect of differing concentrations o f CCCP on the A\|/m as 
represented by the geometric mean using the fluorochrome DiOC6 (3). The membrane 
shift is very clearly demonstrated as opposed to the control by the overlapped 
histograms. This trace shows the shift that occurs after application o f 200pM CCCP. 
The abscissa displays the fluorescence intensity and the ordinate displays the number of 
cells.
98
CJ3
<S
w
3
Ol.+■»3
OO
"3 \®^  0 s
&
S
1 50 -i
1 0 0 -
50-
0 J
100 200 300 400 500
C o n c e n tr a t io n  (t iM ) C C C P
600
Figure 3-13. Survival of rat neonatal cardiomyocytes following exposure to CCCP.
Cardiomyocytes were exposed to varying concentrations o f the mitochondrial uncoupler 
CCCP and survival rates were measured by MTT viability assay. Data is representative 
o f the mean S.E.M± o f at least three determinations for each experiment *P<0.001 v 
control
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Figure 3-14. Representative diagrams demonstrating the shift in fluorescence.
This panel o f diagrams in Figure 3-14 (A, B, C, D), represent the effect o f CCCP 
treatment on cardiomyocyte cells as visualised on the FACscan. The effect o f increasing 
concentration o f CCCP ranging from 200uM (Figure 3-14A) to 500uM (Figure 3-14D) 
is manifested as decrease in Ai|/m and physical shift o f the cell population as CCCP 
uncouples the mitochondrial respiratory chain. The shift to the left occurs, as there is a 
decrease in size and granularity o f the whole population, representing loss o f viability. 
This shift to left o f the population increases from Figure 3-14 A to B, C and finally in 
Figure 3-14D, the shift is dramatically different from the control (Figure 3-14A).
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Figure 3-15 Cyclosporin A (CsA) protection against 3 hours LSI/R.
Graph demonstrating the effect o f 3 hours LSI with followed by 24 hours reperfusion 
(LSI/R) with and without prior incubation with 30nm CsA as determined by the 
mitochondrial membrane potential dye, DiOC6 (3). Protection afforded against 6 hours 
LSI/R is not statistically significant, but there is an increase suggesting a trend towards 
protection by CsA. Data are representative o f means S.E.M o f 3 individual experiments.
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Figure 3-16. Graph displaying the effect of LSI/R on Av|/m in cardiomyocytes.
The effect o f increasing lethal simulated ischaemia/reperfusion (LSI) and reperfusion 
(R) on the Avj/m, which is represented as the geometric mean. Data are representative of 
the mean S.E.M ± o f 2 experiments performed in quadruplicate (n=4) *P<0.01, 
fPO.O Ol vs control as analysed on the FACScan.
Figure 3-16 demonstrates the effect o f LSI/R on A\|/m. It can be seen that 3 hours LSI 
does not affect mitochondrial membrane potential in comparison to the control, and 6 
hours LSI does not differ significantly. Significant differences are demonstrated by 
cardiomyocytes, which have been subjected to 3 hours LSI with 24 hours reperfusion 
(LSI/R) and 6 hours LSI with 24 hours reperfusion (LSI/R). The Av|/m decreases by 
approx 50% and 80% for 3 hours LSI/R and 6 hours LSI/R samples respectively in 
comparison to control levels. Figure 3-15 proves that the Ai\jm occurs as a result of the 
formation o f the MPTP. In these experiments CsA is able to protect against the 
formation of MPTP and this is represented in Figure 3-15 by preservation o f A\j/m.
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3.4.4 The Apoptotic and Necrotic Cell Death Ratio Resulting from LSI/R
It is a well established fact that myocardial ischaemia reperfusion results in cell death. 
However there is much debate as to the significance of apoptosis in cardiac cells 
following ischaemia. It has been reported that global ischaemia results in mostly 
necrotic death in cardiac cells. The ratio is about 8: 92 of apoptotic to necrotic cells 
respectively.21,152,153 One of the reasons this LSI/R model was developed was to 
investigate whether cardiac cells died by apoptosis or necrosis in conditions which 
mimic myocardial IR. In order to achieve this, cardiomyocytes were subjected to 3 hr 
LSI and 24hr reperfusion as previously described. In addition another incubation time of 
6hr LSI with 24 hr reperfusion was used. Immediately after the reperfusion period the 
supernatant from the culture vessels was spun down and prepared for electron 
microscopy analysis. The monolayer was removed and prepared for electron 
microscopy and a count was made on how many cells were apoptotic or necrotic. 
Identification of the cellular death types was based on the criteria listed below.
Morphological criteria of apoptosis were:
• Membrane blebbing, but no loss of integrity
• Aggregation of chromatin at the nuclear membrane
• Shrinkage of cytoplasm and condensation of nucleus
• Fragmentation of cells into smaller bodies
• Formation of membrane bound vesicles (apoptotic bodies)
Morphological criteria of necrosis were:
• Loss of membrane integrity
• Swelling of cytoplasm and mitochondria
• Disintegration (swelling) of organelles
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Figure 3-17. Apoptosis and necrosis post LSI/R.
The effect o f LSI on the rate o f apoptotic and necrotic cell death was assessed in 
primary neonatal cardiomyocytes after 1, 3 and 6 hr lethal ischaemia followed by 24hr 
reperfusion. S and M represent cells that have been extracted from those floating in the 
supernatant and that are adherent on the monolayer respectively.
As was demonstrated in the above graph (Figure 3-17), there was minimal apoptosis 
present. There was no significant difference in the amount o f apoptotic cells between 
each o f the different treatments. The vast majority o f cells died by necrosis ranging 
from 4 - 100% necrosis in the supernatant and monolayer o f cardiomyocytes subjected 
to 1 - 6hr LSI alone and with 24hr reperfusion.
3.4.5 Ultrastructural Analysis o f  Cardiomyocytes after LSI/R
The following electron micrograph pictures show ultrastructural changes as they 
occurred in cardiomyocytes subjected to LSI/R at different incubation time points. In
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the control (non-ischaemic) cells in Micrograph B, the plasma membrane was intact and 
the chromatin structure is evenly distributed with a prominent nucleus (NUC). All cell 
organelles are intact and mitochondria have double membranes.
Micrograph B. Control myocytes
EM diagram o f control myocytes, which demonstrate regular distribution o f nuclear 
chromatin and an intact plasma membrane. The membrane is clearly visible in orderly 
rows. (Total magnification 5000x)
NUC=nucleus; PM= Plasma membrane
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DMicrograph C. Cardiomyocytes after 1 hour LSI
Swollen mitochondria, plasma membrane rupture and chromatin condensation. 
MIT=mitochondria; PM= plasma membrane (5000x)
Micrograph D. Cardiomyocyte after 1 hour LSI + 24 hours reperfusion
Vacuoles are present in the cytoplasm. VAC=vacuoles (5000x)
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After 1 hour ischaemia and 0 hour reperfusion, we can observe that this cell is damaged 
due to the appearance o f swollen mitochondria (MIT), though many cristae are still 
intact and there is some plasma membrane rupture (PM) in Micrograph C and some 
evidence of patchy chromatin condensation. In Micrograph D Cardiomyocytes have 
been subjected to 1 hr ischaemia and 24 hr reperfusion resulting in the appearance of 
some vacuoles (VAC).
E F
Micrograph E. Cardiomyocytes subjected to 2 hours SI
Nuclear clumping, increased vacoulation and swollen mitochondria (5000x). 
MIT=mitochondria; VAC=vacoulation
Micrograph F. Cardiomyocytes subjected to 2 hours LSI and 24 hours reperfusion
Increased damage but overall structure is still intact. (5000x)
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Where cardiomyocytes have been subjected to 2 hour ischaemia and 0 hours 
reperfusion. Early signs o f nuclear clumping, characteristic o f necrosis are observed.
The nucleus is intact and at this stage the damage is probably reversible (Micrograph E). 
In the subsequent Micrograph F in which cardiomyocytes have been subjected to 2 
hours ischaemia and 24 hour reperfusion there is the appearance o f vacuoles (VAC) but 
still overall cellular structure is intact.
Micrograph G. Cardiomyocytes subjected to 3 hours LSI
Mitochondria are swollen and there is vacuolar formation (magnification 6000x)
Micrograph H. Cardiomyocytes subjected to 3 hours LSI and 24 hours reperfusion
Nucleus has marginated chromatin (arrow) and cytoplasm is shrunken, classic features 
o f apoptosis (magnification 5000x).
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In Micrograph G featuring cardiomyocytes subjected to 3 hours LSI and 0 hour 
reperfusion the mitochondria are distinctly swollen. Instead o f regular stacking of 
cristae (inner mitochondrial membrane) many o f the vacuoles present are caused by the 
large spaces that appear in the mitochondria, pushing the cristae apart. This is probably 
due to the accumulation of electrolytes and water that are early signs o f damage to the 
enzymes o f the membrane sodium pump. The beginnings o f nuclear margination can be 
seen, but the plasma membrane is still intact and muscle fibres are still visible. 
Micrograph H displays cardiomyocytes subjected to 3 hours ischaemia and 24 hours 
reperfusion in which there is enhanced nuclear margination as indicated by the arrow 
and the cytoplasm has been severely reduced which are characteristic features of 
apoptosis.
Micrograph I. Cardiomyocytes subjected to 6 hours LSI
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Plasma membrane damage, indicates that cell is severely damaged (magnification 
6000x)
Micrograph J. Cardiomyocytes subjected to 6 hours LSI and 24 hours reperfusion
Secretary granules (arrow) present released mitochondria in the cytoplasm. 
MIT=mitochondria (magnification 6000x)
In the following diagram, Micrograph I, after 6hr ischaemia only, damage sustained is 
irreversible. Upon 24hr reperfusion later in Micrograph J, there is total disruption of the 
cell resulting in unrecognisable cell organelles as is evident in the photographs of cells 
subjected to 6hr ischaemia only (I), and 6 hours of ischaemia followed by 24 hour 
reperfusion (J). There is complete breakdown of the plasma membrane and spillage of 
cellular debris and cell organelles into the surrounding environment.
3.5 Discussion
The model of ischaemia reperfusion injury that was established in isolated rat neonatal 
cardiomyocytes, attempts to mimic the conditions heart cells experience during 
myocardial IR injury including depleted oxygen, substrate deprivation, hyperkalemia, 
acidosis and lactate accumulation.
In this model, it has been determined that the mode of cell death is predominantly 
necrotic. The number of cells undergoing necrosis increases with the extension of 
LSI/R.
Treatment of cardiomyocytes with LSI over a period of 3 hours ischaemia alone 
resulted in little change in LDH release, but a dramatic change occurred upon 
reperfusion. In contrast metabolic activity as determined by the MTT assay was 
severely decreased to 50% of the activity in control cells after 3 hours ischaemia alone 
and continued to decrease upon reperfusion. A sudden cessation in contraction on the 
addition of the ischaemic buffer was observed. This coincided with the instantaneous 
decrease of metabolic activity as determined by MTT assay. It was concluded that the
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duration of ischaemia is an important factor in controlling whether or not 
cardiomyocytes initiate contraction upon reperfusion; for example after 3 hours 
ischaemia, cells would contract up to 48 hours after reperfusion, after 6 hours LSI/R 
they contracted for up to 12 hours only and after 18 hours LSI/R they would not 
contract at all when reperfused.
The main source of ROS in cardiomyocytes is the mitochondrial respiratory chain. 41,50 
Greater than 90% of total body oxygen is utilized by the mitochondrial respiratory 
electron transport chain 19 of which 2% of the mitochondrial energy consumption results 
in production of ROS from complex 1 and 3. Ischaemia decreases mitochondrial 
antioxidant defence mechanisms such as MnSOD and glutathione peroxidase activity 
predisposing the mitochondrion to oxidative damage.154 Mitochondria as well as being a 
source of ROS are also the target for the damaging effects of ROS.154 This damage 
manifests itself in the formation of the MPTP with a concomitant decrease in the Ai|/m46
As ischaemia progresses, inhibition of oxidative phosphorylation occurs, which causes 
ATP concentration to decrease. The ever decreasing ATP concentrations and increasing 
anaerobic glycolysis inhibit the Na+/K+ ATPase resulting in a moderate increase in
9 +  1 ^  i o  c 7Ca . Acidosis develops, which delays the onset of cell death, and pore opening.
7  i
Upon reperfusion there is a much larger increase in intracellular Ca . The formation of 
ROS increases, inducing oxidative stress and the pH returns to normal, which along 
with Ca2+ overload, act in concert to induce the onset of the MPT and a decrease in the 
mitochondrial membrane potential (A\|/ra). This process is believed to occur as a 
consequence of reperfusion injury.156 Controversy exists in regards to the use of 
lipophilic dyes to measure Ai|/m and whether collapse of Avj/m is indicative of MPTP 
formation.151 Some researchers have developed models, which demonstrate that pore
IO
opening and collapse of the A\pm are interdependent. However, it is generally agreed
that maintenance of the Avj/m is important in ensuring viability of the cell as
1 1
mitochondrial diseases affect ATP production, and thus ultimately A\|/m collapses. As 
collapse of Aij/m is an early indicator of cell death, therefore in this study A\j/m decrease 
in conjunction with survival assays are used to ascertain cell viability. Moreover, from 
the data of published reports, this study assumes or is based on the fact that the greater
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the decrease in A\j/m therefore the greater the likelihood that this is as a result of the 
opening of the MPTP.22,118And as previously mentioned an uncoupler (CCCP) was used 
in this study to obtain depolarisation of Av|/m and to confirm that the fluorescent probe 
DiOC6 (3) can record this change. It has also been proved by the use of CsA that 
depolarisation of mitochondrial membrane potential measured by DiOC6 (3) in this 
model relates to the formation of the MPTP.
In the present studies, ischaemia alone did not cause a decrease in Ai|/m> only after 
reperfusion, which would suggest that the MPTP may have been formed after 
reperfusion, corresponding with previous reports by Halestrap and colleagues 140 as well 
as Duchen and colleagues.156 By incubating in LSI only, there was no observable 
decrease of A\|/m in this model.
There was no LDH release during ischaemia. However, we observed an increase in 
LDH release after 2 and 24 hours reperfusion and MTT activity was reduced by more 
than 50%. The decrease in metabolic activity was due to glycolysis inhibition and ATP 
decrease, which in turn may explain why the cardiomyocytes stopped contracting after 
addition of the ischaemic buffer. Soon after reperfusion metabolic activity continued to 
decrease, although some of the cardiomyocytes began to contract. A previous report has 
stated that heart muscle contraction occurs mainly during aerobic metabolism, 41 which 
would explain the cessation in ischaemia and continuation of contraction after 
reperfusion. We have previously observed and it is well reported, that the duration of 
ischaemia determines viability of cells. With moderate ischaemia the cells recover when 
reperfused, but with severe ischaemia (in this model, 3 hours) cells may die 157 upon 
reperfusion. It is generally believed that the determining factors involved in this form of 
cell death are loss of ATP and adenine nucleotides, increase in intracellular Ca2+, and 
oxidative stress, all these events acting synergistically to provoke both necrotic and 
apoptotic cell death.38’41’157’158
Reports from other centres relating to the presence of apoptosis in IR injury are quite 
divergent. In 1994 Gottlieb and colleagues 159 initially described the occurrence of 
apoptosis in rabbit hearts, which had been subjected to IR damage. In contrast, a
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Japanese group reported that in their experiments with rabbit hearts subjected to 
coronary artery occlusion, EM analysis revealed no signs of apoptosis. Taimor and 
colleagues found using a simulated ischaemic (SI) model of adult cardiomyocytes, that 
they could not induce apoptosis. Increasing SI only resulted in a greater degree of 
necrotic cells.160 They speculated that the lack of apoptosis was due to the fact that 
exogenous sources of ROS in ischaemically reperfused myocardium may contribute to 
the induction of apoptosis. In vivo the exogenous ROS might originate from other cell 
types such as neutrophils. In their model (as in the model in this study) single cells 
populations were used (cardiomyocytes) and therefore no exogenous sources of ROS 
were present. Taimor and colleagues used the same model again but using H2O2 as 
exogenous sources of ROS caused apoptosis in another study.161
Using our model of LSI/R, we investigated which type of cell death pathway 
predominated, whilst subjecting cells to differing periods of ischaemia and reperfusion. 
Using transmission electron microscopy (TEM) it was possible to differentiate between 
apoptotic and necrotic cells during the different ischaemic and reperfusion time points. 
We observed that very little apoptotic cell death occurred during the shortest ischaemic 
and reperfusion time points. As the duration of ischaemia progressed from 1 to 6 hours, 
the rate of necrotic cell death increased to 100%. The LDH assay, which measures 
enzyme release from cells with compromised plasma membranes, in other words 
necrotic cells, correlated with the TEM data. Decrease of metabolic activity was 
registered with prolonged LSI/R.
Electron microscopy has been described as “the gold standard in identifying apoptosis 
and necrosis.162 Nevertheless, some authors disagree and argue that this method is too 
labour intensive and prone to “subjective interpretation of morphological findings.” 
They instead recommend the use of terminal deocynucleotidyl transferase (TdT) 
mediated dUTP-biotin nick end labelling (TUNEL). This assay detects single and 
double stranded DNA breaks with 3’ OH termini and therefore TUNEL may not be so 
specific for the detection of apoptosis as some necrotic cells could also be TUNEL- 
positive.164 Ohno and colleagues have used electron microscopy to analyse plasma 
membrane integrity coupled with TUNEL (EM-TUNEL ) and they identified TUNEL
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positive cells with compromised membranes. A few years earlier, Majno and Joris 
described myocardial cell death occurring by apoptosis, oncosis and necrosis (the final 
steps in oncotic and apoptotic cell death). Oncosis is accidental cell death which 
features “classical” cell swelling and membrane rupture. 165 In the same vein, Anversa 
has classified myocardial cell death as necrosis, apoptosis and necrosis-apoptosis, the 
latter being a form of cell death with common features. This type of “shared” 
features in cell death is mentioned by other authors.166 Apoptosis is an energy requiring 
process; however, during apoptosis if energy levels fall necrosis ensues and hence the 
phenomenon is commonly known as secondary necrosis occurs. Cell death can not be 
solely defined as one or the other, apoptotic and necrotic pathways are becoming quite 
blurred and so another type of cell death name was coined, necrapoptosis. This term 
represents the shared characteristic form of both apoptosis and necrosis. 166
Ischaemia, heavy metals and other pathological stresses induce the production of 
cytoprotective stress or heat shock proteins (HSP).58’65’147 The relationship between 
duration of LSI/R, heat shock protein expression and cytoprotection was analysed. This 
was achieved by screening for induction of HSP 10, CyP-D, HSP60 and HSP70 using 
mono- and polyclonal antibodies for Western blotting. An induction in HSP70 
expression was detected after 3 and 6 hours ischaemia with 0 hour's reperfusion. Upon 
reperfusion an increase in HSP70 expression reached a maximum in cells subjected to 3 
hours LSI and 24 hours reperfusion only. Many investigators have stated that 
upregulation of HSP70 expression confers cytoprotection against a stress induced lethal
• • 167-170injury.
As well as using Western blotting to examine CyP-D expression, PPIase activity 
measurements did not reveal any differences. It has been reported that increased binding
171of CyP-D to the ANT-VDAC complex is partially caused by oxidative stress. We 
proposed that this might manifest itself as a change in PPIase activity or protein 
expression. However the results in this study have demonstrated that this increased 
binding was not manifested as an alteration in any of these factors. In this study the 
demarcation between apoptosis and necrosis were assumed to be distinctly different
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with the methods used as described. Other researchers corroborate the results that have 
been obtained,160 but this model has its limitations especially in the methods used for 
analysis of cell death. No biochemical assay to discern apoptosis and necrosis were used 
in this model. This model also does not take into consideration that apoptotic myocytes 
in vivo are phagocytised, and therefore in this model they may have developed necrotic 
features as a function of secondary necrosis. The use of TUNEL labelling in 
combination with the other methods used, may have altered the apoptotic count. The use 
of TUNEL in combination with TEM would have enabled the identification of so 
called necrapoptotic cells. There is no doubt that using these methods would have 
helped to give a more accurate idea as to the processes occurring in this model and 
therefore add more strength to our argument and possibly raise a few more questions, 
however, the overall results probably would not have changed.
3.6 Conclusion
The aim of this present study was to develop a model using neonatal rat cardiomyocytes 
to investigate the effects of LSI/R on parameters such as mode of cell death, A\j/m, HSP 
expression, PPIase activity. HSP70 expression increased in relation to duration of LSI/R 
and was substantially reduced after 6 hours ischaemia and 24 hours reperfusion. A\|/m 
decreased relative to the increasing duration of LSI/R. This study has shown that rat 
neonatal cardiomyocytes subjected to LSI/R die predominantly by necrosis with 
minimal apoptosis occurring. This is in agreement with a previous study160 in adult rat 
cardiomyocytes using a similar ischaemic buffer. Over the years many investigators 
have supposedly demonstrated the occurrence of apoptosis in the heart. However the 
percentage of apoptosis occurring following myocardial infarction in IR is highly 
controversial. This is partly due to the problems associated with false positives 
associated with techniques such as TUNEL labelling of double stranded DNA breaks. 
Some groups have speculated that there are apoptotic-inducing factors released from 
exogenous blood or non-myocyte cells in ischaemically reperfused tissue. It also is 
thought that apoptosis may be induced in cardiomyocytes, as a result of sublethal injury
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when mitochondria are in slight energy depleted state.172 Their report demonstrated that 
slight metabolic depression due to ischaemia/reperfusion results in apoptosis, whilst 
severe metabolic depression due to prolonged ischaemia /reperfusion causes mostly 
necrotic cell death.
In summary this present study demonstrates that as the duration of LSI/R increases 
apoptosis decreases until cell death is necrotic as determined by the survival assay 
employed and ultrastructural analysis. Elevation of HSP70 protein expression reached a 
peak at 3 hours LSI and 24 hours reperfusion and no significant increase in PPIase 
activity or expression of cyclophilin was observed.
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CHAPTER 4
4. ISCHAEMIC PRECONDITIONING OF 
NEONATAL RAT CARDIOMYOCYTES WITH SI/R
4.1 Introduction
Ischaemic preconditioning (IPC) describes the phenomenon whereby a single or series 
of sublethal ischaemic stresses with intervening reperfusion enhances the tolerance of 
the myocardium to a more subsequent lethal ischaemia/reperfusion stress. This 
endogenous protective mechanism was first described in 1986 by Murry and 
colleagues72 in a canine heart model. Dogs were anaesthetized and subjected to four 
sequential 5-minute periods of regional ischaemia, each followed by 5 minute 
reperfusion, before a sustained 40 minute ischaemic insult. They found that brief 
periods of ischaemia did not cause necrosis but reduced the depletion of ATP. This 
preconditioning phenomenon since then has been demonstrated in many species such as 
rat77,173,174 pig175 and rabbit80,95,96,176 as well as several organs such as liver77 and 
brain.141,174 IPC in the myocardium occurs in two distinct phases: early, (acute or 
classical) preconditioning which starts immediately after the initial trigger and lasts for 
2 - 3  hours, and a second window of protection, termed late or delayed preconditioning, 
occurs 12 to 24 hours after the initial stimulus lasting up to 3 - 4 days which is not as 
potent as classical preconditioning.71,80,177'179 This innate protection can enhance or 
restore contractile function of post ischaemic myocardium and protect skeletal 
muscle180,181 as well as reduce ATP depletion in the canine (preconditioned) 
myocardium72 subjected to a sustained ischaemic insult. The interest generated in such 
a powerful phenomenon has led to the drive to investigate the mechanisms of IPC, 
which in turn have helped to achieve a better understanding of the mechanisms involved
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in ischaemia/reperfusion injury. It has been demonstrated that adenosine, bradykinin, 
noradrenaline, prostanoids, free radicals and nitric oxide (NO) are released from the 
myocardium182'184 of which some, but not all are believed to lead to the opening of K a t p
1 81 1 8Schannels. ’ By the nature of the different methods of preconditioning, it seems that 
different induction mechanisms are involved.
Adenosine is a breakdown product of ATP, which occurs, in high concentrations in 
ischaemic tissue.77,186 Adenosine is an initiator of preconditioning and is necessary for
I o  1
the mediation of preconditioning effects. The binding of adenosine can be blocked by
selective A1 or A3 receptor antagonists, which lead to the inhibition of protection and
1 81therefore confirm the receptor-mediated nature of preconditioning. Once the 
adenosine receptors have been activated, G-proteins coupled to these receptors are also 
activated.77 This in turn, results in the activation of phospholipase C and DAG 
production followed by activation of membrane-associated protein kinase C, thereby 
inducing the translocation of specific PKC isoforms from an inactive cytosolic pool to 
the cell membrane. This has been proposed as a fundamental component of the PC 
mechanism. 71 As K a t p  channels are linked to G-proteins, it has been suggested that 
they play a part in acute preconditioning responses. This is confirmed by the 
pharmacological action of K a t p  channel antagonists, which abolish the preconditioning
71 183response. ’
We investigated the existence of the delayed preconditioning phenomenon in primary 
cardiomyocytes. We also studied the correlation between cyclophilin enzymatic 
activities and delayed preconditioning as well as the expression of HSP’s in these 
preconditioned cells.
4.2 Methods
4.2.1 Cell Culture
Primary neonatal cardiomyocytes were isolated as previously described in Chapter 2.
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4.2.2 Ischaemic Preconditioning Protocol
The cardiomyocytes that had been seeded into 6 or 12 well plates were subjected to 1 
hour simulated ischaemia (SI), reperfused for 24 hours and then subjected to 3 hours 
lethal simulated ischaemia (LSI) and reperfused for 24 hours (LSI/R) as indicated in the 
following diagram (Figure 4-1). The control cells in contrast were kept in maintenance 
media during the preconditioning process prior to subjection to LSI for 3 hours.
Control 24 hour incubation in medium 3 hr LSI + 24 hr rep*
1 hr SI 24 hour reperfusion 3 hr LSI + 24 hr rep
IPC
— Preconditioning phase  Ischaemic/rep insult—
Figure 4-1. This is a description of the IPC protocol used in cardiomyocytes
*rep= reperfusion. Control cells were maintained in maintenance medium prior to 
subjection to the ischaemic/reperfusion insult. In contrast another group of 
cardiomyocytes were subjected to 1 hour simulated ischaemia (SI) and reperfused for 24 
hours. This was the preconditioning stimuli required, prior to exposure to the 
ischaemic/reperfusion insult.
4.2.3 Assessment o f  Viability, Protein Expression and PPIase Activity
After the end of 3 hours LSI + 24 hour reperfusion (LSI/R), some of the buffer was 
collected and the lactate dehydrogenase release from the cardiomyocytes was 
determined as described in Chapter 2. Metabolic activity was measured using the MTT 
assay also as previously described. Protein was extracted and Western blot analysis was 
performed in order to determine of heat shock protein expression. Cells were also 
collected for the PPIase enzymatic activity assay, which was described in Chapter 2.
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4.2.4 Measurement o f Mitochondrial Membrane Potential (A y/m)
Cells were preconditioned as described above and then subjected to LSI/R. Controls 
were incubated in media alone and then subjected to LSI/R. After these incubations 
cells were collected and stained with DiOC6 (3) and the change in DiOC6 (3 
fluorescence was measured as previously described in Chapter 2.
4.3 Results
4.3.1 Determination o f Protection Afforded by Various Preconditioning Protocols
Cardiomyocytes were initially subjected to lhr SI and reperfused for different periods. 
Then each differently reperfused group of myocytes were all exposed to 3 hr LSI with 
24 hr reperfusion (LSI/R) as a lethal insult. The viability of each of these differentially 
reperfused cardiomyocytes was assessed by the MTT assay. This assay demonstrated 
which group of cardiomyocytes better survived LSI/R and was therefore ischaemically 
preconditioned. The graph in Figure 4-2 demonstrates that lhr SI with 24hr reperfusion 
afforded the best protection against LSI/R. Consequently lhr SI with 24hr was then 
used to precondition the cardiomyocytes in all of the following experiments.
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Reperfusion Time after Simulated 
Ischaemia (hr)
Figure 4-2. Viability of Cardiomyocytes following 1 hour SI and different 
reperfusion time points
Each o f these samples were initially incubated in 1 hour SI buffer and differing 
reperfusion time points, followed by subjection to LSI/R, then metabolic activity was 
measured in order to ascertain which time point afforded the best protection. These 
values are representative o f means ± SEM of 6 different preparations. *P<0.001, 
tP<0.01 v control.
4.4 Effect of IPC on Cell Survival against LSI/R
The degree o f protection reflected in LDH release, in the preconditioned cells in 
comparison with non-preconditioned cells subjected to LSI/R was 30%. In comparison 
to the preconditioned and non-preconditioned cells, the difference in LDH release 
between these and the control was 40% and 30% respectively (Figure 4-3A). The MTT 
assay also demonstrated the increased level o f metabolic activity in preconditioned cells 
in comparison with non-preconditioned cells, however the difference was only 
approximately 20% (Figure 4-3B). We also observed the effect o f preconditioned and 
non-preconditioned cells on mitochondrial membrane potential. As is shown in Figure
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4-4, LSI/R significantly decreased DiOC6 (3) fluorescence and therefore decreased the 
Avj/m in non-preconditioned cardiomyocytes, but preconditioned cells maintained a 
significantly high A\|/m (p<0.001) after subjection to LSI/R. In preconditioned cells, 
contractile activity returned after reperfusion was established as visualised by the light 
microscope, but the same was not observed in non- preconditioned cells.
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Figure 4-3. Effect of IPC cardiomyocytes after exposure to LSI/R
Demonstration o f the protection afforded to preconditioned primary cardiomyocytes 
against non- preconditioned cells that have been subjected to 3 hour LSI/R as
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determined by (A) LDH release and (B) MTT cell metabolic assays. In both graphs 
protection of IPC treated cells is significant (fP O .O l) for IPC samples after subjection 
to LSI/R for both assays. These results are representative o f the means ± SEM from 3 
independent experiments (n=18). tP<0.01 vs LSI/R
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Figure 4-4. Effect of LSI/R on Av|/m in non-IPC and IPC treated cardiomyocytes.
This graph demonstrates the significant protection (PO.OOl) afforded to IPC treated 
cardiomyocytes in comparison to non-IPC treated cardiomyocytes after subjection to 
LSI/R. These results are representative o f the means ± S.E.M of 3 independent 
experiments (n=9) for each sample and *P<0.01 compared with control and ¥P<0.001 
compared with non-IPC.
125
Hours of reperfusion
Figure 4-5 Graphic representation of HSP70 protein expression.
This graph reflects different levels o f HSP70 expression in non-preconditioned and 
preconditioned cells and is a graphic representation o f the Western blot below. The 
positive control (+ control) is a heat-shocked sample. The control is non-IPC treated 
cardiomyocytes and the +24 hour (IPC) sample is representative o f ischaemically 
preconditioned cardiomyocytes with an increased expression o f HSP70. Data are 
representative o f mean S.E.M ± 3 individual experiments **P<0.001 vs control
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Figure 4-6 Western blot of HSP70 expression.
Effect o f preconditioning stimuli on HSP70 expression in primary neonatal 
cardiomyocytes. Protein lysates were isolated after each o f the reperfusion intervals and 
electrophoretically separated on a 12% SDS/PAGE gel. The individual bands were 
analysed on a densitometer and the above graph was constructed from the results.
The current preconditioning protocol was determined by increased viability o f cells 
when subjected to LSI/R as opposed to non-preconditioned cells subjected to LSI/R. We 
analysed whether any o f the heat shock proteins such as CyP-D, HSP10, 60 and 75 were 
upregulated (Figure 4-7). Upregulation was only observed in HSP70 as demonstrated in 
Figure (4-6), where a distinctive band is visible at 70 KDA. The Western blot 
expression o f HSP70 is shown in regards to the degree o f reperfusion after 1 hour 
simulated ischaemia. Generally as the reperfusion time increased, the expression of 
HSP70 increased and reached a peak at 24 hours and declined thereafter. These values 
are also represented in graphical form (Figure 4-5)
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HSP75
HSP10
Figure 4-7 Western blot analysis of IPC treated cardiomyocytes
Primary neonatal cardiomyocytes were subjected to 1 hour SI and then reperfused for 0, 
6, 24 and 48 hours reperfusion. Total proteins were isolated and each sample was 
electrophorectically separated on a 12.5% SDS/PAGE gel. Following protein transfer 
each gel was probed with the relevant antibody. *As mentioned in the materials and methods 
chapter, mitochondria was isolated and the CyP-A antibody was used to probe for CyP-D expression.
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4.5 Discussion
Here, an effective protective preconditioning protocol for primary neonatal 
cardiomyocytes subjected to LSI/R was devised. The analysis of HSP70 Western blot 
demonstrated that the protein level reached its peak at 24 hours after 1 hr SI and 24 hrs 
reperfusion. We believe that the protection observed in this study may correlate with the 
increasing HSP70 levels which have been shown to be protective against ischaemic 
stress in other studies167’169,170 although other factors are also known to be present and
1 R7are also protective such as activation of p42/44 mitogen-activated protein kinase. 
Also we cannot exclude the complex protective effects of angiotension II, bradykinin, 
catecholamines, opioids and endothelin that are released during ischaemia and involved
1 8 0  1 8 4in the early and late stages of preconditioning.
Cardiac protection by preconditioning has been well documented and is known to occur 
as a biphasic phenomenon with an early or “classic” phase developing in minutes and 
lasting for 2 to 3 hours followed by a “second window of protection” or delayed 
preconditioning which starts 24 hours after the initial stimulus and lasts for a few 
days.72,104,188 In the model presented here, only the late phase of preconditioning was 
studied. In studying this phenomenon a simulated ischaemic buffer was used in which 
myocytes were subjected to a 1 hour ischaemic episode followed by 24 hour reperfusion 
in normal medium. The SI buffers, which are used in many preconditioning protocols, 
are glucose free with the addition of sodium lactate to create acidic conditions. Some of 
the respiratory buffers contain protonophores such as CCCP189 and respiratory chain 
inhibitors (NaCN).146 Sodium dithionite was used here because it is an effective oxygen 
scavenger and is able to reduce the cytochrome oxidase component of the mitochondrial
1 87respiratory chain and these effects are known to be completely reversible.
In this study it was found that simulated ischaemia produced delayed protection in a 
time dependent manner with a maximum effect at 1 hour SI and 24 hours reperfusion. 
These results correlate with other studies conducted on neonatal cardiomyocytes, 
whereby metabolic inhibition has resulted in upregulation of HSP70 and increased 
protection.169 Other groups have upregulated HSP70 expression by transfection and
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found that HSP70 is protective against LSI.61,133,145,190 Analysis of protein expression of 
CyP-A and CyP-D in the cytoplasm and in mitochondria respectively, did not reveal 
any changes in comparison to their respective controls. Also in the present study no 
upregulation of mitochondrial chaperones HSP60, 10, and 75 were detected. In this 
preconditioning model, it is not possible to speculate on the role of these HSP’s but, it 
must be noted that previous studies by other authors have demonstrated in rodent 
myogenic cell lines and neonatal cardiomyocytes that, overexpression of individual 
HSP60 and HSP10 does not afford these cells protection against SI.69 Only the 
combined overexpression of these HSP’s protects these cells during simulated 
ischaemia and reperfusion (SI/R) from induced apoptotic cell death.191
79Major progress in IPC has occurred over the years since Murry and colleagues first
OA
described the process of preconditioning and Marber and colleagues defined the 
“second window of protection” or delayed preconditioning. Although classical 
preconditioning is more potent, delayed preconditioning is believed to be clinically 
more practical because of the longer duration of protection not just against myocardial 
infarction, but also against reperfusion induced myocardial stunning. 10,104 It is believed 
that initial triggers of this protective phenomenon are NO, ROS and adenosine. These 
are transduced by signalling chemicals such as PKC and NF-*B, and are transported to 
the nucleus where transcription of iNOS, COX-2 and other cardioprotective genes 
occurs. In this phase, synthesis of HSP’s and activation of K a t p  channels occurs. 104 
This present study was primarily concerned with the involvement of a limited number 
of HSP’s, (HSP10, 60, 70, 75 and cyclophilin). However, there is growing evidence that 
other HSP’s such as HSP32192 and HSP27 170 have an important part to play in the 
sequelae of events involved in IPC. It also appears that certain other HSP’s and 
signalling processes are activated depending on the method of preconditioning.169
The present study demonstrates that in this ischaemic preconditioning model, 
upregulation of HSP70 is directly correlated to protection of isolated neonatal 
cardiomyocytes against LSI/R. The protection observed also preserves Av|/m. It is 
currently unclear as to whether the mitochondrial chaperonin complex (HSP60, 10 and 
75) is upregulated in IPC. Our studies did not reveal any new data regarding this
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complex. No difference in enzymatic activity of cyclophilin (PPIase) or protein 
expression was observed. A lot of work has been carried out on the role of HSP70 in 
preconditioning; it would be interesting to investigate the degree to which it is involved
1 QTin IPC. Using compounds such as quercetin to attenuate HSP70 expression could 
help to determine its role in IPC in conjunction with other HSP’s. Determination of 
other factors such as oxygen consumption, free radical production and ATP levels could 
further help to understand the events occurring in this phenomenon. Then it may be 
possible to develop drugs that can initiate a similar stress response and therefore 
precondition cells to severe insults. Kume and colleagues194 used a chemotherapeutic 
agent, doxorubicin, an anticancer drug, to initiate a stress response within rat liver, 
which protected against an ischaemic insult. From their results, they believe that 
pharmacological preconditioning does have a clinical application; however doxorubin 
has toxicity problems in the heart.194 Therefore this approach would necessitate the 
development of novel drugs. Furthermore, although the time course of HSP70 
experiments following IPC in our model strongly correlates with the developments of 
protection, we have not causally linked HSP70 function to the mode of protection. In 
order to do this, we would have to perform experiments using anti-sense 
oligonucleotides to HSP70 or an RNA approach. HSP70 knockout in vivo is not 
possible due to its essential role in development of the organism and the heart.
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CHAPTER 5
5. HSP EXPRESSION IN SUBSARCOLEMMAL 
AND INTERFIBRILLAR MITOCHONDRIAL 
FROM A RAT LAD OCCLUSION MODEL
5.1 Introduction
Mitochondria have been described as “the powerhouse of the cell” as they provide the 
majority of ATP. Hence loss of mitochondrial function will inevitably lead to cell death. 
In fact it has been determined that mitochondria not only decide whether a cell will die 
but also whether cell death is by apoptotic or necrotic pathways.195 These and other 
findings have led to a resurgence of interest in mitochondrial physiology during the 
1990’s until the present day.
In the process of myocardial ischaemia (specially during periods of ischaemia greater 
than 30 minutes), damage occurs when the blood flow is re-established, resulting in 
reperfusion injury, characterised by high Ca2+ accumulation, ATP depletion, membrane 
depolarisation and high phosphate concentrations.37,44,49 These factors cause the 
mitochondria to swell in the process known as mitochondrial permeability transition 
(MPT) as a result of the formation of the mitochondrial permeability transition pore 
(MPTP). This is due to the opening of these non-specific pores in the inner 
mitochondrial membrane, and depending on the duration of pore opening may, result in
■JO
irreversible damage and ultimately cell death.
In heart muscle, electron microscopy reveals the existence of two distinct populations of 
mitochondria by virtue of their different locations,154 subsarcolemmal and interfibrillar. 
Subsarcolemmal mitochondria (SSM) reside just below the sarcolemma whereas
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interfibrillar mitochondria (IFM) are located between the myofibrils.196 These different
1 0 7  1 QOtypes of mitochondria are affected differently by ischaemia, ageing and 
cardiomyopathy.199 SSM and IFM can be isolated by mechanical and enzymatic 
methods as originally described by Palmer and colleagues196 and both methods have 
been reported to produce good, separate yields of both mitochondrial types.198
Using variations of the isolation procedures first described by Palmer196 SSM and IFM 
were isolated. It is known that under normal and pathological conditions, these 
mitochondrial subsets respond differently in normal and pathological 
conditions.154’197’198’200,201 SSM possess a greater content of the molecular chaperones 
HSP60 and mitochondrial HSP70 (mHSP70) than IFM.202 During myocardial IR, 
redistribution of mitochondrial chaperones may occur in SSM and IFM. These are 
factors that were investigated in the following experiments.
This study aimed to use a rat left anterior descending (LAD) occlusion model to
• Explore the protein expression of HSP’s and mitochondrial membrane potential 
(A\j/m) in the different mitochondrial subsets.
• Investigate enzymatic (PPIase) activity in normal and occluded mitochondrial 
populations.
• Define ultrastructural differences between the different populations 
These aims will help to prove or disprove the hypothesis that;
Myocardial IR will cause Avj;ra to decrease to a greater extent in SSM than IFM due to 
differences in HSP expression and activity of cyclophilin.
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5.2 Methods
5.2.1 Rat LAD Occlusion Model
As previously explained in Chapter 2, hearts from female Sprague Dawley rats, 
weighing between 250 -300g were subjected to IR and then the hearts were surgically 
removed and mitochondria isolated. Rats were separated into 6 groups,
Table 5-1. List of groups with their respective LAD occlusion and reperfusion 
times
Group 1 (control) Hearts (n=4) surgically removed after 60 minutes with loosely 
attached suture around LAD coronary artery
Group 2 Hearts (n=4) surgically removed after 60 LAD minutes occlusion 
as described (section 2.1.5) and perfusion of Evan’s blue dye
Group 3 Hearts (n=4) surgically removed after 60 minutes occlusion and 15 
minutes reperfusion
Group 4 (control) Hearts (n=4) surgically removed after 90 minutes with loosely 
attached suture around LAD coronary artery
Group 5 Hearts (n=4) surgically removed after 90 minutes LAD occlusion
Group 6 Hearts (n=4) surgically removed after 90 minutes occlusion and 15 
minutes reperfusion
5.2.2 Electron Microscopy
Following the harvest of SSM and IFM, they were then processed by electron 
microscopy as previously described in Chapter 2. This was performed in order to
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ascertain if there were any morphological differences in SSM and IFM. Also electron 
microscopy was used as a method of evaluating the purity of the mitochondrial 
isolations, by assessing the amount of cellular debris relative to single mitochondria in a 
given field.
5.2.3 PPIase A ctivity
SSM and IFM were isolated from the rat hearts as previously described in Chapter 2. 
The mitochondria were washed thoroughly and resuspended in HEPES buffer.
A Bio-Rad protein assay was performed on the isolated mitochondrial fractions.
Then equal amounts of SSM and IFM of the different heart groups were assayed for 
cyclophilin (PPIase) activity as previously described in Chapter 2.
5.2.4 Western Blotting
From the protein measurements, equal amounts of protein were separated on an SDS- 
12% polyacrylamide gel and after overnight transfer; the membranes were probed with 
antibodies for HSP 10, CyP-D, 60 and mHSP70 (GRP75) for an hour. The appropriate 
secondary antibodies were added and the blots were developed using the ECL protocol 
as described in Chapter 2.
5.2.5 Measurement o f A y/m in Mitochondria
To register the decrease in Ai|/m, as previously performed with cardiomyocytes 150>203>204 
a population of rat heart mitochondria were subjected to an uncoupler of oxidative 
phosphorylation carbonyl m-chlorophenylhydrazone (CCCP) that causes a decrease in 
A\|/m.203 CCCP is a necessary positive control for Avj/m as depolarisation of A\\fm is not 
always indicative of MPTP formation, but once the MPTP has formed then 
depolarisation of A\\fm follows.46 The A\\rm is a component of the proton motive force 
(pmf) that is generated by the electron transport chain. The formation of the MPTP
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results in depolarisation of the A\j/m as the oxidative phosphorylation that produces ATP 
and A\|/m is disrupted. Mitochondria isolated from untreated rats were separated into 
two samples. One sample was treated with 60 pM CCCP for 30 minutes and the other 
being the control sample was left untreated. Then both the control and CCCP treated 
samples were analysed on the fluorescence -activated cell sorter (FACS) after 
incubation with 0.8nm of the fluorescent probe 3,3'- dihexyloxacarbocyanine iodide 
DiOC6 (3). Following this, SSM and IFM from the different groups were incubated with 
DiOC6 (3) and any differences between the groups were identified by FACS analysis.
5.3 Results
5.3.1 Electron Microscopy
Electron micrograph pictures did not reveal any significant ultrastructural differences 
between the different mitochondria (Micrograph K and L). They do however reveal the 
purity of the mitochondrial isolations as previously described in Chapter 2, as well as 
comparing the quantity of mitochondria isolated between the two different populations. 
Nagarse treatment appears to have released far more mitochondria (Micrograph L) than 
non-nagarse treated heart and more cellular debris was evident in the SSM population.
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Micrograph K. Subsarcolemmal Mitochondria (SSM)
SSM are located below the sarcolemma and are isolated by physical disruption of 
tissues. Electron microscopy confirms that these mitochondrial populations have 
maintained their structural integrity after the disruptive isolation process.
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Micrograph L Interfibrillar Mitochondria (IFM)
The Figure show non-nagarse treated SSM (Micrograph K) and nagarse treated IFM 
(Micrograph L) harvests from female Sprague - Dawley control hearts. IFM are located 
between the myofibrils and they are released by nargarse protease digestion. (Total 
magnification lOOOOx)
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5.3.2 Changes in A y/m in SSM and IFM form the Rat Heart LAD Occlusion Model
***
control CCCP
CCCP treated mitochondria
Figure 5-1. CCCP treatment of mitochondria.
This graph demonstrates the change in DiOC6 (3) fluorescence in mitochondria that 
have been treated with the protonphore CCCP. Application o f CCCP collapses the A\|/m 
reducing the fluorescence of the mitochondrial dye DiOC6 (3) in comparison to the 
untreated control. CCCP resulted in a significant reduction when compared to the 
control (***P<0.0001).
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Figure 5-2. SSM and IFM from an LAD occlusion.
SSM and IFM were isolated from a rat LAD occlusion cardiac model. The A\j/m was 
measured for all 6 groups and compared as demonstrated in these graphs. In Figure 5-
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2 A, there was no significant difference between the control SSM (Group 1) and Group 
2. Group 2 has been LAD occluded for 60 minutes only whereas Group 3 has been LAD 
occluded for 60 minutes and reperfused for 15 minutes prior to mitochondrial isolation. 
SSM in Group 3 were significantly different from control (Group 1) (*P<0.05). Figure
5-2B is representative of the statistical difference between mitochondria of control 
(Group 4) and Group 6. Group 6 rats were LAD occluded for 90 minutes and reperfused 
for 15 minutes only whilst Group 5 rat were LAD occluded for 90 minutes only prior to 
mitochondrial isolation. |P<0.001 only for SSM when compared to Group 4 (control), 
**P<0.01 for IFM (Group 6) in comparison to Group 4 IFM (control). These results are 
the standard error of the mean of n=4 independent experiments.
An uncoupler of mitochondrial oxidative phosphorylation (CCCP) was used, which by 
attacking the proton gradient across the inner mitochondrial membrane reduces the 
Av|/m150 and consequently leads to a cessation in ATP production. As in Chapter 3, it 
was necessary to ensure that we could measure any changes in mitochondrial Ai\fm in the 
isolated mitochondria from the rat heart LAD model, using the fluorescent probe 3,3'- 
dihexyloxacarbocyanine iodide (DiOC6 (3)) on the flow cytometer. In Chapter 3, CsA 
afforded protection, not statistically significant, but these results were suggestive of an 
inhibition of the MPTP by an increase in A\j/m upon pre-incubation of CsA prior to 
subjection of the cells to LSI/R ion as measured by DiOC6 (3). Thereby relating A\j/m to 
MPTP in these experiments.
On the FACScan, two mitochondrial populations were identifiable as control and CCCP 
treated. In Figure 5-2A SSM (Group 3) posses a statistically significantly (P<0.05) 
decreased Avj/m as opposed to the SSM control (Group 1). IFM (Group 3) Ai|/m 
decreased but not statistically different in respective to control IFM (Group 1). Group 2 
mitochondria from 60 minute LAD occluded rats demonstrated no change in respect to 
control SSM/IFM in Group 1.
Figure 5-2B demonstrates the significant reduction in A\\rm of both SSM and IFM 
(Group 6) (**P<0.001) as opposed to A\j/m of SSM and IFM of their respective controls 
(Group 4). Group 6 rats were LAD occluded for 90 minutes and reperfused for 15 
minutes only prior to mitochondrial isolation whereas Group 5 rats were LAD occluded
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for 90 minutes only. There was very little change between Group 5 rats and control 
(Group 4) occlusion with 15 minute reperfusion.
5.3.3 Heat Shock Protein Expression in SSM and IFM
There were no observed significant differences in expression of heat shock proteins in 
normal, ischaemic or reperfused SSM and IFM. We compared HSP 10, 60, mHSP70 and 
CyP D expression. (Figure 5-3).
Group 1 Group 2 Group 3 Group 4 Group 5 Group6
SSM IFM SSM IFM SSM IFM SSM IFM SSM IFM SSM IFM
HSP60
HSP75
CyP-D
II I t
m
SSM IFM SSM IFM SSM IFM SSM IFM SSM IFM SSM IFM 
Group 1 Group2 Group3 Group4 Group 5 Group 6
Figure 5-3 Western blot analysis
Western blot showing protein expression of rat heart cardiac mitochondrial fractions, 
after incubation with a panel of antibodies HSP 10, HSP60, HSP75 and CyP-D. There is 
no change between SSM and IFM before or after ischaemia and reperfusion.
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5.3.4 PPIase Activity in SSM and IFM
The enzymatic activity of cyclophilin was measured between SSM and IFM in normal 
heart tissue as well as in ischaemic and reperfused. The activity of cyclophilin-D (CyP- 
D) was assessed, which as already mentioned is an integral member of the MPTP that 
plays a role in cell death. No difference in PPIase activity between SSM and IFM in 
normal heart tissue was observed. The same observation was seen in PPIase activity 
between SSM and IFM in the ischaemic and reperfused groups. Even between SSM and 
IFM between normal, ischaemic and reperfused the same results were obtained 
irrespective of the degree of reperfusion.
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Figure 5-4. PPIase activity of mitochondria isolated from LAD occluded rats
SSM and IFM were isolated from rats, which have been occluded and reperfused for 
differing time periods (as described in the materials and methods). There was no
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statistical difference in PPIase activity between any of the groups and their respective 
controls as visualised in Figure 5-4A and 5-4B.
5.4 Discussion
The objectives were to emulate myocardial ischaemia/reperfusion using a rat heart LAD 
occlusion model, in order to examine the effect on:
• The A\|/m in the different groups in comparison to their respective controls
• Heat shock protein and cyclophilin expression and activity in SSM and IFM
• Any ultrastructural differences.
In order to achieve these objectives, hearts from female Sprague Dawley rats were used 
and organized into 6  groups. Groups 1 and 4 were the controls for 60 and 90 minutes 
ischaemia only (Groups 2 and 5), and groups 3 and 6  were subjected to 60 and 90 
minutes ischaemia with 15 minutes reperfusion. The method used for isolating SSM 
and IFM were adaptations of established protocols, 196 and electron microscopy helped 
to confirm purity of isolated samples as previously described.
The main findings in this study are that in this model, A\j/m decreased significantly when 
compared to their respective controls only in the reperfusion groups (3 & 6 ) in SSM 
(p<0.05) (p<0.001) respectively. In IFM the decrease was significant only in group 6  
(p<0.01). Our findings are partly consistent with our initial hypothesis, SSM sustain 
increased damage during IR in comparision to IFM, possibly due to their close 
proximity to the plasma membrane. Ultrastructural analysis did not reveal any major 
differences between these different types of mitochondria, which correlates with what 
has been observed by other researchers. 154,198,206 There were no differences in the PPIase 
assay between the control and treated samples, and the same was found for expression 
of the heat shock proteins (HSP 10, HSP60, mHSP70 and CyP-D) tested.
Our findings are not wholly in agreement with previously published data. Gatellitelli 
and colleagues207 in measuring total mitochondrial Ca2+ discovered that Ca2+
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accumulated to a far greater extent in SSM than IFM in guinea-pig cardiac myocytes 
when they are loaded with calcium and sodium and potentiated, whereas in resting cells 
the levels of Ca2+ were equal. This may help to explain why in experiments upon 
subjection to ischaemia /reperfusion, Ai(/m decreased to a greater degree in SSM than in 
IFM. It is a known fact that one of the major contributors to ischaemic cell death is high 
concentrations of cytosolic Ca2+. 208'210 Subjecting these myocytes to ischaemia and 
reperfusion may alter the levels of Ca2+ in SSM. In many cells there is a continuous 
shuttling of Ca2+ between the mitochondria and endoplasmic recticulum. Dismption of 
this movement results in overloading of Ca2+ in the mitochondria. This activates 
processes leading to the formation of the MPTP and therefore cell death ensues.37,210,211 
As a consequence of the formation of MPTP, oxidative phosphorylation that maintains 
A\|/m is disrupted and therefore there is a decrease in A\ | / m .46
In the study reported in this Chapter, it has been demonstrated that in this model of 
LAD occlusion, there was no difference in expression of mitochondrial heat shock 
proteins in ischaemically reperfused compared with normal SSM and IFM. In other 
studies mitochondrial chaperone expression has been found to be absent in SSM from 
muscle suffering from respiratory chain deficiency, but overexpressed in the 
corresponding IFM. This would indicate that there was also a reduction or absence of 
protein import in SSM. Previous work has established the importance of HSP60 for cell 
survival 213 and refolding 214 as well as the importance of mHSP70 in its role as an ATP 
dependent import “motor”, importing precursors into the mitochondrial matrix. 
Takahashi and colleagues upon investigating protein import into mitochondria 
discovered that both HSP60 and mHSP70 levels are present in the mitochondrial 
subpopulations but their levels are increased in SSM in ATP depleted rat muscle, 
although the rate of protein import is greater in IFM. They suggested this contradiction 
was probably due to the rate of mitochondrial import, which is determined by ATP 
consumption, which is greater in IFM.
Battersby and colleagues 206 isolated mitochondrial subpopulations from below the cell 
membrane and in the myofibrils, using classical methods of isolating these 
subpopulations 196 in rainbow trout. They were not able to discern any biochemical or
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genetic differences between the two populations. They speculated that although these 
populations appear to be identical, they might be regulated differently in vivo, as their 
location could also provide differential rates of access to mitochondrial substrates. This 
contrasts with mammalian muscle, which possesses biochemically distinct populations. 
196,197,207 Although Battersby and colleagues looked at some respiration rates, they did 
not examine levels of mitochondrial chaperones within these subpopulations. Import 
and processing of mitochondrial peptides do contribute to mitochondrial heterogeneity 
202,215 o ther investigators have looked at the effect of aging on these subsets 154’197’198’200 
and have discovered that oxidative metabolism and protein yield declines with age in 
IFM in a rat model of aging, but SSM are unaffected by these aging related decreases.
In summary, this present study has demonstrated that ischaemia/reperfusion damage 
decreases mitochondrial A\j/m SSM to a greater extent than IFM in the LAD rat 
occlusion model. It is likely that SSM, because of their locality, are more susceptible 
than IFM to damage from external stresses. Also SSM, as in the potentiation
171experiments of Galitelli were found to contain double the amount of calcium as 
opposed to IFM, which may mean that SSM possess a greater propensity to form 
MPTP, as Ca2+ is one of the major inducer of pore formation 86. This may help to 
explain the results of A\|/m experiments, but further experiments involving sodium and 
calcium loading in ischaemic tissue need to be conducted in correlation with A\j/m. It has 
been suggested that the protein import pathway may be dependent on A\j/m 202. As in 
these experiments SSM demonstrated a lower A\|/m than IFM, it would be interesting to 
ascertain if conditions which decrease A\\im cause the rate of protein import to decrease 
also. A\|/m decreases in protein import would decrease in parallel as ATP is necessary to 
maintain proton motive force (pmf) (which in turn sustains Ai|/m.) and protein import. 
Preservation of mitochondrial function is very important to the cell; therefore further 
experiments involving a global preconditioning protocol could be used and then 
determine whether protection was afforded to one or both of the mitochondrial subsets.
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CHAPTER 6
6. THE ROLE OF NITRIC OXIDE IN 
PROTECTION OF THE MYOCARDIUM AGAINST 
OXIDATIVE STRESS
Data from this chapter has recently been published Ekaterina Monastyrskaya. 
Najeem Folarin, Igor Malyshev, Colin Green and Larisa Andreeva: Application of 
the nitric oxide donor SNAP to cardiomyocytes in culture provides protection 
against oxidative stress. Nitric Oxide.2002 Sep; 7(2): 127.
6.1 Introduction
Furchgott, in 1989 125 suggested that endothelial derived relaxing factor (EDRF) and 
nitric oxide (NO) were one and the same. Ever since then, NO has been considered to be 
a very important molecule, such that in 1993 it was voted "molecule of the year" due to 
its role as a universal regulator of physiological and defence mechanisms. Some of 
its roles include mediation of the cytotoxic immune response, regulation of vascular 
tone in the cardiovascular system as well as neurotransmission in the nervous system 
182. Its absence or insufficiency is thought to be a contributory factor in the pathogenesis 
of vascular diseases such as hypertension, atherosclerosis and myocardial ischaemia. 217
NO is generated from the oxidation of the substrate amino acid L-arginine and an 
enzyme, NO synthase (NOS) of which there are several known isoforms including 
neuronal NOS (nNOS), endothelial or constitutive NOS (ecNOS) and inducible NOS 
(iNOS) 124. NO is a labile compound, which reacts spontaneously with molecular 
oxygen to produce numerous oxides, including nitrogen dioxide (NO2), dinitrogen
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trioxide (N2O3) and nitrite (NCV)- 124 Some of these oxides will nitrosate primary and 
secondary amines producing potentially carcinogenic nitrosamines. 124 NO reacts with 
reactive oxygen species such as hydrogen peroxide (H2O2) and its reaction with the 
superoxide ion (O2’) yields a potent oxidant and cytotoxic agent the peroxynitrite anion 
(ONOO ) . 121
There are many scientific reports about NO functions. In macrophages, NO is released 
in large quantities as part of a cytotoxic defence mechanism. 124 Bolli and colleagues 
have demonstrated that iNOS is involved in delayed preconditioning. 100,218 Some 
investigators have reported on the cytoprotective properties of NO donors afforded to 
cardiomyocytes undergoing reperfusion injury 48 whilst others have observed that 
peroxynitrite damages vascular endothelium 44
Evidence is accumulating to support the role of NO and peroxynitrite in modulation of 
mitochondrial functions.51,121 NO can reversibly inhibit cytochrome oxidase whereas 
peroxynitrite irreversible inhibits it, causing mitochondrial dysfunction. Addition of 
peroxynitrite to mitochondria results in the opening of a non- selective channel for 
solutes of <1.5kDA 121 called the mitochondrial permeability transition pore 
(MPTP) , 116 regulated by Ca2+ concentrations, ROS and depleted adenine nucleotides.25 
The formation of the MPTP causes respiratory inhibition 25 and may result in the release
910of apoptogenic factors from the mitochondria thereby resulting in apoptosis and 
ultimately necrosis. Furthermore it has been demonstrated, that NO and peroxynitrite 
can control Ca2+ efflux which determines whether or not the MPTP forms with the
1 9Rconcomitant collapse of A\j/m.
It has been suggested that NO participates in many complex signalling pathways, such
99 nas activating heat shock proteins. Malyshev and colleagues have reported that NO 
can induce the synthesis of HSP70. We have observed that NO activates cyclophilin and 
HSP70 in cardiomyocytes (abstract from cold spring harbour meeting). We propose 
that: 1) NO induced cyclophilin and HSP70 contribute to protection against IR injury; 
2) NO donors confer protection against oxidative stress by modulating Avj/m.
149
The aim was to subject cells to oxidative stress after pre-treatment with the nitric oxide 
donor S nitroso N acetylpenicillamine (SNAP) in order to access the effect on:
• Changes in mitochondrial membrane potential
• Cell viability
• Expression of CyP-D, HSP70, HSP75 and HSP60 (mitochondrial chaperone 
complex)
6.2 Methods
6.2.1 Cell Culture
H9c2 cells were obtained from the American Type Culture Collection (CRL-1446, 
ATCC Rockville, MD, USA). H9c2s were grown until 50% confluence in culture 
vessels and incubated with S nitroso N acetylpenicillamine (SNAP) which was at a final 
concentration of ImM in full growth medium (FGM) consisting of Dulbecco’s 
Modified Eagle Medium (DMEM) with sodium pyruvate and 1000mg/l glucose (Gibco- 
BRL) and 10% foetal calf serum in 95% atmosphere and 5% CO2 . Cells were seeded 
into 6  well culture dishes for viability assays or left in 75cm2 flasks a day before 
experiments were conducted. The nitric oxide donor SNAP (Sigma) was initially 
dissolved in DMSO to create a 1M stock solution and kept at -20°C until used.
6.2.2 Cell Viability Assays
MTT assays were performed as previously described in Chapter 2.
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6.2.3 Trypan Blue Exclusion Assay
Treated cells were incubated with a 0.8% Trypan blue solution (Sigma) and then using a 
haemocytometer the average number of viable cells able to exclude this dye was 
calculated.
6.2.4 Mitochondrial Membrane Potential (A y/nj Assay 
This assay was performed as previously described in Chapter 2
6.3 Results
In order to evaluate the effect of oxidative stress and NO on the onset of the MPT we 
assessed the A\|/m by incubating the cells with DiOC6 (3) a lipophilic cationic dye.221
Various concentrations of the NO donor SNAP were incubated with H9c2 cells for 2 
hours, then reperfused for 24 hours and harvested for cell viability analysis. This was 
performed in order to ascertain the optimum concentration to be used in these 
experiments (Figure 6-1), which was decided to be ImM.
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Figure 6-1. Viability of H9c2 cells treated with various concentrations of SNAP.
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Cells were incubated with SNAP for 2 hours, washed and reperfused for 24 hours prior 
to analysis for (A) MTT cell viability assay and (B) change in DiOC6 (3) fluorescence 
as a measure of the mitochondrial membrane potential (A\|/m). In graph (A), only 2mM 
SNAP exhibits statistically a significant decrease in viability (*P<0.05} in comparison 
to the control. There is no statistically significant decrease in DiOC6 (3) (Avj/m) (A) for 
any of the SNAP concentrations Data is expressed as S.E.M for 3 pooled separate 
experiments (n=9). *P<0.05 represents statistical significance in comparison to the 
control
Pre-treatment with ImM SNAP elicited a definite resistance to 50pM H2O2 in H9c2 
cells. Those cells that had not been pretreated with SNAP showed a significantly 
marked reduction in A\|/m (Figure 6-2) when compared to untreated control cells.
Cells not reperfused prior to challenge with oxidative stress show a 10% difference in 
A\|/m Figure 6-2A when compared to Figure 6-2B.
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The Ai|fm was monitored by the change in DiOC6 (3) fluorescence after H9c2 
cardiomyocytes were treated with SNAP and H2O2 as described in the materials and 
method. After 2 hour pre-incubation with ImM SNAP, H9c2 cells were reperfused for 0 
hours (A) and 24 hour (B) prior to 1 hour exposure to 50pM H2 O2 and the fluorescence 
changes in DiOC6 (3) were determined by FACS analysis. H9c2 display a significantly 
increased preservation of Ai|/m in (B) than comparison to (A). Data is representative of 
the S.E.M of n=9 from 3 pooled experiments. *P<0.001 v control, ¥P<0.05 v H2O2 . 
fPO.OOl v H2O2 ; JPO.Ol v control
This difference rises to a maximum in those cells that have been reperfused for 24 hours 
prior to exposure to oxidative stress after SNAP incubation; this difference is 60% 
(Figure 6-3A) when H2O2 and H2O2 + SNAP treated cells are compared. The correlation 
between A\|/m and cell viability is demonstrable by Figure 6-2A, 6-2B, 6-3A & 6-3B 
where cells which have been pretreated with SNAP demonstrate a higher cell survival 
rate in contrast to those which have not had this pretreatment. Although the resistance 
afforded to H9c2 cells was not as elevated in Figure 6-3A, as observed in Figure 6-3B, 
the difference between H2O2 only and H2O2 + ImM SNAP was significant (¥P<0.05).
In the MTT assay (Figure 6-3A and B), the relative protective response of SNAP treated 
cells is visually different between these two. This response parallels the protective 
response to Av|/m decrease as observed in Figures 6-2A and 6-2B following 0 and 24 
hours reperfusion prior to exposure to H2O2 mediated oxidative stress. Demonstrating 
the greater protection after 24 hours reperfusion, as opposed to 0 hours reperfusion and 
subsequent exposure to oxidative stress. Figure 6-3B demonstrates that a 2 hour 
incubation and subsequent 24 hour reperfusion time course with ImM SNAP and the 
vehicle (DMSO) has no toxic effects on H9c2 cells over the time course of these 
experiments.
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SNAP afforded significant protection of H9c2 cells against 1 hour exposure to 50pM 
H2O2 after 0 hours (A) and 24 hours (B) reperfusion as determined by MTT analysis. 
Graph (Figure 6-3B) demonstrates that there are no damaging effects from incubating 
these cardiomyocytes with DMSO and SNAP for 2 hours with 24 hours reperfusion. 
These results represent means ± S.E.M of 6 separate experiments for each group (n=6). 
(Figure 6-3A) *P<0.001 v control; tP<0.001 v H2O2 . (Figure 6-3B) tP<0.001 v H2O2 , 
**P<0.05 v control.
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Figure 6-4. Survival of SNAP treated H9c2 cells after exposure to H2O2
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After subjection to 1 hour 50pM H2O2 without (Figure 6-4A) and with (Figure 6-4B) 
24 hour reperfusion as previously described in the materials and method. Cells were 
assayed for viability by trypan blue. The survival rate of cells treated with H2O2 was 
also recorded and plotted. However, protection afforded to these cardiomyocytes was 
not statistically significant without (Figure 6-4A) and with (Figure 6-4B) 24 hour 
reperfusion prior to exposure to oxidative stress. Data are means S.E.M of 6 
independent experiments. *P<0.01 vs control; tP<0.001 vs control
As a sign of irreversible damage to cardiomyocytes caused by loss of plasma membrane 
integrity, cardiomyocytes able to exclude the blue dye were recorded as part of the 
tryphan blue assay as shown in Figure 6-4A and 6-4B. There is virtually no difference 
between the two graphs in survival rates after H2O2 exposure is virtually the same 
immediately after SNAP incubation (Figure 6-4A) after 24 hour incubation prior to 
subjection to oxidative stress (Figure 6-4B).
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6.3.1 Mitochondrial Heat Shock Protein Expression in Cells Exposed to Oxidative 
Stress and Nitric Oxide donor SNAP
A
HSP 10  ►
B
HSP 60 ______
Control SNAp
c
HSP 75  ►
D
CyP-D ----------- ►
E
HSP70  ►
G
HSP 27
Figure 6-5. Western blot expression of SNAP treated cells.
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Cardiomyocytes were left untreated (control), subjected to 2 hour incubation with ImM 
SNAP only, reperfused for 24 hours before they were harvested and probed with 
antibodies recognising (A) HSP10, (B) HSP 60, (C) HSP 75 (E) CyP- D, (F) HSP70, 
(G) CyP-A and (H) HSP27 epitopes. In order to analyse the CyP-D expression, 
mitochondria were isolated from the treated samples as previously described in Chapter 
2. Protein was extracted from these mitochondrial isolations and equal quantities of 
protein were run on a SDS-acrylamide gel and probed for mitochondrial HSP60 (Figure
6-5D) in order to confirm purity of the mitochondrial isolations. Then the antibody for 
cyclophilin A was used to probe these mitochondrial samples and any expression 
detectable around 20kD would be due to CyP-D (Figure 6-5E) as this is the only 
cyclophilin present in mitochondria.
As is demonstrated in Figure 6-5, there is no significant induction of any heat shock 
protein apart from mitochondrial HSP75 and a slight induction of HSP27. All these 
experiments were repeated 3 times and HSP75 and HSP27 expression levels were 
elevated in all. Following densitometry it was only HSP75, whose levels were elevated 
significantly.
6.4 Discussion
Nitric oxide is known to be a major molecule in the regulation of various physiological
processes in the immune, nervous and cardiovascular systems. It induces mitochondrial
010permeability transition by causing the release of apoptogenic factors. It is a paradox 
that NO can act as physiological regulator as well as a cytotoxic agent. NO mediates 
these activities and its main pathological derivative is formed by reacting with 
superoxide, to produce the peroxynitrite ion (ONOO'), which is a potent oxidant and 
cytotoxic agent. Much later it was discovered that small quantities of NO inhibited 
mitochondrial respiration by competing with molecular oxygen thus acting as a 
regulator of mitochondrial respiration.145
219 126 172 222There is increasing evidence regarding the cytoprotective properties of NO ’ ’
Rakhit and colleagues 223 suggest that free radicals produced by NO, depending on the
circumstance may mediate preconditioning. Later they presented evidence that the
protection they observed using SNAP in cardiomyocytes subjected to oxidative stress 
was via a cGMP mechanism.173 HSP70 has been implicated in NO induced protection
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of the heart; Malyshev and colleagues 220 have proposed that HSP70 is activated by NO 
via heat shock factor (HSF) synthesis. They hypothesise that HSF trimerisation is 
catalysed by the nitrozonium ion (NO+). Another group have also reported on the 
upregulation of HSP70 via HSF but in smooth muscle cells. 224 Kim and colleagues 225 
have determined that NO induction of HSP70 expression by the NO donor SNAP may 
possibly explain the protection afforded to hepatocytes against TNFa induced 
apoptosis. We have previously observed that the NO donor SNAP and sodium 
nitroprusside (SNP) are able to upregulate HSP70 as well as heme oxygenase-1 (HO-1) 
and cyclophilin A (CyP A) expression (abstract from Cold Spring Harbour meeting, 
1998) in H9c2 cells. Consequently in this study H9c2 cells were also used. However, 
HSP70 induction was not observed in this study which could be due to a shorter 
incubation time course for H9c2. Previously, H9c2 were incubated for 6 hours in ImM 
SNAP whereas in this study H9c2 cells were incubated for 2 hours.
Cyclophilins participate in de novo protein folding 108,226 which leads us to believe that 
they may be cardioprotective. Doyle and colleagues 227 demonstrated that cyclophilin A 
protects cardiomyocytes against oxidant induced necrotic cell death.
In these sets of experiments cardiomyocytes were exposed to SNAP for 2 hours. These 
results show initial protection immediately after exposure to oxidant stress that was 
originally thought to be partly due to HSP70 upregulation. However, Western blot 
analysis did not reveal any upregulation of HSP70 that could account for the observed 
early protection. Delayed protection was afforded to the cells 24 hours later which in 
part may be explained by the action of cyclophilin in conjunction with HSP70 and other 
heat shock proteins as was demonstrated previously (abstract from Cold Spring Harbour 
meeting, 1998). Once again Western blot analysis disproved this hypothesis. Western 
analysis instead revealed the significant upregulation of HSP75 and a slight increase in 
expression of HSP27.
Heat shock protein 75 is a mitochondrial protein that is a member of the HSP70 
molecular chaperone protein family. It is primarily involved in unfolding proteins and
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translocation of polypeptides into the mitochondrial matrix (a process which is ATP 
dependent) whereupon the polypeptide is released to the chaperonins (HSP60, HSP 10) 
that assist them in refolding these peptides to their native state. 228Presumably increased 
expression of HSP75 may occur due to the greater requirement in translocation and 
folding of proteins.
The main aim of this work was to determine the effect on A\|/m and cell viability of the 
nitric oxide donor SNAP pre-treatment on cardiomyocytes. We have been able to 
demonstrate that NO is able to partially restore A\j/m and therefore decrease the potential 
to form MPTP as well as improve cell viability of cells that have been challenged by 
oxidative stress with the possible involvement of HSP75 activation.
Although the mechanism of this protection is not known in detail. Balakirev and 
colleagues report that NO reduces formation of the MPTP by reversible inhibition of 
cytochrome oxidase which alters membrane potential and Ca2+ efflux 30. Lowestein 
speculated that NO inhibition of mitochondrial respiration might be beneficial. 
Moncada and Erusalimsky state that NO binding to cytochrome oxidase may ensure that 
O2 is more available to surrounding tissue. Reduction in O2 will cause an increase in
1 9 8NO production resulting in vasodilatation and increased perfusion of tissue.
We were interested in analysing HSP27 expression because it has been shown to play a 
protective role in cytoskeletal formation. It is a member of the so called small heat 
shock protein family (sHSP) which include ap-crystallin also upregulated in response to 
oxidative stress and providing protection by stabilising cytoskeletal structures.230 We 
previously reported that HO-1 was upregulated by NO donor pre-treatment (abstract 
from Cold Spring Harbour, 1998). Therefore it is very likely that upregulated HO-1 
participates in the protection afforded to these cardiomyocytes.
Assessment of cell viability in this model by the trypan blue exclusion assay, which 
measures total cell death, (Figure 6.4) did not reveal any statistical significant protection 
in any of the two models. Other cell viability assays that measure plasma membrane 
lysis, as does the trypan blue assay, such as lactose dehydrogenase assay (LDH) release
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and the fluorescent dye propidium iodide (PI) may help to clarify these discordant 
results. Differences in the response of H9c2 to 50pM H2O2 only, as observed in the 
viability assays may be a reflection of the poor condition of the cells initially although, 
cells were not used past passage 29 and confluency was never more than 60 -  80%. 
However, the data obtained from the Trypan blue assay can be quite subjective as it is 
reliant on the researcher visually counting all the compromised cells within a given area. 
Taken together, PI, LDH and Trypan blue are good assays to determine plasma 
membrane lysis and as such, complement the MTT assay. The MTT assay, which by 
determining the energetic status of the cell, may be used as a crude assay to measure 
apoptosis231 in conjunction with the DiOC6 (3) assay.
In summary, we have reported on the cytoprotective properties of the NO donor SNAP 
against oxidative stress. According to FACS and MTT data, protection was at its 
greatest 24 hours after the initial SNAP incubation. This may result from the fact that 
SNAP not only liberates NO but also metal ions,232 which after 24 hours may activate 
protective signalling cascades or HSP’s. Elevated levels of HSP75 expression in 
conjunction with HSP27 may be responsible in part for the observed protection. Further 
studies are needed in order to ascertain the degree to which these HSP’s and other 
factors are involved in NO induced protection
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CHAPTER 7
7. OVEREXPRESSION OF CyP-D IN IN VITRO 
CELL SYSTEMS
7.1 Introduction
Mitochondria play a primary part in the onset and development of ischaemia/ 
reperfusion injury and are recognised as major targets of toxicity, due to their key role 
in oxygen utilisation and ATP synthesis. It is widely accepted that mitochondrial 
permeability transition pore (MPTP) formation is a crucial event in ischaemia - 
reperfusion injury and cell death. 139 Heat shock proteins are up regulated in conditions 
of stress and form part of the mitochondrial chaperone complex; they are essential for 
protein, folding, refolding, transport and translocation through the intracellular 
membranes. 67
HSP70 is the most abundant and widely studied stress protein. It is one of the essential 
regulators of the stress response mechanism in eukaryotes. HSP75 is localised in the 
mitochondrial matrix where it is essential for import, folding and assembly of 
mitochondrial proteins. 68 The function of HSP75 is affiliated with the chaperonins, 
HSP60, HSP 10 and cytoplasmic HSP70. 68 HSP60 is a crucial part of the mitochondrial 
chaperoning complex and is obligatory for normal mitochondrial biogenesis. It has been 
demonstrated that simultaneous overexpression of HSP60 and HSP 10 confers protection 
against ischaemic damage, whereas overexpression of HSP60 or HSP 10 separately does 
not offer any significant protection in rat cardiomyocytes. 69 In Neurospora crassa, it 
was recently discovered that cyclophilin 20 plays an essential role in mitochondrial 
protein folding in conjunction with HSP70 and HSP60. 68 We are able to demonstrate 
that cyclophilin expression is elevated in eukaryotic myocytes in response to heat and
t (VIoxidative stress.
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All cyclophilins can be thought of as editing mechanisms in the process of protein 
folding and we consider some of them such as cyclophilin 20 in yeast to be an essential 
element of the mitochondrial chaperone complex. CyP-D exists as an integral member 
of the MPTP and cyclosporin A can potently inhibit MPTP formation by binding to 
CyP-D, thereby preventing it from binding to components of the inner mitochondrial 
membrane.38
We are interested in CyP-D because, along with the voltage dependent anion channel 
(VDAC), hexokinase and the adenine nucleotide translocase (ANT), has been 
implicated in the formation of the MPTP 29)44)55 leading us to the following hypothesis 
and null - hypothesis:
• Cyclophilins are an essential component of the mitochondrial chaperone machinery, 
and therefore, simultaneous overexpression of the basic complex of molecular 
chaperoning proteins in myocytes may afford the cells a greater degree of 
protection.
Null:
• The basic MPTP structure which forms, causing reperfusion injury comprises the 
voltage - dependent anion channel (outer membrane), cytosolic proteins 
(hexokinase), adenine nucleotide translocase (inner membrane) and CyP-D; hence 
CyP-D overexpression would cause a decrease in cell viability due to its 
involvement in the formation of the MPTP structure.
We suggest that the mitochondrial chaperone complex is crucial for maintaining the 
mitochondrial function and integrity in the process of intracellular adaptation, 
specifically relating to ischaemic stress. We propose that overexpressing cyclophilins 
will enable cells to tolerate ischaemia/reperfusion injury, because the increase in this 
molecular chaperone means that a greater amount of denatured protein is being refolded 
thereby preserving the structure and function of the mitochondrion.
166
7.2 Methods
7.2.1 Cell Culture
COS-7 and human embryonic kidney 293 (HEK 293) cells were obtained from the 
American Type Culture Collection (CRL-1446, ATCC Rockville, MD, USA) These 
were grown until half confluent for transfection in full growth medium (FGM), 
Dulbecco’s Modified Eagle Medium (DMEM) with sodium pyruvate and 1000mg/l 
glucose (Gibco-BRL) and 10% (v/v) foetal calf serum in 95% atmosphere and 5% CO2 .
7.2.2 Primary rat neonatal cardiomyocytes
Chapter 2 offers a full description of primary rat neonatal cardiomyocyte isolation
7.2.3 Plasmid Construction and Transfection
The CyP-D gene was a gift from Dr D.Bergsma and was subcloned into pBluescript. 
After its orientation was ascertained via restriction mapping, it was further subcloned 
into the expression vector pcDNA3 (designated pcDNA3-CyP-D) in the correct 
orientation for expression into the BamHI and Hindlll site. CyP-D was transfected into 
3 day old isolated primary neonatal cardiomyocytes using a novel integrin transfection
i i o
method ’ in the order as shown in Figure 7-1. Green Fluorescent Protein (GFP) in 
the pCAGGS vector (designated pCAGGS-GFP) was used as a control for transfection 
efficiency. A second control consisted of the vector pcDNA3 with no DNA. (A more 
detailed description is available in Chapter 2).
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7.2.4 SDS -  PA GE and Western blotting
Cells were harvested into 200pl (2x) concentrated SDS-PAGE sample. The samples 
were loaded into 4% stacking gel and separated by electrophoresis on a 12% running 
gel. The proteins were transferred at 30V overnight into nitro-cellulose membrane 
(Hybond-C, Amersham, UK) and probed with anti-cyclophilin A (used as a general 
cyclophilin antibody, it was thought that any increase in CyP expression could be 
accountable to CyP-D as this was overexpressed and not CyP-A due to the non 
avaliabiity of a specific CyP-D antibody) at a concentration of 1:1000 in PBS 
(phosphate buffered saline) with 0.05% Tween 20 in 0.1% Marvel. Using peroxides- 
conjugated rabbit anti-mouse antibody (DAKO), the blot was conjugated at a dilution of 
1:2500 and detected using enhanced chemiluminescence (ECL: Amersham, UK).
7.2.5 Lethal Simulated Ischaemia /Reperfusion (LSI/R)
Cells in 12 well tissue culture plates (Nunc) washed once with PBS followed by the 
addition of 1ml SI buffer (as described in Chapter 2). The culture vessel containing the 
cells were then transferred to anaerobic GasPak pouches (Becton Dickinson, Sparks 
Md) and incubated at 37°C for 1 hour and reperfused for 1 hour. The pouches were pre­
gassed with 5% CO2 , 95% Argon and the O2 content in these bags was <1% during the 
experiment and was monitored by an anaerobic indicator.
7.2.6 Isolation o f Mitochondria from Cells
Transfected and non-transfected 293,COS-7 and primary neonatal cardiomyocytes cells 
were grown in 35x 10cm petri dishes were harvested and resuspended in MSMEB 
(210mM mannitol, 70mM sucrose, lOmM MOPS, ImM EGTA and 0.5% BSA). The
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following procedures were all performed at 4°C. Digitonin (5% in DMSO) was added 
until >90% cell permeabilisation occurred as confirmed by Trypan blue exclusion. After 
the addition of a further 1ml MSMEB the samples were spun and the supernatant 
removed. The pellet was homogenised 10 times in a dounce homogeniser. The 
supernatant was spun at 2500g for 3 minutes and finally 10 minutes at 12000g. The 
resulting pellet (mitochondrial fraction) was washed along with the supernatant 
(cytosolic fraction). 234 Protein concentration was calculated using a Bio-Rad protein 
assay.
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7.2.7 Determination o f  Peptidyl -  Prolyl isomerase (PPI-ase) Activity
After the mitochondria were freeze- thawed as previously described (section 2.2.1). 
They were resuspended in 35mM HEPES buffer (generally lOOpl). From the lysate the 
protein concentration was ascertained (Biorad protein assay). Generally 20pg protein 
was used in each assay. HEPES buffer, oc-chymotrypsin, mitochondrial lysate was 
added to a cuvette to volume o f 990pl. They were cooled to 4°C, 5 minutes before the 
addition o f lOjul o f the peptide N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide at a 
concentration o f 8mM. This initiated the reaction that was recorded over two minutes 
on a spectrophotometer (Helios a , Unicam Ltd., Cambridge, U.K.) at an absorbance of 
390nm at 4°C. Each sample was assayed three times in order to determine an average of 
the PPIase enzymatic activity that was finally calculated by an enzymatic data fitting 
computer software package (GraFit). This method was taken from Kofron and 
colleagues. 134
7.3 Results and Discussion
Primary rat neonatal cardiomyocytes were seeded into 6 well plates and transfected in 
the order as indicated in Figure 7.1 with either pCAGGS-GFP (positive control) or 
pcDNA3-CyP-D plasmids. After transfection cells were subjected to 6 hours SI with 2 
hours reperfusion.
CyP3 (CyP-D)
Figure 7-1 Western blot of transfected cells.
This Western blot shows expression levels o f CyP-D in neonatal cardiomyocytes 
transfected with the vector pcDNA3-CyP-D; pCAGGS-GFP; control untransfected 
cells; heat shocked sample acting as positive control and pcDNA3-CyP-D with 0.2pM
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CsA. Tranfected CyP-D samples were not significantly different from the control. CsA 
treated samples also do not significantly affect CyP-D expression levels. Only the 
positive heat shock samples are significantly different from the control. GFP (1) and 
GFP (2) refer to the different batches o f GFP used as mentioned below.
Two days following transfection, GFP expression was detected using a fluorescence 
microscope (Figure 7.3). Two differently prepared batches o f GFP were used (Batch 1 
and Batch 2). According to fluorescence analysis, Batch 1 fluoresced more intently. The 
difference between the two became more evident in the Western blot (Figure 7.2). 
Binding o f GFP antibody was only evident in Batch 1.
GFP (1) GFP (2)
Figure 7-2 Western blot demonstrating two different batches of GFP.
GFP (1) was used in the transfections as these blots demonstrated its correct functioning
*CyP3 =CyP-D
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Figure 7.3. GFP expression as visualised by fluorescence microscopy
The Cyclophilin probed blots Figure 7.1 did not demonstrate any overexpression of 
CyP-D when compared with the control and heat shock samples, which suggested that 
these cells were not properly overexpressing CyP-D.
We hypothesised that cells in wells which had been transfected with CyP-D and 
subjected to oxidative stress would have a lower survival rate, since CyP-D is believed 
to form the MPTP that leads to cell death, in comparison to cells not transfected with 
CyP-D. Transfection o f CyP-D had no effect on COS-7 cells as determined by 
functional assays (MTT) Figure 7-11 A. However, the PPIase assay demonstrated 
statistical significant difference when compared to the control. We also re-transfected 
neonatal cardiomyocytes and increased the amount o f DNA used (4-8 pg), but this also 
had no effect. It is possible that the transfection may have been successful but there was 
a possibility that the non-specificity o f the cyclophilin antibody to CyP-D was unable to 
detect upregulation.
Control pcDNA3 pcDNA3-CyP3
Figure 7-4 PPIase activity of neonatal cardiomyocytes transfected with CyP3
Primary rat neonatal cardiomyocytes were transiently transfected with pcDNA3-CyP3 
or pcDNA3 without an insert (sham). Mitochondria were isolated from control, 
pcDNA3 and pcDNA3-CyP3 transfected cells and activity was determined in each of 
the three groups. CyP3 transfected cells show a significantly increased level o f activity 
as opposed to the control. The PPIase activity was measured at least three times in each 
group (mean ± SEM) Statistical significance o f difference was compared with control. 
|P <0.05
PPIase assays were conducted on the transfected samples as another mode in which to 
determine if  the transfection was successful. The CyP-D insert possesses a sequence 
that targets it to the mitochondria, 109 and as this assay works on isolated mitochondria, 
where only CyP-D is present. Therefore any increases in PPIase activity when 
compared to the control will be due to the transfected CyP-D. Figure 7-4 demonstrates 
the detectable increase in the PPIase activity o f the transfected samples in primary 
neonatal cardiomyocyte cells. It was quite apparent that in primary cardiomyocytes 
overexpression was only detectable in PPIase activity assays (Figure 7-4). Western 
analysis o f control and vector transfection only in HEK 293 cells (Figure 7-6) still 
revealed no detectable overexpression, possibly due to the non-specificity o f the 
cyclophilin antibody. The results from the previous experiments have led us to believe 
that the problems we were experiencing may be because of:
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1. Contamination of the DNA insert, CyP-D, by protein, phenol.
2. The CMV promoter of the pcDNA3 vector did not work effectively in primary rat 
neonatal cardiomyocytes cells.
3. Non-specificity of the cyclophilin antibody for the mitochondrial CyP-D
In order to circumvent these problems, we cleaned the CyP-D and pcDNA3 vector 
using a caesium chloride gradient (as described in Chapter 2) and transfected into 
human 293 commercially available cell lines which are known to have high transfection 
efficiencies, and express pcDNA3. There are many publications demonstrating the 
effectiveness of the CMV promoter in pcDNA3 when transfected into COS-7 and 293 
cell lines. 235>236
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Figure 7-5. Effect of overexpression of CyP-D in HEK 293 cells.
M itochondria from HEK 293 cells were extracted and analysed for differences in PPIase 
activity. This is another method of comparing whether or not CyP-D was successfully 
overexpressed in cells when compared to control and samples containing vector alone 
(pcDNA3).
Control pcDNA3 pcDNA3-CyP3
CyP-D
Batch 1 Batch 2
Figure 7-6 Western blot of HEK 293 cells transfected with pcDNA3, pcDNA3- 
CyP3 and pCAGGS-GFP
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HEK 293 cells were transfected with pcDNA3, pcDNA3-CyP3 and pCAGGS-GFP and 
protein was isolated and probed with a cyclophilin and GFP antibody. Overexpression 
of CyP3 was not detected from protein isolates although GFP transfection control 
expression is visible.
Transfection into these cell lines would test the possibility that the inability to detect the 
overexpression by Western blot protocol, would indicate that the problem may lie with 
the cyclophilin antibody. The 293 cells were harvested post transfection for Western 
blotting (Figure 7-6) and PPIase activity assay (Figure 7-5). Overexpression was only 
detected by the PPIase method only (Figure 7-5). Another problem with this 
transfection protocol was that the positive control and CyP-D insert were on two 
completely different vectors, so the GFP was not an accurate or direct control for CyP- 
D expression. Furthermore, we know from previous work that cDNAs (such as GFP) 
are efficiently expressed from the pCAGGS vector in cardiomyocytes. 237
A redesigned vector was provided by Martin Goss (a colleague at the Rayne Institute) 
(Figure 7-7) that has the pCAGGS vector backbone with the GFP control gene and 
multiple cloning sites already incorporated. It therefore has an p-actin promoter and in 
addition a CMV enhancer to drive the expression of the CyP-D and GFP The original 
pCAGGS vector with GFP subcloned into it worked well as a control in all the cells it 
was transfected into. Therefore we knew there should not be any problems with the 
p-actin promoter on the new vector. If the downstream GFP is expressed then CyP-D
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should be overexpressed as the same promoter drives them both on this vector.
,Nde 1
coR1
EcoR1
am H1
Figure 7-7. Schematic representation of the redesigned plasmid (pcDCAG-CyP3) 
provided by Martin Goss.
GFP and the coding region of CyP-3 are under the control o f chicken p-actin promoter 
and immediate early enhancer o f cytomegalovirus. GFP was co-expressed with the gene 
o f interest using an IRES (internal ribosome entry segment) expression cassette.
This vector was initially transfected into COS-7 cells, as this was the cell line the 
integrin transfection protocol was originally used in. After 48 hours GFP expression 
was visualised on the fluorescence microscope, which were later harvested for Western 
blotting (Figure 7-9A) and PPIase activity (Figure 7-8) was accessed. After probing 
with the cyclophilin antibody the blot was re-probed with GFP antibody (Figure 7.9B).
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«  f*. 30
Figure 7-8. Transfection of pcDCAG-CyP3 in COS-7 cells
Transient transfection into COS-7 cells results in an increase in PPIase activity. Cells 
were transiently transfected with pcDCAG-CyP3 in order to test the efficacy of this new 
construct. These cells were cultured until confluent (usually 2 days after transfection) 
and harvested for protein and mitochondrial isolation. PPIase activity was estimated as 
described previously. Bars represent S.E.M of triplicate samples. The PPIase activity of 
pcDCAG-CyP3 is significantly different from that o f the control and (vector without 
CyP-3 insert) pcDAG sample at *P<0.05 v control.
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In Figure 7-9A Western blot analysis of the transfectants using the protein lysate 
isolated from the above transfection with the new expression vector, demonstrates that 
there is no increase in CyP-3 when probed with cyclophilin antibody. Although when 
probed with GFP antibody, expression of GFP is present (Figure 7-9B) which means 
that if GFP was transcribed then CyP-3 should also have been expressed.
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(A)
18 kDA
( B )
Figure 7-9. Western blots of COS-7 cells transfected with pcDCAG-CyP3 and 
probed with antibodies to cyclophilin (A) and GFP (B).
W estern blot results (Figure 7-9) confirmed GFP (B) expression but no overexpression 
o f CyP-D was visible (Figure 7-9A). (Two different aliquots o f CyP-D were prepared 
and labelled as A and B, and transfected in duplicate as indicated in Figure 7-9A).
180
The results in Figure 7-9, confirm the lack o f specificity antibody. We also considered 
the possibility that mitochondrial CyP-D expression was obscured by high levels of 
cytoplasmic CyP-A, coupled with the fact only CyP-D exists in the mitchondria, 
therefore pcDCAG-CyPD was transfected into COS-7 cells and mitochondria were 
isolated from transfectants and their controls.
The cyclophilin antibody was not specific for CyP-D, but it was used as it was thought 
that overexpression as a result o f transfected CyP-D might be detected by this antibody. 
As none was observed it might be that the antibody is not able to detect CyP-D. To 
answer this question mitochondria was isolated from the transfected COS cells and then 
probed with the cyclophilin antibody. As CyP-D is the only cyclophilin present in the 
mitochondria any expression present would be due to the presence o f CyP-D. Initially to 
determine the purity o f the mitochondrial isolations, mitochondria and cytosol were 
probed with HSP60, a heat shock protein that generally resides in mitochondria 
Figure 7-9C.
(C)
cytosol mitochondria
Figure 7-9C. HSP60 expression in the mitochondrial fraction from CyP-D 
transfected cells,
Western blot demonstrating HSP60 expression, which was used to confirm the purity of 
mitochondrial isolations from COS-7 cells, as HSP60 generally, exists in mitochondria.
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The mitochondrial isolates were then analysed by Western blotting. They were probed 
with the cyclophilin antibody (Figure7-10) as performed previously. CyP-D expression 
was detectable at 20 kDa implying that this antibody was able to detect the protein 
expression o f this cyclophilin subset. The protein expression o f the transfected samples 
however, was no different from that o f the non-transfected controls. Nevertheless, as the 
PPIase assay revealed significant differences between transfected and non-transfected 
samples, we decided to conduct cell viability assays.
<  CyP-D
* CyP+ Control pcDCAG pcDCAG-CyP3
Figure 7-10 Western blot expression of mitochondria isolated from transfected 
COS-7 cells.
COS-7 cells were transfected with the control plasmid (pcDCAG) and pcDCAG-CyP3 
vector. Mitochondria were harvested from these transfected cells and the protein lysates 
were probed with cyclophilin antibody. As CyP-D is the only cyclophilin subset that 
resides in the mitochondrion therefore any protein expression derived from probing with 
the CyPA antibody should be CyP-D. The Western blot in this Figure does not 
demonstrate that CyP-D has been overexpressed in these cells
*CyP+ = cyclophilin positive control
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Figure 7-11. Cell viability assays COS-7 cells transfected with pcDCAG-CyP-D.
These graphs display that the CyP3 transfectants had no effect on survival o f COS-7 
cells that were subjected to 1 hour SI/R as determined by MTT (A) and PI (B) assays
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when compared to non-transfected control and positive control (B). Positive control 
were COS-7 cells, which were freeze-thawed in liquid N2 to rupture cell membranes 
prior to incubation with PI solution.
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7.4 Conclusion
We have attempted to solve the problems that we have encountered with the 
transfection procedure by re-extracting and purifying the plasmid with the CyP-D insert. 
The cyclophilin antibody was not able to recognize CyP-D overexpression. We 
concluded that the transfections were working with the new vector due to the consistent 
positive results from the PPIase assay. However, RT-PCR did not reveal overexpression 
of CyP-D. These are classical methods of determining overexpression of a gene and 
until we are able to achieve this we cannot evaluate any results we obtain from these 
assays.
It may have been possible to use other strategies such as creating a stable cell line 
overexpressing CyP-D, which would have meant that, repeated time consuming 
transfections would not have been necessary, and there would always be a constant 
renewable source of transformed cells. The CyP-D insert could have been subcloned 
into other vectors, which we have subsequently demonstrated to work well in 
cardiomyocytes. A major problem we encountered was the possible non-specificity of 
the cyclophilin antibody used, which is why we conclude we could not detect 
overexpression. Our attempts to produce a specific polyclonal antibody were 
unsuccessful. However, based on the PPIase activity assay data, we can say that the 
transfection was successful, and therefore more assays should be conducted to ascertain 
the effect of overexpressing CyP-D in cardiomyocytes. However, the initial data we 
have obtained from the viability assays that have been conducted with COS-7 cells. 
Suggest that overexpression did not afford the cells any protection (Figure 7-10). Based 
on these results it would be interesting to repeat these mitochondrial isolations in CyP-D 
transfected neonatal cardiomyocytes.
The concept of gene transfer has had a great impact on biological research. Numerous 
studies have demonstrated the protective effect that transfection of heat shock proteins 
confers to cardiac cells. 69,133,145,239'241 The use of adenovirus-mediated transfections into 
human myocardium may be impractical because of the possibility of mutation to active
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forms and their immunogenic properties. Cationic lipids are the preferred reagents for 
transfer of genes because of their simplicity, high transfection efficiency and low safety 
risks. With the advancement of gene therapy technology, it may only be a matter of time 
before HSP’s are used to afford protection to patients undergoing heart bypass surgery 
and other procedures.
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CHAPTER 8
8. GENERAL DISCUSSION
8.1 Overview
Ischaemia / reperfusion injury induces cell death, but the mechanisms that are critical 
for causing cell death are not known. In this thesis I sought to clarify the relationship 
between cyclophilins (specifically mitochondrial CyP-D) and mitochondrial heat shock 
proteins (mHSP) HSP75, 60 and 10 in this phenomenon. The aims of this thesis are to 
explore the role of cyclophilin and the mHSP’s in myocardial ischaemia /reperfusion 
injury. This thesis is based on the overall hypothesis:
“Cyclophilins are components in the formation of the MPTP and therefore we state that 
they play a major role in the cell death pathway”.
This hypothesis has been investigated using 5 approaches. These involved using an in 
vitro lethal simulated ischaemia/reperfusion (LSI/R) model to investigate effects of 
ischaemia/ reperfusion (IR) injury on the development of apoptosis and necrotic cell 
death. A buffer and nitric oxide donor S nitroso N acetylpenicillamine (SNAP) were 
used to precondition cells in another two chapters in order to investigate cyclophilins 
and the mHSP’s as well as mitochondrial membrane potential (A\j/m). The expression of 
the HSP’s was investigated in subsarcolemmal (SSM) and interfibrillar (IFM) 
mitochondria in female rats, which were subjected to left anterior descending (LAD) 
coronary artery occlusion and reperfusion for predetermined periods. Finally CyP-D 
was transfected into cells in order to determine whether it was deleterious or afforded 
cell protection during IR.
Myocardial IR is a complex phenomenon that induces cell damage through a biphasic 
process. Ischaemia initiates the injury by deprivation of the energy process needed to
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maintain ionic gradients and homeostasis. Reperfusion exacerbates this damage by 
generation of deleterious agents such as free radicals. Various techniques and models 
have been used in this thesis to investigate the different theories proposed.
8.2 Discussion of Methodology
8.2.1 LSI/R and SI/R model
In Chapter 3 a cellular model of lethal simulated ischaemia/reperfusion (LSI/R) was 
established. This in vitro model attempted to mimic conditions that occur during 
myocardial IR. Rat neonatal cardiomyocyte cells were incubated in the ischaemic 
buffer, which attempted to mimic conditions such as high salt concentration, acidosis, 
substrate depravation, inhibition of mitochondrial respiration and low oxygen tension. 
Similar ischaemic buffers are used to generate what is termed “chemical hypoxia” aptly 
named because chemical compounds such as sodium dithionite 187 or amobarbital 242 are 
used that inhibit mitochondrial respiration and so aid in simulation of myocardial 
ischaemic conditions. Some researchers also employ the use of systems to lower pC>2 in 
addition to ischaemic buffers to lower oxygen tension to between 1 to 8mmHg. 22,243 In 
our model as described in Chapter 2, a hypoxic chamber was used to lower pC>2 to 
2mmHg, which was maintained throughout the course of the experiment. Experiments 
with a Clark type oxygen confirmed that the buffer alone did not maintain hypoxic 
conditions for the duration of the experiments. Using the chamber ensured that hypoxia 
as we defined it (~2mmHg) was maintained. The conditions produced were termed 
lethal simulated ischaemia/reperfusion (LSI/R). A milder form was named simulated 
ischaemia/reperfusion (SI/R) and was used in Chapter 4 in which the chamber was not 
used. This was due to the fact that the cells were incubated in the SI buffer for short 
periods that is adequate to precondition cardiomyocytes; however, LSI/R was used as a 
severe insult to the cells to determine protection conferred by preconditioning.
Cellular models of myocardial IR are not generally accepted (even though they are not 
complex and can be easily manipulated) because some of the adopted endpoints cannot 
be extrapolated to in vivo models, 97and the time course of ischaemia needed to inflict
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myocardial damage has no clinical relevance. 6 These endpoints are invariably achieved 
by hypoxia using markers, which are substitutes for tissue infarction. Hearse and 
Sutherland 244 state that these models are inexpensive and generate highly reproducible 
data but also admit their low clinical relevance. There are many types of 
preconditioning models, which are cell 77’189,237’245'2470r animal based 98,185,248using 
isolated perfused hearts. In spite of their reservations expressed above, large amounts 
of data generated from these cell-based models are supported by data from in vivo 
models. Moreover, it is recognised that these in vitro models are excellent for studying 
signal transduction pathways that are involved in many aspects of cardiovascular 
disease.
The cells used in these models are quite diverse. Mature adult cardiac myocytes are 
commonly used but are resistant to transfection. Hence many researchers use immature 
or dedifferentiated cardiomyocytes, which explains the rationale for using rat neonatal 
cardiomyocytes in Chapter 7. Using human cardiomyocytes is a distinct advantage but 
has obvious ethical issues. Although these systems may not reflect exactly what occurs 
in vivo, they give an idea of the mechanisms involved. Ultimately the true test bed for 
any therapeutic advance has to be in some form of human clinical trials. 249
8.2.2 Left Anterior Descending (LAD) Coronary Artery Occlusion model
This is a commonly used in vivo model to study myocardial ischaemia/reperfusion
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injury as well as preconditioning studies. ’ Various ischaemic and reperfusion 
time courses were employed as described in Chapter 5 in the study of subsarcolemmal 
and interfibrillar mitochondria characteristics.
8.2.3 Flow Cytometry
Flow cytometry is a technique that measures fluorescence and scattered light from the 
analysed particles. It differentiates between size and cell granularity and is able to 
differentiate between viable and non- viable cell populations. Throughout this thesis 
flow cytometry has been used in conjunction with propidium iodide (PI) to measure cell
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viability and mitochondrial membrane potential was measured by retention of the 
lipophilic dye DiOC6 (3).
8.2.3.1 Mitochondrial membrane potential (A\|/m)
The cessation of blood flow followed by a reperfusion periods is detrimental to many 
cell structures. Loss of energy, alteration of ionic homeostasis, accumulation of H+, 
generation of ROS and Ca+ are the complex cascade of events, which are induced. In 
this context, mitochondria as key components of the cell are susceptible to injury and 
are known to modulate cell death. 41
Energy is produced in mitochondria in the form of ATP by oxidative phosphorylation, 
which is coupled to electron transport. Electron transport chain enzymes catalyse the 
transfer of electrons from NADH to O2 . An electrochemical gradient is generated from 
energy released through electron transport driving protons across the inner 
mitochondrial membrane. This gradient, which is known as the proton motive force 
(pmf), drives the formation of ATP from ADP (using F1F0 ATPase). The mitochondrial 
membrane potential is the major component of the pmf. 25,43 The maintenance of Avj/m is 
a necessary requirement for normal function of cardiomyocytes and collapse of the A\j/m 
has been implicated in ischaemia/reperfusion injury due to the formation of MPTP. 
50,i56Therefore, mitochondrial membrane potential (A\|/m) is indicative of the functional 
or energisation state of the mitochondrion, 251,252 and as such, changes in the A\j/m are 
integral to the life -  death transition in a cell.30 Maintenance of the A\|/m is not only a 
requirement for ATP synthesis; it also drives the uptake of Ca2+ into the mitochondria 
by the Ca2+ uniporter. This is generally regarded as the signal for increased energy 
demand by the cell that simulates ATP production.253 Due to the importance of Aq/m, 
lipophilic fluorescent cations that accumulate in the mitochondrial matrix in relation to 
the Av|/m are commonly used controversial indicators of Av|/m in cardiomyocytes. DiOC6
(3) is the indicator used in this thesis. It was used according to the recommendations of 
Rottenberg and colleagues who specify that using this dye at high concentrations (40- 
lOOnM), the plasma membrane potential (Avj/P) and not A\|/m is measured and these
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concentrations also inhibit cell respiration to the same degree as rotenone. To avoid this, 
he recommends using concentrations <lnm, 136 which also reduces the risk of 
quenching of the mitochondrially bound membrane dye DiOC6 (3) as long as the 
concentrations are at subnanomolar proportions. He also used the uncoupler CCCP to 
collapse the Avj/m at low concentrations of 5pM where the plasma membrane (A\|/P) was 
not affected as determined by DiOC6 (3). High concentrations of 50pM resulted in both 
the collapse of Avj/m and Av|/P. 136 In these experiments, we used CCCP as a positive test 
to determine that the A\\im was accurately measured by the lipophilic dye DiOC6 (3). 
However, we used concentrations of up to 500pM CCCP. Flow cytometry analysis in 
conjunction with propidium Iodide (PI) allows viable and non-viable cells to be easily 
distinguished. Using this in combination with mitochondrial dye DiOC6 (3) would have 
help to ensure that the change in DiOC6 (3) fluorescence was based on viable cells only.
Other researchers argue that this is not the optimun dye to use; they instead state that 
5,5’, 6,6’ -tetrachloro-1, 1’, 3,3’ -tetraethylbenzimidazolcarbocyanine iodide (JC-1) is a 
better choice, 251,254 while some disagree and recommend the use of rhodamine 123. 255 
JC-1 unlike most other fluorescence dyes emits light at red and green wavelengths with 
both emissions indicating changes in A\j/m. Rhodamine 123 is a single-emission dye 
which at high concentrations may inhibit mitochondrial respiration, and undergo self- 
quenching in mitochondria.144 Mather and colleagues have noted that there was no 
change in rhodamine 123 fluorescence in response to A\j/m depolarsation and 
recommend using JC-1.251 Due to the controversy over the use of these dyes, it would 
appear that the best course of action would be to use protocols that can confirm the 
observed data, in other words have positive controls integrated into the experimental 
protocol. In this study, CCCP an uncoupler of oxidative phosphorylation stimulating 
mitochondrial FiFo -ATPase, causing ATP hydrolysis with resultant depolarisation of 
the Avj/m 44 was used to ensure that Avj/m was measured accurately by DiOC6 (3) in 
subsequent experiments as performed by other authors.204,255
Laser scanning confocal microscopy in conjunction with the fluorescent probes calcein 
and tetramethylrhodamine methylester (TMRM) was used to directly measure formation
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of MPTP by Lemasters and coworkers. 44 Calcein normally remains in the cytoplasm 
and TMRM labels polarized mitochondria. Upon subjection to oxidative stress, 
mitochondria filled with calcein and TMRM fluorescence decreased. These events were 
indicative of the formation of MPTP and A\|/m depolarization respectively as 
redistribution of calcein was blocked by cyclosporin A, they concluded that pore 
opening was CsA sensitive. 44 Griffths and Halestrap devised a model in isolated 
mitochondria in which loading radiolabeled 2 -deoxy [3H] glucose in perfused hearts, 
they were able to demonstrate pore opening following ischaemia/reperfusion. 
106Another more recent technique used by this group measures pore opening by 
measuring mitochondrial swelling as a decrease in light scattering recorded at 520nm on 
a spectrophotometer. These methods allow “real time” visualization of MPTP formation 
as opposed to the use of indirect and controversial mitochondrial membrane potential 
dyes.
8.2.4 Biochemical Assays
The MTT assay is based on the reduction of the yellow (3,4- 5 dimethylthiazol-2-yl)- 
2,5-diphenyl tetrazolium bromide into a blue formazan colour. This reaction is 
dependent on mitochondrial reductase activity linked to NADPH and NADH dependent 
redox systems and is thus a good method for determining cellular metabolic status. 148 
The MTT assays in Chapter 3 demonstrate a decrease in viability that can be used as 
indicator of the potential of a cell to undergo apoptosis. This in combination with a cell 
viability assay such as lactose dehydrogenase assay (LDH), trypan blue or propidium 
Iodide (PI) which determine plasma membrane lysis (necrosis). In Chapter 3, Figure 3- 
5A, LDH release from cardiomyocytes undergoing LSI is similar to the control 
untreated sample. The comparable MTT assay for cardiomyocytes undergoing 3 hours 
LSI only (Figure 3-5B) reveals that the metabolic activity of these cells has decreased 
by more than have in comparison to the control. It is possible that these cells may be 
undergoing apoptosis as opposed to necrosis as long as they possess enough residual 
energy to initiate this energy dependent process. In this manner, this assay can be used 
as a crude method to measure apoptosis, although the data would be more robust if used 
in conjunction with an apoptotic assay such as annexin V. However, it has been
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reported that MTT can activate phosphatidylinositol-3-OH kinase [PI (3) K] and 
influence cell morphology in some cells, which this group suggest may ultimately affect 
cell viability data. 256 As this assay measures the metabolic status of living cells and as 
such damaged cells may recover their viability over time, especially when cytotoxic 
agents are removed.
LDH assay is a measure of the release of LDH released from the lysed cell. This assay 
is indicative of necrotic cells as LDH is only released from cells with compromised 
plasma membranes as occurs in necrosis.160,257 These two assays were chosen for use 
throughout the whole of this thesis but particularly in Chapter 3 because it was thought 
they complemented each other when used in conjunction to measure cell viability, 
especially in studies investigating apoptotic and necrotic cell death pathways. Using 
these two viability assays, we thought that it would be possible to discern the mode of 
cell death. During LSI and before reperfusion morphological analysis revealed that the 
neonatal cardiomyocytes had ceased contracting. This was probably due to ATP 
depletion as a function of the hypoxic model, however, it is interesting to note that LDH 
release is nearly the same as control and metabolic activity is higher prior to 
reperfusion. Upon reperfusion metabolic activity drops and LDH release increases and 
even though metabolic activity is lower than during LSI, cardiomyocyte contraction is 
re-initiated. These observations can be explained by the findings of Gomez and 
colleagues. 148 They noticed that in MTT analysis of cardiomyocytes cells subjected to 
hyperkalemic solutions, there is a conservation of energy through cell membrane 
depolarization resulting in reduced cell viability in hypoxic conditions. They then go on 
to speculate this is the same protection afforded to cardiomyocytes by cardioplegic 
solutions. However, our data demonstrates that mitochondrial membrane potential 
levels in Chapter 3 have always been high in LSI in comparison to LSI/R and therefore 
does not agree with their statement.
Mitochondrial isolation was an essential requirement in numerous Chapters in this 
thesis. In Chapter 5 in order to isolate interfibrillar mitochondria (IFM), a protease 
nagarse, which is specifically able to isolate IFM that is located between the myofibrils, 
was used. 196 Subsarcolemmal mitochondria (SSM) are located beneath the plasma
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membrane and are easily isolated by mechanical disruption of the tissue. Throughout 
this thesis, generally to isolate mitochondria, mechanical disruption, using a polytron 
processor, and a series of differential centrifugation was used. Purity of isolation was 
ascertained with the use of various Western blot antibodies or electron microscopy. In 
conjunction with other isolation protocols, a discontinuous Percoll density gradient 
could also be used to further separate out non-mitochondrial components such as cell 
membranes, myelin and other cellular debris from the isolated mitochondria. As well as 
using electron microscopy, proton import into mitochondria using malate 
dehydrogenase, measurement of Ai|/m and state 3 and 4 respiration rates using glutamate 
and malate as substrates. These methods would help to assess isolated mitochondrial 
integrity and function and thus confirm purity of these isolations.
8.2.5 Molecular Biology Assays
These techniques were predominantly used in Chapter 7 to prepare CyP-D for 
transfection. CyP-D was initially subcloned into pBluescript cloning vector which 
possesses many restriction enzyme site enabling CyP-D to be easily subcloned into 
expression vectors pcDNA3 and pcDCAG ready for transfection. All of the techniques 
described in Chapter 2 were all common molecular biological procedures that were 
performed in the laboratory of Dr Richard Heads at the Rayne institute.
Western blot was used throughout the present studies described in this thesis to measure 
protein expression levels. Various protein concentrations were loaded onto agarose gels 
and running parallel commaisse gels checked equality of protein loading. Wherever 
possible positive controls were also used.
8.3 Discussion of Thesis
The LSI/R model was employed in Chapter 3 to investigate the following hypotheses:
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• As CyP-D binding to the ANT-VDAC complex increases with 
increasing oxidative stress and the integral PPIase activity induces a 
conformational change to form the MPTP, this may be detectable as an 
increase in PPIase activity or protein expression.
• As the duration of ischaemia increases, more and more cells will die by 
necrosis rather than apoptosis
The data presented in Chapter 3 is consistent with the second proposed hypothesis and 
has enabled the characterization of the LSI/R model. In assessment of the mode of cell 
death in LSI/R, it was observed that at lower ischaemic time points, apoptotic cells were 
detected in the supernatant but cell death was totally necrotic in the monolayer and 
supernatant. As the duration of LSI/R increased cell death increased in the supernatant 
and monolayer to 100% of which the cells were totally necrotic. Apoptosis was detected 
in 3 hour ischaemic and reperfused as well as in the 1 hour ischaemic and reperfused 
samples as determined by ultrastructural analysis and viability assays.
The determining factor in the severity and mode of cell death is the duration of 
ischaemia. This statement is in agreement with work done by other authors. They 
argue that apoptosis is an event which is prone to occur in every cell. However if the 
subroutines or controlling factors are altered then necrosis occurs. To this end, Leist 
gives a cogent argument in favour of this proposal, as he believes that necrosis can be 
represented as aborted apoptosis. 258 A controlling factor is believed to be the severity of 
the insult, which in turn affects ATP energy levels. As was observed by the experiments 
in Chapter 3 when the severity of LSI/R was altered, although to complete the story 
ATP levels need to be measured in the experiments in Chapter 3. Other studies have 
demonstrated the effect of manipulating ATP levels which has been proven to determine 
the mode of cell death.172,259,260 During IR, apoptosis is observed in the heart that has 
experienced less severe insults such as in the tissue surrounding a myocardial infarction. 
159 It has also shown here that the same insult can produce either form of cell death as 
has been reported elsewhere.172,258 The results obtained from this chapter recapitulate 
previous work of Taimor and co-workers who also had similar results. They used
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simulated ischaemia/reperfusion to determine if cell death was predominantly necrotic 
or apoptotic except they used adult cardiomyocytes. 160 Analysis of HSP10, HSP60, 
HSP75 and cyclophilin revealed no difference in protein levels in comparison to their 
controls as accessed in primary rat neonatal cardiomyocytes. However, HSP70 protein 
expression increased with the progression of LSI/R reaching a peak at 3 hours LSI and 
24 hour reperfusion. It is also interesting to note that HSP70 protein expression reached 
a maximum level at 3 hours LSI/R but decreased at 6 hours LSI/R. There may be a 
correlation with increasing necrotic cell death and decreasing protein expression and 
other previously discussed factors, but this was not explored in this Chapter.
The discovery of apoptosis in heart disease 159 has also shed a new light on cell death in 
many different pathophysiological situations, possibly offering other ways to deal with 
heart disease. It has been thought to be a contributory factor for heart failure following 
coronary artery occlusion. 197 The regulation and mechanisms involved in apoptosis are 
still not fully understood and many reports doubt the validity of current methods used to 
identify apoptosis. 261 The results from the electron microscopy data correlate with those 
of the cell viability assays, MTT and LDH. Apoptosis and necrosis has been observed in 
this model, but the causative factors need to be investigated. Reactive oxygen species 
(ROS) or free radicals are known to occur during reperfusion of ischaemic tissue. 
Ideally further experimentation could involve using flow cytometry in conjunction with 
a ROS dye such as 2', T  -dichlorodihydrofluorescein diacetate (H2DCFDA), to measure 
ROS in this model. ROS activity may be partly responsible for the decreases in viability 
observed at some of the MTT and LDH assay time points. It was Bolli and colleagues 
who discovered that major free radical species such as O2’, H2O2 and OONO " are 
generated during the first few minutes of reperfusion and contribute to reperfusion 
injury. 263 These free radical species generated upon reperfusion, exacerbate the 
deleterious effects of Ca2+ accumulation in the ischaemic mitochondrion. Recent 
reports state that hypoxia is known to increase ROS generation in isolated mitochondria. 
264 It is clear that calcium sequestration and production of ROS species go “hand in 
hand”. The source of the reported ROS has been proven to be the mitochondrion 
42,221,243,265,266 wj^cj1 js ajso the target of the ROS resulting in mitochondrial damage.
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This was manifested as depolarization of Avj/m and eventually led to cell death.42,243 
Using inhibitors of specific sites of the mitochondrial electron transport such as 
rotenone and myxothiazol may help to confirm that the source of ROS in this chapter is 
the mitochondrion.
This first hypothesis was proposed as it has been observed that increased oxidative 
stress increases binding of CyP-D to the ANT,140,142 coupled with the fact that CsA does 
not inhibit or completely inhibit binding of CyP-D to the ANT-VDAC 
complex.171,267,268 This has been observed in conditions of high Ca2+ where it is 
speculated that the pore forms without the need for CyP-D binding to the ANT. 55 
Moreover, increased binding occurs as PPIase activity of CyP-D causes a 
conformational change in the ANT complex to form MPTP. Presumably with the 
increased binding there may be an increase in PPIase activity. However, in the PPIase 
activity experiments performed in Chapter 3 there was no statistically significant change 
in PPIase activity as oxidative stress increased. There were no observable differences in 
PPIase activity of cyclophilin between the control, LSI and LSI/R samples.
The LSI/R model used in Chapter 3 was also used to precondition rat neonatal 
cardiomyocytes in Chapter 4. The aim of this Chapter was:
• To investigate the role of cyclophilins and heat shock proteins in ischaemic 
preconditioning.
In Chapter 4 the protective role of HSP’S in delayed preconditioning was investigated. 
In this study HSP10, HSP60 and HSP75 protein levels remained constant in the model 
used. Other data from PPIase activity and protein expression indicated that cyclophilin 
activity and expression did not change. Instead, HSP70 expression was elevated after 1 
hour simulated ischaemia (SI) and 24 hours reperfusion. This correlates with the time 
course needed to induce protection against LSI/R and we suggest that HSP70 may be a
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contributory factor in the observed protection afforded to rat neonatal cardiomyocytes 
against LSI/R that was able to preserve A\|/m. This is not surprising as the presence of 
heat shock proteins are known to protect against cell death, but the protection observed 
may depend on the model systems.225,269,270 The involvement of HSP’s in IPC has not 
been fully elucidated. They are more commonly associated with delayed 
preconditioning, although HSP27 and ap-crystallin have been associated with the so- 
called classic or early ischaemic preconditioning. 271 The application of IPC to clinical 
situations is impractical as described in Chapter 4. A more practical method employs 
the use of drugs that can mimic these effects (pharmacological preconditioning). 
Doxorubicin was used to pharmacologically precondition liver against IR. Nitric oxide 
(NO) donors can be used as pharmacological agent especially as NO has been 
implicated in the late phase of preconditioning. As a consequence of this, they were 
used as described in Chapter 5 to pharmacologically precondition H9c2 embryonal rat 
heart derived cardiomyocyte cell line. The experiments in Chapter 5 were based on the 
proposal that:
1) NO induced cyclophilin and HSP70 contribute to protection against ischaemia/ 
reperfusion injury; 2) NO donors confer protection against oxidative stress by 
modulating A\|/m.
thNO donors have been used in cardiovascular therapeutics since the 19 century because 
they have direct vasoactive effects resulting in their usage to treat heart disease. Some 
of these compounds when applied to biological systems spontaneously release NO 
(while others need to be metabolised) that can substitute an endogenous NO limitation.
979 The choice of NO donor was based on previous results using SNAP (abstract from 
Cold Spring Harbour Meeting, 1998), as it is the donor of choice for many 
researchers.120,224,225,273'277 The proposal or hypothesis was not wholly disproved, as NO 
did modulate A\\fm in protection against oxidative stress possibly due to the induction of 
HSP75. The late preconditioning effect of SNAP is comparable to doxorubin-induced 
protection. The mechanism was believed to involve generation of ROS, which in turn 
initiated a stress response. 194 This is similar to another report in which free radical 
species effect demonstrated delayed protection in a rat LAD model. The mechanism
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was believed to involve upregulation of HSP’s as well as antioxidants. 98 SNAP belongs 
to the group of NO donors known as the s-nitrosothiols (RSNOs) that require trace 
amounts of transition metal ion for decomposition, 273 thereby yielding NO and 
NO+ 272’278 presence 0f  fi-ee radicals can increase the production of NO release 
during hypoxia 273 and in this report its toxicity was also increased. Toxicity could be 
due to the NO+, or from the reaction of NO with O2 ' to form H2O2 and OH' via the 
Haber -  Weiss reaction or peroxynitrite (OONO') resulting in cell damage. 120 There are 
many reports concerning the cytotoxicity of n o ,219’222,273,279’280 as well as reports 
demonstrating the protective effects of n o .220,225,277,281,282 The balance between 
cytotoxicity and cytoprotective activities of NO are very ill defined and depend on the 
concentration of exogenous NO application as well as the cell or tissue type used. Most 
causes of cytotoxicity reside around inhibition of mitochondrial respiration at sites I, II, 
IV and aconitase.120,127,205,280 The severity of damage was a determinant in whether cell 
death was by apoptotic or necrotic pathways, thereby confirming the ATP dependence 
on cell-mediated death. In chick embryo heart cells, SNAP resulted in s-nitrosation of 
caspases in the presence of N -Acetylcysteine (NAC), which prevents glutathione (GSH) 
depletion, thereby inhibiting apoptosis. However if NAC is removed, necrosis ensues. 
Low concentrations of NO may inhibit the MPTP by the action of NO stimulating Ca 
efflux from mitochondria.61,284 NO administration has resulted in HSP production in
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endothelial cells, demonstrating protection against oxidative stress. Xu and 
colleagues discovered that exogenous NO induced HSP70 in vascular smooth muscle 
cells via activation of the heat shock transcription factor 1 (HSF1). They provided 
evidence that the presence of denatured proteins as a result of NO damage initiated a 
stress response, activating HSF1 and thereby inducing HSP70 production. 224 Kim and 
co-workers also determined that via a cGMP mechanism, NO induced HSP70 expressed 
which conferred protection against tumour necrosis factor-a (TNF-a) mediated 
cytotoxicity in rat hepatocytes. A previous report by the same group showed that 
upregulation of HO-1 by a low dose of NO was protective against oxidative stress. They 
used cycloheximide to prove this, but have not discussed the presence of other heat 
shock proteins in the observed delayed protection. As de novo HSP synthesis is a 
feature of delayed protection, in Chapter 4 we set out to illustrate that in the in vitro 
models using different cycles of ischaemia and reperfusion, protection against a more
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lethal stress could be induced by preconditioning cells. In Chapter 6, addition of NO 
displayed late protection against oxidative stress. The resistance displayed in these 
chapters against oxidative stress was in part due to upregulation of HSP75 and maybe 
HSP27.
To date IPC has been demonstrated to occur in all species in which it has been tested; 
however the mechanisms vary from species to species and its clinical relevance has 
always been questioned. Yellon and co-workers demonstrated Ischaemic 
preconditioning in human biopsy samples.78 Alkhulafi proved that it was possible to 
induce preconditioning in patients prior to coronary artery bypass grafting (CABG) . 
There were various other studies which used human cells, biopsies to investigate IPC in 
humans; 181,286 however eliciting IPC by ischaemia is not a practical method in humans. 
The purpose of IPC studies is to develop drugs that can be used to induce chronic 
resistance in humans towards myocardial ischaemia. In Chapter 6, SNAP an NO donor 
was successfully used to precondition rat cardiomyocyte cells. Exogenous 
administration of NO donors is the backbone of a diverse field of pharmacotherapeutics 
used in cardiovascular medicine. Lessar and co-workers using nitroglycerin, have been 
able to mimic late preconditioning in patients, 287 demonstrating that as the mechanisms 
of IPC are elucidated then improved drugs can be developed.
In Chapter 5, subsarcolemmal (SSM) and interfibrillar (IFM) mitochondria were 
isolated from normal and ischaemically reperfused rats in order to evaluate:
• The Avj/m in the different groups in comparison to their respective controls
• Heat shock protein expression in SSM and IFM
• Any ultrastructural differences.
In this present study on SSM and IFM, an LAD occluded rat model was used to mimic 
myocardial ischaemia/ reperfusion. There were no observed differences in mHSP 
expression between SSM and IFM in the individual groups or in respect to the controls.
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Electron microscopy did not reveal any morphological differences. However, there was 
a statistically significantly decrease in Av|/m in SSM and IFM from rats subjected to 90 
minutes LAD occlusion and 15 minutes reperfusion. SSM from 60 minute LAD 
occluded and 15 minute reperfused samples were statistically significant.
Isolation of the individual mitochondrial populations for SSM employed the use of a 
polytron tissue processor to homogenise tissue and differential centrifugation, which 
isolates SSM from the sarcolemma, just below the plasma membrane. IFM is obtained 
by application of protease treatment of the washed polytron pellet with Nagarse and 
differential centrifugation, which release the mitochondria from the myofibrils. These 
methods were originally devised by Palmer and colleagues 196 and are generally used to 
isolate SSM and if m .200,202,206,2 15,249,288 These mitochondria are not identified by 
ultrastructural differences but by their location and biochemical properties 196. The 
differences are listed on the following page in Table 8-1.
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Figure 8-1. Differences between SSM and IFM
This table demonstrates the differences between subsarcolemmal (SSM) and 
interfibrillar mitochondria (IFM) reported from a number of different centres. > = 
increase or greater.
SSM IFM Reference:
^  Oxidative rates
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>HSP60 and HSP75 ^Im port of proteins
202,215
>  Accumulation of Ca2+ 
when muscle potentiated
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>  Aging decrease oxidative 
activity
198,200
>A\|/m
249
In mitochondria isolated from skeletal muscle, import rates of precursor proteins were 
greater in IFM even though SSM had higher levels of the mitochondrial chaperone 
proteins HSP60, 10 and 75. The increase in protein import was attributed to the greater 
ATP levels in IFM. This was confirmed when ATP levels in the subfractions were 
equalised and the rate of protein import in both were similar. As a result of these 
observations this group (Takahashi et al) states “ mitochondrial heterogeneity within a
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cell type can be due to differences in the rates of protein import”. 202 This is quite a 
reasonable statement as mitochondrial DNA is not able to encode all the proteins it 
requires so it is reliant on importing them. The same group also reported an increase in 
mitochondrial import of the protein malate dehydrogenase in response to increased 
chronic contractile activity. This resulted in an increase in mitochondrial HSP60, 
HSP70, and the outer membrane receptor Tom 20 levels. There was also a notable 
increase in cardiolipin, which along with the other factors occurred in both sub­
fractions, although protein import was higher in IFM. 215 Another investigator 
determined that in rats subjected to endurance training, there is a differential response of 
skeletal muscle mitochondrial subsets in oxidative capacity that is dependent on the 
substrate metabolised. IFM generally possess a limited adaptability in modulating 
oxidative capacity. This led to the hypothesis that the less oxidative SSM lie adjacent to 
the plasma membrane thereby allowing a gradient of oxygen and substrate transport into 
the IFM lower region of the cell. 249
Increased oxidative capacity, confirmed by increased cytochrome oxidase activity, 
results in a high proton motive force in IFM. Because the proton motive force generates 
Av|/m, IFM possess higher Av|/m than SSM. 288 This does not correlate with the observed 
Av|/m in Chapter 6; SSM Avj/m was lower than IFM but only after subjection to IR. It is 
interesting to note that in the majority of mitochondrial studies, SSM mitochondria are 
isolated by mechanical shearing techniques. Only enzymatic digestion releases IFM. 
Studies on mitochondrial physiological aspects such as aging and protein import have to 
consider these subpopulations. In the article by Craig and Hood, they found that ageing 
did not affect these parameters, but their mitochondrial isolation procedures may have 
released SSM only which do not demonstrate ageing affects whereas they should have 
isolated IFM also. 289
Ever since cyclophilin-D (CyP-D) was confirmed to be the PPIase present in the 
mitochondrial matrix,52,290 its association with the MPTP has been suggested to be 
deleterious to the cell as it occurs in cell death.41,52 The final chapter discusses a 
transfection procedure, which aimed to elucidate the role of CyP-D in cell death by 
myocardial IR. This chapter is based on the hypothesis:
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• Overexpression of CyP-D may confer protection, as cyclophilins are molecular 
chaperones.
The null hypothesis states that as:
• CyP-D is an important component of MPTP and as such is associated with cell 
death, overexpression may enhance the formation of MPTP and leads to death 
of the cell.
A novel transfection protocol was employed which used a novel non-viral integrin 
targeting peptide moiety that had been proven to possess high transfection 
efficiency.138,233,291 Green fluorescent probe (GFP) demonstrated good transfection 
efficiency (~50%). However, overexpression of CyP-D was not detected by Western 
blot, but PPIase activity assay registered a statistically significant increase as opposed to 
controls in all cell types tested irrespective of expression vector used. It is concluded 
that the transfection worked but due to the use of a non-specific antibody 
overexpression was not detectable by the classic means of Western blot, but CyP-D 
overexpression was visualised by an increase in PPIase activity by use of a specific 
CyP-D peptide.
Controversy exists over the components of the MPTP. Crompton and colleagues 
suggest that it is composed of VDAC, ANT and CyP-D, a view supported by other 
authors. 50 In order to verify this they constructed a fusion protein of glutathione S- 
transferase (GSH) and CyP-D. This was combined with purified VDAC and ANT to 
reconstitute the MPTP that on addition of Ca2+ and phosphate opened and although 
CsA blocked the pore they could not remove it once it was bound. They however were 
not convinced that these experiments confirmed the nature of the pore 
components.157,267 Halestrap has been unable to find evidence for the existence of 
VDAC. He suggests that MPTP is composed of CyP-D and ANT and as such also 
employed a GST/CyP- D fusion protein to investigate this. In his reconstituted pore, 
CyP-D bound tightly to ANT and CsA prevented binding as opposed to Crompton’s
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experiment in which CsA did not prevent binding. These differences in results were 
ascribed to the different protocols used. 292 It is interesting to note that under conditions 
of elevated Ca2+ CsA does not inhibit pore formation. This proves that CyP-D is not an 
absolute requisite for the opening of the MPTP. It is thought that cis trans 
isomerisation around a proline bond causing a conformational change that sensitises the 
pore to components that induce pore formation. Rather, it seems that this step can be 
bypassed and binding of CyP-D serves to enhance MPTP opening. 143 This is in 
agreement with other authors who argue about the involvement of PPIase activity in 
pore formation. 293 Bauer and co-workers 56 screened an expression library for 
dominant apoptosis-inducing genes. Overexpressing ANT-1 in various cell lines 
resulted in spontaneous apoptosis. Overexpression of ANT-2 was perfectly innocuous. 
Interestingly co-transfection of CyP-D repressed apoptosis. These protective 
characteristics of CyP-D were evident in another report where the author demonstrated 
that transfection of CyP-D protected against apoptosis via a PPIase dependent 
mechanism. 143 This recent report by Lin and Lechleiter 118 best describes what was 
attempted in Chapter 7 of this thesis. None of the vectors used were able to demonstrate 
overexpression by the classical method of Western blotting in Chapter 7. However, it is 
interesting to note that cells transfected with the CyP-D insert, irrespective of the vector 
used, demonstrated a significant increase in PPIase activity. Based on these results it 
seems probable that we may have successfully overexpressed CyP-D. However, 
viability assays did not demonstrate any significant protection afforded to the CyP-D 
transfected cells. This may indicate that although overexpression of CyP-D as 
determined by PPIase activity was successful, it may seem that in our model, this CyP- 
D insert does not afford protection in the cell models tested in Chapter 7 against lethal 
ischaemia and reperfusion as determined by MTT and PI viability assays. Further 
studies could involve the use of more flow cytometry based assays to measure 
differences in A\j/m between CyP-D transfected and non-transfected cells subjected to 
lethal ischaemia and reperfusion.
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8.4 Final Conclusion
This thesis has been very challenging in its attempt to define a role for cyclophilin in 
progression of myocardial ischaemia reperfusion injury. It has employed the use of 
various in vitro and in vivo models that has resulted in some interesting data, which has 
generated far more questions than have been answered. Most notable were the large 
increases in PPIase activity of the transfected cells. In all other experiments, no change 
in PPIase activity was observed. Cyclophilins are the subject of an emerging science. 
They are generally thought of as being detrimental to the cell but in some instances are 
regarded as survival factors.56,143 The studies described in this thesis focused on CyP-D, 
but there is emerging interest in cyclophilin A and B (CyP-A and CyP-B). CyP-A has 
been reported to be produced by vascular smooth muscle cell (VSMC) in response to 
ROS production. 294 Other authors have implicated CyP-A in caspase activation 295 and 
CyP-A and CyP-B in rheumatoid arthritis, HIV infection and inflammation. Their 
involvement it seems arises from their inherent PPIase activity that has been speculated 
to induce signalling and chemotactic response in T-cells, 296 which is a change from its 
putative role as a molecular chaperone. 297 The role of heat shock proteins was also 
investigated (specifically the mitochondrial chaperone complex) in order to ascertain 
protective functions under various conditions (as described in the previous chapters), 
perhaps in conjunction with cyclophilin relating to cardiac protection. Most recently 
research on the molecular chaperones is now investigating the role of heat shock 
proteins in the activation of the immune system. 298 Indeed, interest in this field is 
burgeoning, as it may be relevant to many pathological conditions.
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